Affective symptoms over the life course and cognitive ageing by John, Amber
   
 
A University of Sussex PhD thesis 
Available online via Sussex Research Online: 
http://sro.sussex.ac.uk/   
This thesis is protected by copyright which belongs to the author.   
This thesis cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the Author   
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the Author   
When referring to this work, full bibliographic details including the 
author, title, awarding institution and date of the thesis must be given 
Please visit Sussex Research Online for more information and further details   
1Affective symptoms over the life course
and cognitive ageing
Amber John
Thesis submitted for the qualification of Doctor of Philosophy in Psychology
University of Sussex
July 2019
2STATEMENT
I hereby declare that this thesis has not been and will not be, submitted in whole or in
part to another University for the award of any other degree.
Signature: ………………………………. Date: ……………………
3DECLARATION
The thesis conforms to an ‘papers style format’ in which chapters 2 to 6 report
empirical work written in a style that is appropriate for publication in peer-reviewed
journals in the field. The first chapter is a general introduction outlining the existing
literature and summarising the work undertaken in this thesis. The final chapter presents
discussions of the field and the research undertaken.
Study 1 is published in Psychological Medicine as:
John, A., Patel, U., Rusted, J., Richards, M., & Gaysina, D. (2018). Affective problems
and decline in cognitive state in older adults: a systematic review and meta-analysis.
Psychological Medicine, 49(3), 353-365.
The author contributions are as follows: Amber John was responsible for initial
conception of the research, conducting the systematic literature review, data analysis,
writing and editing the manuscript. Urvisha Patel was responsible for assisting with
aspects of the systematic search and for providing feedback on the manuscript. Jennifer
Rusted, Marcus Richards, and Darya Gaysina were responsible for initial conception of
the research and providing feedback on the study design and manuscript.
Study 2 is published in the Journal of Affective Disorders as:
John, A., James, S. N., Rusted, J., Richards, M., & Gaysina, D. (2019). Effects of
affective symptoms in adolescence and adulthood on trajectories of cognitive function
from middle to late adulthood. Journal of Affective Disorders, 259, 424-431.
The author contributions are as follows: Amber John was responsible for initial
conception of the research, data cleaning and analysis, writing and editing the
manuscript. Sarah James was responsible for assisting with some aspects of data
4analysis and providing feedback on the manuscript. Jennifer Rusted, Marcus Richards,
and Darya Gaysina were responsible for initial conception of the research and providing
feedback on the study design and manuscript.
Study 3 is under revision in the Aging and Mental Health.
The author contributions are as follows: Amber John was responsible for initial
conception of the research, data cleaning and analysis, writing and editing the
manuscript. Jennifer Rusted, Marcus Richards, and Darya Gaysina were responsible for
initial conception of the research and providing feedback on the study design and
manuscript.
Study 4 is published in the British Journal of Psychiatry (BJP) as:
John, A., James, S. N., Patel, U., Rusted, J., Richards, M., & Gaysina, D. (2019).
Longitudinal associations of affective symptoms with midlife cognitive function:
evidence from a British birth cohort. British Journal of Psychiatry.
The author contributions are as follows: Amber John was responsible for initial
conception of the research, data cleaning and analysis, writing and editing the
manuscript. Sarah James was responsible for providing feedback on the manuscript.
Urvisha Patel was responsible for some aspects of study design and providing feedback
on the manuscript. Jennifer Rusted, Marcus Richards, and Darya Gaysina were
responsible for initial conception of the research and providing feedback on the study
design and manuscript.
Study 5 is published in Brain Behavior and Immunity as:
5John, A., Rusted, J., Richards, M., & Gaysina, D. (2020). Accumulation of affective
symptoms and midlife cognitive function: The role of inflammation. Brain, Behavior,
and Immunity, 84, 164-172.
The author contributions are as follows: Amber John was responsible for initial
conception of the research, data cleaning and analysis, writing and editing the
manuscript. Jennifer Rusted, Marcus Richards, and Darya Gaysina were responsible for
initial conception of the research and providing feedback on the study design and
manuscript.
6SUMMARY
Affective symptoms over the life course and cognitive ageing
Affective symptoms, such as depression and anxiety, are commonly comorbid
with dementia. Estimates report that up to 40% of people with dementia also present
with symptoms of depression. Research has also shown that a longitudinal association
between affective symptoms and cognitive function may exist over time. However, the
majority of research has focussed on older samples (aged 60+ at baseline) with short
periods of follow up (<10 years). Less is known about how the association between
affective symptoms and cognitive function operates over a longer period of time,
including much earlier in the life course. The studies within this thesis aim to test the
nature of this complex association, using a life course approach.
The first study in this thesis used a systematic review and meta-analysis method
and concluded that depression in older adulthood was associated with a faster
subsequent cognitive decline. The second study used secondary data from the National
Survey of Health and Development (NSHD), a nationally representative birth cohort of
over 5,000 people born in England, Scotland and Wales, during one week of 1946. This
study found that adolescent, but not adult, affective symptoms significantly predicted
poorer baseline memory and information processing speed scores, but not rate of
decline over time. The third study also used data from NSHD to test bidirectionality
between affective symptoms and cognitive function. This study found that affective
symptoms significantly predicted subsequent level of memory and processing speed
over a 16 year period, but that this association did not operate in the opposite direction.
The fourth study used data from the National Child Development Study (NCDS), a
population representative birth cohort of over 18,000 people born in England, Scotland
and Wales, during one week of 1958. This study revealed that accumulation of
7persistent affective symptoms was a better predictor of midlife memory function than
sensitive periods. The fifth and final study in the thesis also used data from NCDS to
explore inflammation as a potential mediator in the association between affective
symptoms and cognitive function. This study showed that C-Reactive protein (CRP)
fully explained the association between adult affective symptoms and memory function,
suggesting that inflammation is an important explanatory factor of this relationship.
Taken together, these findings suggest that chronic and persistent affective
symptoms across the life course play an important but complex role in contributing to
cognitive function across mid to later life, with particularly strong effects observed on
memory function. In addition, inflammation may be one important explanatory
mediator of the association between affective symptoms and midlife memory function.
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CHAPTER 1
General Introduction
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The general introduction provides a brief overview of cognitive function and
cognitive ageing, including definitions of key terms used throughout the thesis, societal
and economic costs of cognitive ageing, and the importance of using a life course
approach to study this phenomenon. Secondly, the introduction reviews evidence
regarding associations between affective symptoms and cognitive ageing, including
literature surrounding the nature of this association, primary hypotheses proposed to
explain such associations, and plausible biological and social mechanisms which can
potentially underlie this association. Finally, the primary overarching aims of the
research in this thesis are outlined, and the specific objectives and methods used for
each empirical chapter (Chapters 2-6) are also provided.
1.1. Cognitive function and cognitive ageing
1.1.1. Definitions.
Cognitive function encompasses many different but inter-related processes,
including memory (working memory and long term memory), information processing
speed, attention, executive functioning, and many others. These key cognitive domains
are outlined and defined below.
Memory comprises multiple different components. Working memory refers to
the active manipulation or reorganisation of information held in the short term memory.
Long term memory is a multidimensional construct, which encompasses different
functions, including episodic, semantic, procedural, and prospective memory (Glisky,
2007). Episodic memory refers to memory for specific events and experiences, with
contextual information playing an important role. Semantic memory is memory for
general knowledge, including abstraction such as what words mean. Episodic and
semantic memory are both declarative functions, as they are explicit rather than implicit.
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Procedural memory is implicit memory for acquired skills, such as riding a bike.
Prospective memory refers to memory for the intention to complete future tasks.
Memory function is important for effective everyday functioning, and memory loss can
cause considerable distress and anxiety (Vinkers, Gussekloo, Stek, Westendorp, & van
der Mast, 2004).
Information processing refers to how information is taken in, made sense of, and
responded to. Information processing speed is the pace at which these processes are
completed, and reflects the efficiency of cognitive performance. Information processing
speed may underlie efficiency of other cognitive domains (Salthouse, 1996), and as
such this cognitive domain is particularly important for effective daily functioning.
Attention is involved in some form in many other cognitive domains and
processes and refers to the capacity for processing information in the environment
(Glisky, 2007). Attention comprises multiple sub-processes specialised for different
functions, including selective attention, divided attention, and sustained attention.
Selective attention refers to the ability to attend to relevant stimuli in the environment,
while simultaneously ignoring irrelevant stimuli. Divided attention, also known as
multitasking, refers to the ability to process two or more competing stimuli
simultaneously. Sustained attention is the ability to maintain focus on a stimulus over a
period of time. This requires both the ability to focus on the task (concentration) and
the ability to monitor the appearance of a stimulus (vigilance). Attention is particularly
important for the effective functioning of other cognitive domains.
Executive function is important in goal-directed activities, and consists of a
range of complex processes, including planning, organising, and evaluating behaviours.
It is the capacity to control and monitor behaviour and subsequently adjust responses on
19
the basis of environmental cues. Effective executive functioning is necessary for
decision making and planning, correcting errors, solving novel problems, and inhibition
of responses. Higher executive functioning predicts better quality of life (Brown &
Landgraf, 2010; Davis, Marra, Najafzadeh, & Liu-Ambrose, 2010), and greater success
in school (Borella, Carretti, & Pelegrina, 2010; Duncan et al., 2007; Gathercole,
Pickering, Knight, & Stegmann, 2004) and work (Bailey, 2007).
Finally, overall cognitive state refers to a composite assessment of overall
cognitive functioning. This is usually derived as a composite score combining a
selection of cognitive domains, representing an individual’s global cognitive state.
Overall cognitive state is important to study, because low scores on tests of cognitive
state have been shown to predict functional impairment and dependence (Gill, Williams,
Richardson, & Tinetti, 1996; Wang, Belle, Kukull, & Larson, 2002). Overall cognitive
state is described in more detail in the first empirical chapter of this thesis (chapter 2).
These cognitive functions follow distinct developmental patterns across the life
course, with rapid cognitive development occurring in the first five years of life, and
continuing to increase through to early adulthood (Richards & Hatch, 2011). There are
two distinct categories of cognitive functions which follow different developmental
trajectories from early adulthood to later life. Crystallised cognitive function refers to
the ability to use skills and acquire knowledge, and encompasses general knowledge,
vocabulary, and numerical abilities. These crystallised cognitive functions are resistant
to age-related cognitive decline, and can improve with age from early adulthood
through to later life as a result of lifelong learning (Anstey & Low, 2004). In contrast,
fluid cognitive function is independent from pre-existing knowledge or experience
(Anstey & Low, 2004). Fluid cognitive functions include memory, information
processing, executive function and attention. These processes are particularly sensitive
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to age-related cognitive decline, which can be observed from relatively early in the life
course, from early to middle adulthood onwards (Salthouse, 2009; Salthouse, 2004).
Cognitive ageing is characterised by decline in these fluid functions over time; however
the extent and rate of decline is highly variable between individuals. This can range
from mild age-related cognitive change, through to mild cognitive impairment, through
to clinically diagnosable conditions that impact cognitive functioning, such as dementia.
It can be challenging and complex to distinguish between normative and pathological
ageing along this cognitive continuum (Brayne, 2007). In this thesis, particular attention
will be paid to overall cognitive state, memory and information processing speed, and
the life course factors which can be associated with these domains.
1.1.2. Societal and economic costs of cognitive ageing.
Due to population growth and increasing life expectancies, the proportion of
older adults in the UK population is rising (ONS, 2017). Cognitive ageing is therefore a
social and healthcare priority in the UK. It is estimated that there are 850,000 people
living with dementia in the UK, and this is projected to increase (Prince et al., 2014).
Poorer cognitive ageing outcomes have a considerable detrimental impact on
individuals, families and society. This can include negative effects on an individual’s
psychological and emotional health, functional outcomes, social life, and financial state
(Alzheimer's Society, 2018). Poorer cognitive ageing also has profound effects on close
persons, including family and friends, due to emotional stress, burdens associated with
caregiving, and increased financial costs (Dunkin & Anderson-Hanley, 1998; Etters,
Goodall, & Harrison, 2008; Papastavrou, Kalokerinou, Papacostas, Tsangari, & Sourtzi,
2007). Finally, there are also important economic impacts of poorer cognitive ageing on
society. In the UK, approximately 40% of admissions to institutional care are due to
cognitive decline (Deary, Corley, et al., 2009). In the UK, the cost of dementia is
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estimated to be £26 billion (Lewis, Karlsberg Schaffer, Sussex, O’Neill, & Cockcroft,
2014), and this is forecasted to increase to £55 billion by 2040 (Prince et al., 2014).
Given rapid population ageing and the detrimental outcomes associated with cognitive
ageing for individuals, families, society, and the economy, this is increasingly a matter
of great importance for public health.
In the absence of a cure for dementia or any disease modifying treatment,
increasing resources are being invested in preventative methods (Livingston et al.,
2017). It has been estimated that delaying the onset of dementia by just one year has the
potential to reduce worldwide incidence by 9 million cases over the next 4 decades
(Barnes & Yaffe, 2011). Experimental and epidemiological studies have identified a
range of biological, socio-behavioural and environmental factors which can play an
important role in the pathogenesis of dementia and poorer cognitive ageing outcomes
(Plassman, Williams, Burke, Holsinger, & Benjamin, 2010). Due to the long preclinical
period of dementia, it is of utmost importance to adopt a life course approach in the
identification of potentially modifiable risk factors.
1.1.3. Life course approach to study cognitive ageing.
Cognitive ageing has been studied from a variety of different perspectives,
including socio-behavioural and biomedical approaches. Biomedical approaches to
cognitive ageing address biological mechanisms of cognitive ageing across cellular,
molecular, and physiological levels. For example, advanced modern neuroimaging
techniques can provide insight into neural mechanisms underlying cognitive ageing.
Specifically, structural and functional neuroimaging techniques can develop existing
understanding of neural underpinnings of cognitive impairments in older adulthood and
the role of neuropathology in cognitive ageing across the population spectrum from
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normal cognitive ageing to pathological cognitive ageing (Grady, 2012; Hedden &
Gabrieli, 2004). Related to this, genetic testing is increasingly being used to investigate
variability and individual differences in the ageing process. It has been proposed that
heritability of cognitive function is about 50%, suggesting that more than half of the
variance in adult cognitive function can be explained by genetic factors (Bouchard Jr &
McGue, 2003; Carmelli, Swan, LaRue, & Eslinger, 1997; Finkel, Pedersen, Plomin, &
McClearn, 1998; Mattay, Goldberg, Sambataro, & Weinberger, 2008; Plomin &
McClearn, 2001; Plomin & Spinath, 2002). This is not fixed over the life course, with
evidence showing that heritability of cognitive function is around 30% in early
childhood, rising to 80% in later life (Deary, Johnson, & Houlihan, 2009). Genetics,
therefore, seem to play an important role in cognitive function over the life course. As
such, there is growing interest in studying the genetic underpinnings of cognitive ageing
and how these can develop across the life course. Socio-behavioural methods and
approaches are also commonly used to investigate how lifestyle factors, particularly
those which are potentially modifiable, are associated with individual differences in
cognitive ageing (Barnes & Yaffe, 2011; Livingston et al., 2017). Specifically, this
approach focusses on how demographic, social, and behavioural factors can contribute
to cognitive reserve and promote healthy cognitive ageing.
The life course approach to the study of cognitive ageing is valuable because it
can integrate socio-behavioural and biomedical perspectives. Specifically, the life
course approach highlights lifelong changes or trajectories of cognitive ageing across
individual and system levels. As such, use of the life-course approach can facilitate
integration of multidisciplinary methods in the study of cognitive ageing. Use of a life
course approach allows investigation into how early life determinants and processes
which operate across various life stages can contribute to adult health and ageing
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outcomes (Kuh, Ben-Shlomo, Lynch, Hallqvist, & Power, 2003). The availability of
biological and social information across multiple life stages provides a unique
opportunity to test this, for example by exploring cumulative effects of an exposure
over the life course, joint action of early and later exposures, or sensitive periods of an
exposure on adult health outcomes (Power, Kuh, & Morton, 2013). This life course
approach is particularly useful in the context of ageing, as age-related cognitive decline
is a lifelong process which becomes evident from early adulthood (Salthouse, 2009;
Salthouse, 2004). Additionally, pathological brain changes associated with cognitive
ageing may also become apparent from early adulthood (Salthouse, 2009). As such, it is
important to establish how determinants over multiple periods of life from childhood
through to older adulthood can influence cognitive trajectories, rather than focussing
exclusively on determinants present during later life once cognitive decline and
associated brain changes are already well established.
For this reason, birth cohort data are an important and powerful resource for
addressing these questions. Birth cohort data can contain social, behavioural, and
biomedical data measured longitudinally from birth across multiple life stages. This
facilitates the integration of socio-behavioural and biomedical approaches to study
cognitive ageing across the entire life course. This is important, because results from
birth cohort studies show that focusing on determinants of cognitive ageing only in
midlife or older adulthood may offer incomplete or partial explanations, because early
life factors and trajectories also play an important role in predicting ageing outcomes, as
well as interacting with more proximal health indicators to shape outcomes (Power et
al., 2013). There are four national birth cohorts in Great Britain: 1. National Survey of
Health and Development (NSHD); 2. National Child Development Study (NCDS); 3.
1970 Birth Cohort Study (BCS70); and 4. Millennium Cohort Study (MCS). This thesis
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utilises data from the two oldest British birth cohorts: NSHD and NCDS. NSHD
comprises a representative social-class weighted sample of 5,362 people born during 1
week of 1946. This cohort includes repeated measures of cognitive function in
childhood (ages 8, 11, and 15) and from mid to later adulthood (ages 43, 53, 60-64, and
69), including verbal memory (assessed using word list recall tests) and information
processing speed (assessed using letter cancellation tasks). NCDS includes a nationally
representative sample of 18,558 individuals born during a single week of 1958. This
comprised 98.2% of all births in England, Scotland and Wales during that week.
Cognitive data is available in this cohort in childhood (ages 7, 11, and 16) and midlife
(age 50), including measures of immediate and delayed verbal memory (measured using
word list recall test with an immediate and delayed component), verbal fluency
(measured using animal naming test), and information processing speed and accuracy
(measured using letter cancellation task). Data included in NSHD and NCDS are
complementary and offer a unique opportunity to study life course determinants of
cognitive ageing.
1.2. Affective problems and cognitive ageing
1.2.1. Affective problems: prevalence and socio-economic costs.
Affective problems refer to a set of psychiatric mood disorders, including
depression and anxiety, and their symptoms. The Office for National Statistics (ONS)
reported that 17% of adults in England met the diagnostic criteria for an affective
disorder in 2014 (McManus, Bebbington, Jenkins, & Brugha, 2016). According to
official UK statistics, affective symptoms are prevalent within all age groups, including
in childhood from ages 5-10 (4%), in early adolescence from ages 11-16 (9%), in later
25
adolescence from ages 17-19 (15%), in adulthood from ages 25-64 (18%), and in older
adults age 65+ (9%) (McManus et al., 2016; Sadler et al., 2018).
Mental health problems are the largest cause of disability in the UK, ahead of
both cancer and cardiovascular disease, accounting for 22.8% of total disease burden
(Department of Health, 2011). Specifically, affective disorders are associated with
increased physical morbidity and mortality and have been linked to an increased risk of
dementia (Da Silva, Gonçalves-Pereira, Xavier, & Mukaetova-Ladinska, 2013), stroke
(Surtees et al., 2008), and heart disease (Hemingway & Marmot, 1999). Affective
symptoms in older adults may also be a contributing factor to falls, frailty, and greater
disability (Cronin-Stubbs et al., 2000; Iaboni & Flint, 2013; Strawbridge, Shema,
Balfour, Higby, & Kaplan, 1998). Individuals with affective symptoms also show lower
adherence to management regimes for comorbid physical conditions (Ciechanowski,
Katon, & Russo, 2000; Gonzalez et al., 2008; Krousel-Wood et al., 2010). This results
in more missed medical appointments and more hospital admissions, increasing
associated costs. Economic costs of mental illness are vast in the UK, estimated at
£105.2 billion annually (Department of Health, 2011). This estimate includes direct
costs of health and social care services, indirect costs through reduced quality of life and
poorer physical health, and lost productivity in the workplace (through both
presenteeism and absenteeism). In England, it is estimated that £7.5 billion is spent on
depression and £8.9 billion on anxiety disorders annually, including direct service costs
and lost employment and earnings, but not public services or informal care costs
(Department of Health, 2011). In addition, looking after a loved one with an affective
disorder also brings risks of mental and physical health problems to carers (Shah,
Wadoo, & Latoo, 2010). Poor health in carers is linked with greater use of health and
social care services, such as increased admissions, delayed discharge, or unplanned
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readmission to hospital (Hirst, 2004). As such, protecting mental health is important to
improve quality of life, decrease caregiver burden, reduce demand on NHS services, cut
social and healthcare costs associated with mental health, and increase the number of
people who are able to continue working for longer.
1.2.2. Affective problems and cognitive ageing: state of the art and
methodological limitations.
Research suggests that affective problems, such as depression and anxiety,
frequently occur in individuals with late-life cognitive problems, including dementia
(Potter & Steffens, 2007). Several studies have investigated prevalence rates of
depression in dementia patients, but there is variation in prevalence rates reported.
Approximately 30-50% of people diagnosed with dementia also present with symptoms
of depression (Zubenko et al., 2003), though some studies report much higher estimates
of up to 75% (Jost & Grossberg, 1996). Some evidence suggests that depression in
people with dementia is particularly common during the early stages of dementia, and is
also prevalent once dementia symptoms have become more advanced and at this later
stage is often observed in parallel with agitation symptoms (Lyketsos & Lee, 2004).
In addition to cross-sectional evidence, a growing body of longitudinal research
has found associations between affective problems and cognitive ageing over time.
Several systematic reviews and meta-analyses have been conducted to address this
research question. Specifically, depression has been associated with an increased risk of
developing subsequent dementia (Da Silva et al., 2013; Diniz, Butters, Albert, Dew, &
Reynolds, 2013; Jorm, 2001; Livingston et al., 2017; Ownby, Crocco, Acevedo, John,
& Loewenstein, 2006). For example, Jorm (2001) conducted a review and meta-analysis
of seven case-control and six prospective cohort studies testing associations between the
life history of depression and risk of dementia. The study revealed that depression was
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significantly associated with an increased risk of developing dementia, specifically
concluding that depression approximately doubles this risk.
Additionally, Ownby et al (2006) reviewed nine case-control and eleven cohort
studies with the total sample of 102,172 participants, testing associations between
presence of depression (both retrospectively and prospectively measured) and risk for
developing Alzheimer’s disease. Overall, pooled odds ratios from the meta-analysis
revealed that presence of depression was significantly positively associated with risk for
developing Alzheimer’s disease. Specifically, the odds of developing Alzheimer’s
disease are around two times higher in people with depression than those without. In
addition, meta-regression analyses showed that the interval between diagnosis of
depression and Alzheimer’s disease was positively associated with increased risk of
developing dementia. The authors concluded that depression may act as a remote risk
factor for Alzheimer’s disease, rather than as a prodrome. It is, however, acknowledged
that due to the small number of studies included in the meta-regression analysis, these
results should be interpreted with caution and replicated in future research for
confirmation.
Da Silva et al (2013) conducted a systematic review of 51 case-control and
cohort studies (with the total sample of 464,724 participants) investigating associations
between affective disorders and risk of developing dementia. Overall, this review
concluded that depression is associated with increased risk. The review also reported
that greater severity of affective symptoms at baseline and the frequency of affective
episodes experienced are both associated with a higher risk of dementia. Results
revealed inconsistent evidence regarding how age of onset of depression may affect
dementia risk. Equally, Da Silva et al (2013) reviewed studies which tested sex
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differences in associations between affective symptoms and risk of dementia, but
revealed that the evidence was mixed.
Diniz et al (2013) conducted a systematic review and meta-analysis of 23
population-based prospective cohort studies testing associations between late-life
depression and risk of Alzheimer’s disease (N= 28,746), vascular dementia (N=
14,901), and all-cause dementia (N= 49,612). Results revealed that people with
depression had 1.85 higher odds of developing all-cause dementia, 1.65 higher odds of
developing Alzheimer’s disease, and 2.52 higher odds of developing vascular dementia
then people without depression. In addition, the review concluded that risk for vascular
dementia was significantly higher than for Alzheimer’s disease in adults with
depression during later life. This review did not include studies looking at depression
earlier in the life course, so it is unclear how early onset depression can differentially
affect risk for Alzheimer’s disease and vascular dementia. Integrating these results with
those from Ownby et al (2006), there is evidence that depression in both earlier and later
adulthood may be associated with increased risk of dementia.
Research investigating longitudinal associations between anxiety and dementia
is scarcer than for depression. However, there have been several systematic reviews
aiming to explore these associations (Gimson, Schlosser, Huntley, & Marchant, 2018;
Gulpers et al., 2016). One such review concluded that anxiety symptoms are associated
with an increased risk of incident cognitive impairment and dementia in community-
based samples (Gulpers et al., 2016). In contrast to evidence from Ownby et al (2006),
this review observed strongest associations in later ages. In addition, evidence from a
recent systematic review has shown that clinically relevant anxiety symptoms present
during midlife are associated with increased risk of dementia across a follow up period
of over a decade (Gimson et al., 2018).
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Taken together, these reviews demonstrate that there is reasonably strong
evidence to suggest that depression can increase risk of dementia. In addition to this,
affective disorders have also been shown to increase the risk of progression from mild
cognitive impairment to dementia (Alexopoulos, Young, & Meyers, 1993; Kral &
Emery, 1989; Potter & Steffens, 2007). The number of Alzheimer’s disease cases
attributable to depression is estimated to be 3.6 million worldwide, comprising over
10% of all Alzheimer’s disease cases (Barnes & Yaffe, 2011). A reduction of 25% of
depression cases could potentially prevent as many as 827,000 cases of Alzheimer’s
disease globally (Barnes & Yaffe, 2011).
To date, research has focussed largely on associations between affective
symptoms and dementia, with less attention paid to affective symptoms and cognitive
decline in cognitively healthy older adults. However, this focus on transition to
dementia as an outcome without consideration of cognitive function short of clinically
diagnosable dementia may have methodological flaws. Specifically, there is a long
preclinical period of several decades for dementia. It is therefore possible that
individuals who transition to dementia at follow up may have already had underlying
neuropathological changes indicative of dementia without presentation of clinically
observable symptoms at the baseline assessment. As such, any associations apparent
between affective symptoms and transition to dementia could simply be due to reverse
causality, whereby dementia neuropathology leads to affective symptoms rather than
vice versa.
In addition, evidence has also shown that even before any pathological cognitive
changes, mild cognitive decline can have a substantial impact on both individuals and
society. Specifically, cognitive decline can predict greater functional disability and
dependence in older ages (Millan-Calenti et al., 2012). Additionally, cognitive decline
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remains one of the most feared elements of the ageing process (Deary, Corley, et al.,
2009; Plassman et al., 2010). As such, it is clear that greater understanding of the life
course factors associated with cognitive decline short of dementia is both necessary and
important. A better understanding of associations between affective symptoms and
cognitive ageing over time may be potentially critical for the development of stronger
life course predictive models, which may have important implications for designing
preventative intervention studies.
There have been a few studies investigating associations between affective
symptoms and cognitive decline in healthy older adults, but due to mixed and
conflicting findings as a result of differences in methodology, design, sampling, and
measures used, it is difficult to draw a clear and robust conclusion from this work. Some
research has shown that affective symptoms are associated with poorer cognitive
outcomes and faster cognitive decline (Chang & Tsai, 2015; Chen & Chang, 2016;
Geerlings, Schmand, Braam, & Jonker, 2000; Johnson, Hall, & O’Bryant, 2013;
Paterniti, Verdier-Taillefer, Dufouil, & Alperovitch, 2002; Rajan, Wilson, Skarupski,
Leon, & Evans, 2014; Reyes-Ortiz et al., 2008; Royall & Palmer, 2013). However these
conclusions have not been consistently replicated (Bassuk, Berkman, & Wypij, 1998;
Brailean et al., 2017; Bunce, Batterham, Mackinnon, & Christensen, 2012; Gale,
Allerhand, & Deary, 2012; Ganguli, Du, Dodge, Ratcliff, & Chang, 2006; Neubauer,
Wahl, & Bickel, 2013). There is therefore good reason to hypothesise that affective
symptoms can play an important role in predicting later cognitive function and decline
in cognitively healthy people; however the absence of any systematic synthesis of the
research means that this is still unknown. In addition to this, our understanding of the
nature of this association is also limited. Evidence from previous research suggests that
risk of poorer cognitive ageing outcomes in later life may be proportionate to the
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cumulative effects, symptom severity, or age of onset of affective symptoms. However,
to date limited research has aimed to directly address these questions.
Accumulation of affective problems.
It is possible that the frequency of affective problems over the life course may
influence risk of subsequent cognitive decline and dementia. Paterniti et al (2002)
reported that persistent, rather than episodic, episodes of depression were associated
with cognitive decline. This study, however, only assessed cognitive function at a four-
year follow up, so these findings cannot extend to depressive symptoms present prior to
late life. (Kessing & Andersen, 2004) utilised a case register study design to address this
research question and found that a greater frequency of depressive episodes conferred a
significantly increased risk of dementia. Specifically, there was a 13% increase in rate
of dementia with every depressive episode which resulted in hospital admission.
Additionally there was a 6% increase in dementia rate with every episode of bipolar
disorder. This has also been replicated in a longitudinal study in which participants were
followed for 24.7 years (Dotson, Beydoun, & Zonderman, 2010). Specifically, a
monotonic increase in dementia and Alzheimer’s disease was observed as a function of
the number of depressive episodes over the period of assessment. It was reported that
one episode of depression was associated with an 87-97% increased risk of subsequent
dementia, and two or more episodes resulted in a near doubling of this risk. There have
also been several cross-sectional studies utilising a sample of euthymic phase affective
problem patients, which have reported that the number of affective episodes was
significantly related to severity of cognitive dysfunction (Kessing, 1998; Kessing, Dam,
Jørgensen, & Bolwig, 1996; Tham et al., 1997). These findings suggest that greater
accumulation of episodes over the life course may increase the strength of the
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relationship between affective problems and cognitive ageing, although there has been
some evidence to the contrary.
Timing of affective problems.
Age of onset of affective problems (i.e. early or late-onset specifiers) has been
used to investigate whether affective problems are a real aetiological risk factor for
subsequent cognitive conditions, an early clinical manifestation of dementia
(prodromal), or a psychological reaction to the disease process. Results have been
varied, rendering a straightforward conclusion problematic. Several studies have
presented evidence that late-onset affective problems alone are associated with an
increased risk of cognitive decline (Brommelhoff et al., 2009; Steffens et al., 1997),
while conversely others have reported that early-onset affective problems can increase
this risk (Geerlings, den Heijer, Koudstaal, Hofman, & Breteler, 2008; Pálsson,
Aevarsson, & Skoog, 1999; Speck et al., 1995), with one systematic review showing
that associations are stronger when the interval between depression diagnosis and
dementia is longer (Ownby et al., 2006). Several additional studies have also offered
evidence to suggest that the risk of developing cognitive conditions was increased when
affective problems presented both in years proximal to dementia, and also many years
prior (25 years prior to dementia diagnosis) (Green et al., 2003).
Studies using prospective as well as cross-sectional designs, have investigated
the association between late-life depression and dementia. Several studies reported that
late-life depression was associated with approximately a 2 to 5-fold increased risk of
later dementia (Andersen, Lolk, Kragh-Sørensen, Petersen, & Green, 2005; Byers,
Covinsky, Barnes, & Yaffe, 2012; Chen et al., 2008; Gatz, Tyas, St. John, &
Montgomery, 2005; Saczynski et al., 2010), and Wilson et al (2002) also concluded that
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risk of pathological cognitive ageing increased with each additional symptom of
depression. However, some studies have only reported evidence for an association
between late-life depression and dementia within specific sub-groups, such as in men
only (Fuhrer, Dufouil, & Dartigues, 2003), sub-groups with the APOE4 gene (Irie et al.,
2008), and more highly educated samples (Geerlings et al., 2000). There have also been
two studies which found no association at all (Becker et al., 2009; Lindsay et al., 2002),
although this lack of evidence may have been related to a lack of power in one (Becker
et al., 2009). These contradictory findings across studies may reflect methodological
differences in terms of attrition rates, methods of measuring affective problems, sub-
populations assessed, and definitions or operationalisation of key measures.
Additionally many studies did not specifically report frequency, severity, or duration of
affective episodes.
Research has also begun to use longitudinal methodology to explore the
relationship between earlier-life (defined as before age 60) affective problems and
dementia. Early onset depression has been proposed to be associated with a 2 to 4-fold
increased risk of dementia in late life (Byers & Yaffe, 2011). Dal Forno et al (2005)
analysed depression at multiple pre-set time lengths prior to onset of dementia. They
concluded that depression was associated with a 2-fold increased risk of dementia only
when interval between depression onset and dementia diagnosis was greater than 4
years, suggesting that depression was unlikely to be exclusively a prodromal feature of
dementia. Dotson et al (2010) also examined recurrent depression over several decades,
and concluded that cumulative depression episodes over the life course can increase the
risk of subsequent late-life dementia. Beyond this, Barnes et al (2012) found that age of
onset can have differential patterns of risk depending on dementia sub-type.
Specifically, they reported that depression with an earlier onset and accumulation over
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the entire life course may be associated with an increased risk of vascular dementia,
whereas an increased risk of Alzheimer’s disease may be dependent to a greater degree
on late-life exposure to depression.
Severity of affective problems.
There is also evidence to suggest that greater severity of depressive
symptomology is associated with a higher risk of developing dementia (Saczynski et al.,
2010) and Alzheimer’s disease (Gatz et al., 2005), suggesting that severity is likely to
play an important role within the lifelong relationship between affective problems and
cognitive ageing. Similarly, it was reported in the Cardiovascular Health Study (Barnes,
Alexopoulos, Lopez, Williamson, & Yaffe, 2006) that the presence of a greater severity
of depressive symptoms independently predicted a more than doubled risk of
developing mild cognitive impairment (MCI) after a 6 year follow up. Beyond this, in a
prospective cohort study Yaffe et al (1999) concluded that a greater number of
depressive symptoms was significantly related to increased risk of a dementia diagnosis
after a 4 year follow up. Individuals with 3-5 depressive symptoms were reported to
have a two-fold increased risk of dementia compared with individuals exhibiting 0-2
symptoms. Similarly, individuals who reported 6 symptoms had a three-fold increased
risk of dementia. Wilson et al (2002) reported that for each additional symptom of
depression, global cognitive decline increased by approximately 24% and risk of
Alzheimer’s disease increased by 19% at a 7 year follow up. However, much of this
evidence focuses primarily on late-life depression and limited evidence is available
regarding the influence of severity of affective problems at an earlier stage in the life
course with a longer follow up period (>10 years).
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1.2.3. Affective problems and cognitive ageing: Competing hypotheses.
Three primary hypotheses have been proposed to explain observed associations
between affective symptoms and cognitive ageing. It remains contentious whether
affective problems: 1. act as a real etiological factor for dementia; 2. are an early
prodromal feature of dementia; or 3. share a common cause, e.g. genetic or
neurophysiological.
It has been proposed that affective problems over the life course can act as an
etiological factor for poorer cognitive outcomes. This hypothesis was supported by a
meta-analysis, which showed that the interval length between diagnoses of depression
and dementia was positively associated with risk of developing Alzheimer’s disease,
suggesting that depression can act as a remote risk factor for dementia (Ownby et al.,
2006). However, Brommelhoff et al (2009) argued that only a small minority of the
studies included in this review showed that an onset of depression more than 10 years
prior to emergence of cognitive deficits was associated with an increased risk of late-life
Alzheimer’s disease (Pálsson et al., 1999; Speck et al., 1995), so as such these
conclusions should be interpreted with caution.
The second potential explanation for the observed link between affective
problems and pathological cognitive ageing is that affective problems may act as a
prodromal feature of dementia. Several studies have reported an increased risk of
dementia only for affective episodes in which first onset was proximal to dementia
diagnosis (Berger, Fratiglioni, Forsell, Winblad, & Bäckman, 1999; Chen, Ganguli,
Mulsant, & DeKosky, 1999; Wetherell, Gatz, Johansson, & Pedersen, 1999; Yaffe et
al., 1999). This provides support for the hypothesis that affective problems may
manifest as an early clinical presentation of dementia. However, in a recent review, Da
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Silva et al (2013) argued that the risk of developing dementia is not limited to late life
depression. Although dementia pathology can begin to build up in midlife, Da Silva et
al (2013) propose that it is unlikely that depression would manifest as a symptom of
dementia related neuropathological changes this early in life. For this reason, the
authors concluded that increased risk of dementia as a result of affective problems
cannot be explained exclusively by the prodromal hypothesis. As such, observed
associations between affective symptoms and risk of dementia may be due to reverse
causality, whereby affective symptoms may arise as a response to emerging cognitive
impairment and its functional consequences.
It is also possible that affective problems and cognitive ageing may share
common risk factors (Jorm, 2001). One such example of a mechanism which may act as
a common substrate is vascular disease (Singh-Manoux et al., 2010), which may be
involved in the clinical expression of both Alzheimer’s disease and depression (see
Taylor, Aizenstein, & Alexopoulos, 2013 for a comprehensive review of the vascular
depression hypothesis). There has been some suggestion that a reciprocal relationship
between vascular disease and depression may exist, whereby each condition is related to
a higher risk of subsequently developing the other (Alexopoulos, 2006; Alexopoulos et
al., 1997; Newberg, Davydow, & Lee, 2006). Additionally, vascular disease contributes
to the clinical manifestation and presentation of symptoms of late-life cognitive
conditions, such as dementia (Luchsinger et al., 2005; Whitmer, Sidney, Selby,
Johnston, & Yaffe, 2005).
These hypotheses are not mutually exclusive. Unfortunately, due to the
relatively short follow-up periods (>10 years) in many prior studies in the area (Singh-
Manoux et al., 2010), a straightforward conclusion regarding explanations for
association between affective problems and cognitive ageing is not yet achievable.
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Given that dementia has a relatively long preclinical period, studies with short follow-
ups are unable to distinguish between prodromal symptoms of preclinical dementia and
etiological risk factors. Longitudinal life course studies in which lengthy follow ups are
possible are therefore essential to further elucidate the temporal relationship between
affective problems and cognitive ageing.
1.2.4. Plausible underlying mechanisms of the association: inflammatory
processes.
It is likely that associations between affective problems and cognitive ageing are
underpinned by multiple interacting biological mechanisms, including inflammatory
processes, genetic factors, and neuroendocrine factors. Chronic inflammation may be
particularly important for this association (Byers & Yaffe, 2011). Specifically, chronic
depressive symptoms are associated with an increase in cytokines, which can reduce
anti-inflammatory regulation and increase CNS pro-inflammatory changes, which have
been associated with development of dementia (Sorrells & Sapolsky, 2007; Yaffe et al.,
2003). It is also known that pro-inflammatory cytokines can impair serotonin
metabolism, reduce neurogenesis in the hippocampus, and ultimately increase risk of
dementia (Caraci, Copani, Nicoletti, & Drago, 2010; Maes et al., 2009). Cross-sectional
research has shown that level of depression is significantly associated with plasma
levels of inflammatory markers, such as C-Reactive Protein (CRP) (Dantzer, O’Connor,
Freund, Johnson, & Kelley, 2008; Raison, Capuron, & Miller, 2006), and prospective
longitudinal cohort studies have also provided evidence that depressive symptoms can
be positively associated with levels of inflammation over time (Copeland, Shanahan,
Worthman, Angold, & Costello, 2012). Beyond this, longitudinal studies have also
shown that levels of inflammation during midlife are associated with risk of dementia
after a follow up period of 25 years, and with risk of cognitive decline over time in
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well-functioning older people (Koyama et al., 2013; Kuo et al., 2005; Schmidt et al.,
2002; Yaffe et al., 2003). Taken together, this evidence suggests that inflammation may
play an important role in the association between affective symptoms and poorer
cognitive ageing, though this hypothesis has not been directly tested using birth cohort
resources.
1.3. Research aims
This thesis has an overarching aim to investigate associations between affective
symptoms over the life course, from childhood through to later adulthood, and cognitive
function and ageing from middle to later adulthood in a population without dementia.
Specifically, this work sought to clarify and extend previous research by using a life
course approach to test these associations and to explore inflammation as a plausible
biological mechanism which may underlie associations between affective symptoms
and cognitive function. The conceptual framework for this thesis is presented in Figure
1.4.1.
Chapter 2 presents a systematic literature review and meta-analysis of the
available literature investigating associations between affective symptoms over the life
course and cognitive decline. The primary aims of this review are: 1. to investigate
whether affective symptoms (both as a binary and a continuous measure) are associated
with a faster subsequent cognitive decline; 2. to highlight methodological limitations of
the previous research into this area in order to inform and guide the following empirical
studies included in this thesis.
Chapters 3 and 4 present studies that used data from the National Survey of
Health and Development (NSHD), a nationally representative sample of 5,362 people
born in England, Scotland and Wales during 1 week of 1946. Study 2 focuses on two
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primary aims: 1. to model verbal memory and processing speed trajectories from mid-
to later adulthood, as in previous research (Davis et al., 2017; Rawle, Davis, et al.,
2018); 2. to test how affective symptoms in adolescence & adulthood are associated
with adult cognitive function at baseline (age 43) and decline (age 43 to 69). The
primary aim of Study 3 is to test bidirectional relationships between affective symptoms
and cognition function over a period of 16 years from middle to later adulthood (age 53
to 69).
Chapters 5 and 6 present two studies that used data from the National Child
Development Study (NCDS), a population based birth cohort of 18,558 people born in
mainland UK during 1 week of 1958. Chapter 5 comprised three main aims: 1. to
investigate whether timing or accumulation of affective disorders predicts midlife
cognitive outcomes; 2. to derive longitudinal trajectories of affective symptoms over
adulthood (age 23 to 50); 3. to test how trajectories of affective symptoms are
associated with cognitive function in mid-life. The aim of Chapter 6 was to test whether
inflammation can act as a mediator in the association between adult affective symptoms
and cognitive outcomes in midlife.
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1.4. Tables and figures
Figure 1.4.1: Conceptual framework of thesis
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CHAPTER 2
Study 1: Affective problems and decline in cognitive
state in older adults: a systematic review and meta-
analysis.
Study 1 is published in Psychological Medicine as:
John, A., Patel, U., Rusted, J., Richards, M., & Gaysina, D. (2018). Affective problems
and decline in cognitive state in older adults: a systematic review and meta-analysis.
Psychological Medicine, 49(3), 353-365.
Doi: 10.1017/S0033291718001137.
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2.1. Abstract
Evidence suggests that affective problems, such as depression and anxiety,
increase risk for late-life dementia. However, the extent to which affective problems
influence cognitive decline, even many years prior to clinical diagnosis of dementia, is
not clear. The present study systematically reviews and synthesises the evidence for the
association between affective problems and decline in cognitive state (i.e., decline in
non-specific cognitive function) in older adults. An electronic search of PubMed,
PsycInfo, Cochrane, and ScienceDirect was conducted to identify studies of the
association between depression and anxiety separately and decline in cognitive state.
Key inclusion criteria were prospective, longitudinal designs with a minimum follow-up
period of 1 year. Data extraction and methodological quality assessment using the
STROBE checklist were conducted independently by two raters. A total of 34 studies (n
= 71 244) met eligibility criteria, with 32 studies measuring depression (n = 68 793),
and five measuring anxiety (n = 4698). A multi-level meta-analysis revealed that
depression assessed as a binary predictor (OR 1.36, 95% CI 1.05–1.76, p = 0.02) or a
continuous predictor (B =−0.008, 95% CI −0.015 to −0.002, p = 0.012; OR 0.992, 95%
CI 0.985–0.998) was significantly associated with decline in cognitive state. The
number of anxiety studies was insufficient for meta-analysis, and they are described in a
narrative review. Results of the present study improve current understanding of the
temporal nature of the association between affective problems and decline in cognitive
state. They also suggest that cognitive function may need to be monitored closely in
individuals with affective disorders, as these individuals may be at particular risk of
greater cognitive decline.
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2.2. Introduction
Decline in cognitive state is a central feature of ageing, and severe deterioration
in cognitive function has frequently been associated with poorer quality of life and
worse performance on physical tasks (Tabbarah, Crimmins, & Seeman, 2002).
Accelerated decline in cognitive state also has an influential and adverse impact upon
the psychological, social, emotional and financial status of the individual, which can
subsequently contribute to heightened levels of burden and distress (Wilson et al.,
2007). Cognitive symptoms are common in affective disorders, particularly impairments
in memory, executive control, feedback sensitivity and affective processing (Clark,
Chamberlain, & Sahakian, 2009). These cognitive symptoms are associated with
pathophysiology across a distributed neural circuit, which is made up of various regions
across the prefrontal cortex, as well as subcortical regions and also temporal lobe
structures (Clark et al., 2009). Both affective disorders, such as depression and anxiety,
and poor cognitive function are common in older adulthood (Alexopoulos & Abrams,
1991; Rovner, Broadhead, Spencer, Carson, & Folstein, 1989). It is estimated that after
age 70, the combination of low mood and poor cognition doubles with every 5 years. By
age 85, around one in four of individuals experience both these comorbid conditions
(Arve, Tilvis, Lehtonen, Valvanne, & Sairanen, 1999). Due to the high prevalence of
these conditions in older adulthood, this is a research area of clinical relevance and
importance.
Previous research has proposed that affective problems, such as depression and
anxiety, may be associated with accelerated cognitive ageing (Da Silva et al., 2013;
Gulpers et al., 2016). However, there are significant gaps in our understanding of this
link. For instance, the precise temporal order of the association between affective
problems and decline in cognitive state is currently unclear. It is possible that affective
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problems may act as an early risk factor for decline in cognitive state, or alternatively
that affective problems may be a prodromal symptom of oncoming cognitive
impairment. Additionally, previous studies, including several meta-analyses, have been
largely diagnosis driven, with a primary focus on dementia as an outcome (Bennett &
Thomas, 2014; Byers & Yaffe, 2011; Cherbuin, Kim, & Anstey, 2015; Da Silva et al.,
2013; Jorm, 2001; Ownby et al., 2006). Less is known about the impact of affective
problems on decline in cognitive state across the entire population spectrum. The focus
on the transition to dementia as an outcome may be problematic, as it is now believed
that there is a long pre-clinical period of several decades before cognitive impairment
becomes evident (Morris, 2005). It is possible that participants who transition to
dementia at follow-up assessment may have already developed substantial cerebral
pathology by the time of baseline assessment, even if they had not yet presented with
any cognitive symptoms. In this case, associations between affective disorders and
development of dementia may be the result of reverse causality. The present study
focuses on the association between affective disorders and decline in cognitive state in
healthy older adults in order to minimise effects of possible reverse causality.
Cognitive state refers to a composite measure of overall cognitive function. It
has been studied extensively in previous research (Esslinger et al., 2011; Kave, Eyal,
Shorek, & Cohen-Mansfield, 2008; Nordin, Rosendahl, & Lundin-Olsson, 2006;
Sohrabi et al., 2008), using assessments of overall cognitive status, such as the Mini-
Mental State Examination (MMSE) or composite assessments of multiple cognitive
domains (e.g. memory, information processing speed, executive function). Therefore,
decline in cognitive state is defined in the present review as a decline in overall
cognitive function, rather than decline in specific cognitive domains. There is evidence
from longitudinal research that low scores on cognitive state tests may predict onset of
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functional impairment (Gill et al., 1996; Moritz, Kasl, & Berkman, 1995), and
functional dependence over time (Agüero-Torres, Thomas, Winblad, & Fratiglioni,
2002; Gill, Hardy, & Williams, 2002; Wang et al., 2002). For this reason, it is important
to investigate how affective problems influence decline in cognitive state over time.
There are large individual differences in the extent of cognitive decline
experienced by healthy older adults; however, the decline in cognitive state occurs at a
steady and gradual rate over time. On average there is a decline of around 1–2 standard
deviations in fluid cognition from age 20 to 70, after which average decline increases to
around 0.5 S.D. every 10 years (Anstey & Low, 2004). This stable decline is often
maintained over time until symptoms of dementia begin to manifest, at which point a
sharper decline in cognitive state may be observed (Rubin et al., 1998). As such, studies
in which substantial cognitive decline is apparent within a short time frame of under 1
year may be more indicative of pathological ageing (e.g. oncoming dementia), rather
than healthy ageing. Since the present study aims to examine the longitudinal
association between affective disorders and decline in cognitive state in cognitively
healthy individuals, it includes only longitudinal studies with sufficient time between
baseline and follow-up assessments (i.e., minimum 1 year) for a substantial decline to
occur within these populations. There are several studies that have investigated the
association between affective problems and decline in cognitive state (Bassuk et al.,
1998; Brailean et al., 2017; Bunce et al., 2012; Chang & Tsai, 2015; Chen & Chang,
2016; Gale et al., 2012; Ganguli et al., 2006; Geerlings et al., 2000; Johnson et al.,
2013; Kohler et al., 2010; Neubauer et al., 2013; Paterniti et al., 2002; Rajan et al.,
2014; Reyes-Ortiz et al., 2008; Royall & Palmer, 2013). However, it is difficult to draw
a straightforward conclusion from this work due to conflicting findings. Specifically,
some studies report a significant association between affective problems and decline in
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cognitive state (Chang & Tsai, 2015; Chen & Chang, 2016; Geerlings et al., 2000;
Johnson et al., 2013; Kohler et al., 2010; Paterniti et al., 2002; Rajan et al., 2014;
Reyes-Ortiz et al., 2008; Royall & Palmer, 2013), while conversely others report that
affective problems do not predict decline (Bassuk et al., 1998; Brailean et al., 2017;
Bunce et al., 2012; Gale et al., 2012; Ganguli et al., 2006; Neubauer et al., 2013). These
contradictory results are likely attributable to inconsistencies in methodologies and
study design, such as length of follow-up, sampling, definitions used, differences in
assessment tools and also the primary aim of each study (Bennett & Thomas, 2014).
To date, however, there have been no systematic reviews or meta-analyses
addressing associations between affective problems and subsequent decline in cognitive
state, prior to the onset of dementia. Due to inconsistencies in findings, as well as the
lack of attempts to synthesise these data, it is still unclear whether affective problems
across the life course are associated with a decline in cognitive state, prior to the onset
of dementia and cognitive impairment. The primary aim of the present study therefore
was to systematically review and synthesise current evidence regarding the longitudinal
association between affective problems (depression and anxiety separately) and
subsequent decline in cognitive state, with consideration of several potential
moderators, including mean age of sample at baseline, length of follow-up, quality of
study and publication year. The conceptual framework for the research question of this
chapter is presented in Fig. 2.6.1, testing whether measures of depression and anxiety in
older adulthood are associated with subsequent decline in cognitive state.
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2.3. Method
Search strategy.
This review was conducted in accordance with the Preferred Reporting Items for
Systematic reviews and Meta-Analyses (PRISMA) guidelines (Moher, Liberati,
Tetzlaff, & Altman, 2009). A systematic literature search was conducted using PubMed,
PsycInfo, Cochrane, and ScienceDirect databases for studies investigating the
association between affective problems and decline in cognitive state. All studies
published up to November 2016 were included in the search. There was no restriction
on the start date. Our search terms comprised three search blocks (Table 2.6.1). The first
search block included keywords relating to affective problems. The second search block
contained keywords describing the decline in cognitive state. To reduce the number of
irrelevant hits, a third search block was added, which contained keywords related to
methodology, to ensure all studies with cross-sectional designs were excluded from
search results. In addition, reference lists of relevant papers were scanned for studies of
interest.
Inclusion/exclusion criteria.
Stringent inclusion/exclusion criteria were applied to studies identified through
the initial search.
Design criteria.
Original studies written in English up to November 2016 were included. Only
studies using longitudinal, prospective designs with human participants were included
in order to test for the association between affective disorders and decline in cognitive
state over time. Cross-sectional, case-control, experimental, including intervention and
treatment, studies were excluded. Studies with a follow-up period of 1 year or greater
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were included, as it is possible that substantial decline in cognitive state may not be
observed over very short follow-up periods in a general population. Included studies
used samples drawn from a general population, whereas studies using specific clinical
populations only, for example, a sample of stroke patients, were excluded. This criterion
was used because inclusion of clinical samples may increase the heterogeneity of data
synthesis and reduce the comparability of studies. Studies with a sample size of 100 or
less were also considered ineligible, due to insufficient statistical power.
Outcome-related criteria.
Samples with cognitive impairment or dementia present at baseline were
excluded. In addition to this, studies with any measure of change in cognitive state from
baseline to follow-up were selected for inclusion. Other outcomes, such as the transition
to dementia or cognitive performance at follow-up without consideration of change
from a baseline measure were omitted. This was because the present study aimed to
look at the association between affective disorders and cognitive decline within healthy
ageing populations, rather than samples with dementia. Additionally, studies assessing
specific cognitive domains, such as attention or visuospatial ability exclusively, rather
than cognitive state, were also excluded to reduce heterogeneity.
Predictor-related criteria.
Both diagnostic and dimensional measures of depression and anxiety at baseline
assessment were judged as eligible. Studies with retrospective assessments of affective
problems were excluded, as such assessments may be less reliable. Both binary
indicators of affective problems, defined as either a diagnosis or as a score above a
threshold level, or continuous symptoms scores, as assessed by a validated scale of
affective problems were included in this review.
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Screening procedure.
All studies identified through our search strategy were screened for eligibility
using a three-step process. All references were first reviewed by title. Next, the
remaining references were screened by abstract. Finally, all remaining studies were read
in full and final eligibility determinations were made on this basis. All studies were
reviewed for inclusion by one rater, and 10% of all studies were additionally screened
by an independent rater, in order to assess the consistency of screening. Any
disagreements were resolved during consensus meetings.
Data extraction.
Data from the relevant studies were extracted using a detailed coding form.
Information extracted included: Study information (Authors, publication year, DOI);
Sample information (Country, mean age at baseline, gender composition, ethnicity, year
of data collection, number of follow-ups, time between lags, total length of follow-up,
sample size at baseline, sample size at final follow-up); Instrument information (Type of
affective problem, measure used to assess affective problem, measure used to assess
decline in cognitive state); Statistical information (Statistical test used, effect sizes,
covariates adjusted for in statistical model). Where results for more than one follow-up
were reported, the longest follow-up was selected for our analysis, as longer follow-up
times allow a greater period for the decline in cognitive state to occur. Similarly, where
multiple models were reported with various adjustments made, the most conservative
model (with the greatest amount of adjustments) was selected. In cases where
insufficient statistical information was available, original authors were contacted
directly via email. All studies were evaluated for methodological quality using
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STROBE (Strengthening the Reporting of Observational Studies in Epidemiology)
guidelines (Elm, Altman, Egger, Pocock, & Gøtzsche, 2007).
Statistical analysis and data synthesis.
All analyses were conducted in R Studio (Studio, 2012), using the metafor
package. Separate meta-analyses were run for studies in which affective problems were
assessed as a binary predictor (using a defined threshold), and studies where affective
problems were assessed as a continuous predictor (using a symptom score). In addition,
separate analyses were conducted for studies that used depression or anxiety as
predictors of decline in cognitive state.
Odds ratios (ORs) were used as a common effect size across studies with a
binary measure of affective problems. When ORs were not reported in original studies,
these were estimated from available data using standard computational techniques
(Borenstein, Hedges, & Rothstein, 2009; Field & Gillett, 2010; Lipsey & Wilson,
2000). Log ORs were then computed for subsequent analysis. Standardised regression
coefficients were used as a common effect size across studies with a continuous
measure of affective problems. If unstandardised effect sizes were reported, or measures
were not standardised to a z score before analysis, coefficients were converted to
standardised coefficients using standard computational methods (Duncan, 2014; Kim &
Ferree Jr, 1981). In cases where insufficient information was reported in the study to
calculate the standardised coefficients, authors were contacted directly via email. We
also converted the estimated regression coefficients into ORs to facilitate the
comparison with the analyses using a binary predictor of depression.
Multi-level meta-analyses were conducted to account for multiple effect sizes
within studies (Van Den Noortgate & Onghena, 2003). Heterogeneity across studies
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was assessed using the Q statistic, with p < 0.1 suggesting significant heterogeneity
between studies, and the I2 statistic, in which 25, 50 and 75% represent low, medium
and high heterogeneity (Higgins, Thompson, Deeks, & Altman, 2003).
Additional meta-regression analyses were also conducted to assess the effects of
potential moderators, including the length of follow-up, age of sample at baseline,
publication year, method of affective problem assessment (diagnosis or self-report) and
quality of studies. All moderators were entered initially as continuous variables, except
for the assessment method of affective problems which was coded as a binary variable.
For significant moderators, binary variables were created using the average values and
sub-group analyses were run using these variables.
Publication bias was assessed using Begg’s funnel plot and Begg’s rank
correlation test (Egger, Davey-Smith, & Altman, 2008; Song, Eastwood, Gilbody,
Duley, & Sutton, 2000).
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2.4. Results
Literature search.
Our search identified 25 844 references. After exclusion of duplicates, 20 954
unique citations remained. At stage 1, citations were screened by title and 981 were
determined to be eligible (interrater reliability = 96%). In stage 2, remaining citations
were screened by abstract and 185 were judged as relevant (inter-rater reliability =
91%). Finally, all 185 citations were selected for full text screening, after which 84
references remained (inter-rater reliability = 94%). At this stage, a further 36 studies
were excluded, as they were addressing decline in specific cognitive outcomes, rather
than cognitive state. Of the 48 studies remaining, initially there were 18 with
insufficient information for calculation of effect sizes. Authors were contacted directly
by email about this and four responded to provide the relevant information. This left a
total of 34 studies with sufficient information to calculate effect sizes, with 32 studies
investigating the link between depression and a decline in cognitive state (n = 68 793),
and five studies investigating anxiety and decline in cognitive state (n = 4698; Fig. 2.6.2
and Table 2.6.2).
Depression studies.
Of the depression studies, 17 used a binary measure of depression (k = 34) and
16 measured depression as a continuous variable (k = 36). Depression studies had a
mean follow-up length of approximately 6.61 years (S.D. = 4.41). The mean age of
participants was 72.15 at baseline (S.D. = 7.56) and the gender composition of the
sample was approximately 59.48% female. The majority of studies took place in the
USA (n = 14), followed by the Netherlands (n = 4) and Taiwan (n = 3). Studies also
took place in Australia, Canada, France (n = 2 for each), Germany, England, Italy,
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Singapore and Japan, Hawaii and the mainland-USA (n = 1 for each). Overall, the
majority of studies used the Center for Epidemiologic Studies Depression Scale (CES-
D) to assess depression present at baseline (n = 16), followed by the Geriatric
Depression Scale (GDS) (n = 7), the Diagnostic Interview Schedule (DIS) (n = 3), the
Neuroticism scale from the NEO Personality Inventory, the Duke Depression
Evaluation Schedule (DDES), the Goldberg Depression Scale, Neuropsychiatric
Inventory, Hamilton Rating Scale for Depression (HDRS), the Symptom Checklist (n =
1 for each). Only one study reported separate effect sizes for more than one follow-up
period (Bassuk et al., 1998). This study reported effect sizes at 3 years after baseline (n
= 2030), 6 years after baseline (n = 1447) and 12 years after baseline (n = 756). The
effect size with the longest follow-up (12 years) was selected for inclusion in the meta-
analysis.
Anxiety studies.
Of the five anxiety studies, two used a binary indicator of anxiety (k = 2) and
three used a continuous measure of anxiety (k = 3). Anxiety studies had a mean follow-
up time of 5.9 years (S.D. = 4.36). On average, participants were 76.56 years old at
baseline (S.D. = 4.23) and were predominantly female (60.14% female). The majority
of studies took place in Australia (n = 2), followed by the USA, the Netherlands and
Israel (n = 1 for each). Anxiety was assessed using Sinoff’s Short Anxiety Screening
Test (SAST), Hospital Anxiety and Depression Scale-Anxiety (HADS-A),
Neuropsychiatric Inventory, Goldberg Anxiety Scale and the Neuroticism scale from
the NEO Personality Inventory (n = 1 for each). All anxiety studies had a score of 60%
or greater on the STROBE checklist (maximum score = 81%, median score = 78%).
Depression and decline in cognitive state.
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Meta-analysis of studies with depression as a binary predictor.
There were 34 relevant effect sizes across 17 studies with a binary measure of
depression (Bassuk et al., 1998; Brodaty et al., 2012; Chang & Tsai, 2015; Downer,
Vickers, Al Snih, Raji, & Markides, 2016; Dufouil, Fuhrer, Dartigues, & Alperovitch,
1996; Ganguli et al., 2006; Geerlings et al., 2000; Han, McCusker, Cole,
Abrahamowicz, & Čapek, 2008; Kohler et al., 2010; Niti, Yap, Kua, & Ng, 2009; 
Paterniti et al., 2002; Raji, Reyes-Ortiz, Kuo, Markides, & Ottenbacher, 2007; Reyes-
Ortiz et al., 2008; Rosenblatt, Mehta, Romanoski, Eaton, & Lyketsos, 2003; Sawyer,
Corsentino, Sachs-Ericsson, & Steffens, 2012; Wilson et al., 2016; Yaffe et al., 1999).
A multi-level meta-analysis of 34 effect sizes revealed that depression was associated
with an increased risk of subsequent decline in cognitive state (OR 1.36, 95% CI 1.05–
1.76, p = .02; Fig. 2.6.3).
Assessment of heterogeneity, meta-regression and sub-group analyses.
Significant heterogeneity was observed across the studies with depression as a
binary predictor (Q = 106.83, df = 33, p < 0.0001, I2 = 69.08%). An omnibus meta-
regression analysis including publication year, mean age at baseline, length of follow-
up, method of depression assessment (diagnosis or self-report) and quality of study
revealed that these variables together were able to explain a significant amount of
heterogeneity in the model (QM= 13.32, df = 5, p = 0.02). However, even after
accounting for these factors, significant heterogeneity remained in the model (QE =
93.51, df = 28, p < 0.0001). To further explore the effect of publication year, age at
baseline, length of follow-up, depression assessment and quality on heterogeneity,
individual meta-regressions were conducted for each of these potential modifiers. These
analyses revealed that mean age at baseline (p = 0.13), publication year (p = 0.19),
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quality of the study (p = 0.09) and depression assessment (p = 0.91) did not significantly
explain the between-study variability.
Meta-regression analyses including the length of follow-up showed significant
between-study variability, whereby studies with shorter follow-up periods had
significantly greater effect sizes than studies with longer follow-up periods (B = −0.03, 
S.E. = 0.009, p = 0.002). Additionally, meta-regression analyses including the method
of cognitive assessment (MMSE v. neuropsychiatric batteries) showed significant
between-study variability (B = −0.2, S.E. = 0.08, p = 0.01). To further explore precisely
how these significant factors were involved in this association sub-group meta-analyses
were conducted.
To explore how length of follow-up affected the association, effect sizes were
divided by the mean follow-up length in years (M = 6.35 (S.D. = 4.25) years), resulting
in two groups of longer (k = 7, M= 10.79 (S.D. = 2.45) years) and shorter follow-up
periods (k = 10, M= 3.25 (S.D. = 1.48) years). Multi-level sub-group meta-analyses
revealed that depression was significantly associated with decline in cognitive state in
studies with shorter follow-up periods (OR 1.43, 95% CI 1.03–2.00, p = 0.03) and was
approaching significance in studies with longer follow-up periods (OR 1.15, 95% CI
0.98–1.36, p = 0.08). However, the overall effect size was larger for studies with shorter
follow-up periods than those with longer follow-up periods. Studies with longer follow-
up periods did not differ significantly from studies with shorter follow-up periods on
quality (t (14.29) = 1.08, p = 0.3), publication year (t (15.38) = 0.1, p = 0.92), mean age
at baseline (t (10.67) = −0.41, p = 0.69), or depression assessment (t (14.07) = −0.5, p =
0.63).
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The meta-regression analysis including the method of cognitive assessment
suggested that effect sizes were significantly smaller for studies using the MMSE than
studies using neuropsychiatric batteries (B = −0.2, S.E. = 0.08, p = 0.01). However,
there were only four studies using neuropsychiatric battery assessments of cognitive
state, so results need to be treated with caution.
Meta-analysis of studies with depression as a continuous predictor.
A multi-level meta-analysis of the 36 effect sizes across 16 studies with a
continuous measure of depression was conducted (Bunce et al., 2012; Chen & Chang,
2016; Chiao & Weng, 2016; Dotson, Resnick, & Zonderman, 2008; Gale et al., 2012;
Geerlings et al., 2000; Han, McCusker, Abrahamowicz, Cole, & Capek, 2006; Johnson
et al., 2013; Neubauer et al., 2013; Panza et al., 2009; Rajan et al., 2014; Royall &
Palmer, 2013; Turner, Capuano, Wilson, & Barnes, 2015; Van Den Kommer et al.,
2013; Vinkers et al., 2004; Robert S Wilson, Begeny, Boyle, Schneider, & Bennett,
2011). This analysis revealed that depression was significantly associated with a decline
in cognitive state (B = −0.008, 95% CI −0.015 to −0.002, p = 0.012; Fig. 2.6.4; OR
0.992, 95% CI 0.985–0.998).
Assessment of heterogeneity and meta-regression analyses.
Significant heterogeneity was observed across studies with depression as a
continuous predictor (Q = 93.86, df = 35, p < 0.0001, I2 = 69.74%). In order to try and
explain some of this heterogeneity, an omnibus meta-regression analysis was
conducted, including mean age at baseline, length of follow-up, quality and publication
year as potential moderators. This analysis revealed that together these variables were
not able to explain a significant amount of the heterogeneity in the model (QM = 8.97,
df = 4, p = 0.06), but even after accounting for these factors, significant heterogeneity
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remained within the model (QE = 84.9, df = 31, p < 0.0001). In order to explore the
influence of age at baseline, follow-up length, quality and publication year in more
depth, individual meta-regressions were conducted for each potential modifier. These
analyses revealed that mean age at baseline (p = 0.27), length of follow-up (p = 0.1),
publication year (p = 0.18), method of cognitive assessment (p = 0.47) and quality (p =
0.11) could not significantly explain between-study variability individually.
Publication bias.
Publication bias is unlikely for meta-analyses of depression studies measured as
a continuous variable, as Begg’s rank correlation test was non-significant (p = 0.07).
Begg’s funnel plot also appears relatively symmetrical (online Supplementary Fig. S1).
There may have been some publication bias present in the meta-analysis of studies with
depression as a binary predictor, as although Begg’s funnel plot appears symmetrical
(online Supplementary Fig. S1), Begg’s rank correlation test was significant (p = 0.02).
Results should, therefore, be interpreted with caution.
Anxiety and decline in cognitive state.
Due to the limited number of studies with anxiety which met our inclusion
criteria, meta-analyses for these studies were not possible. Instead, these studies are
described in the form of a narrative review. Of the five relevant anxiety studies, two
used a binary indicator of anxiety (Brodaty et al., 2012; Sinoff & Werner, 2003) and
three used a continuous measure of anxiety (Bierman, Comijs, Rijmen, Jonker, &
Beekman, 2008; Bunce et al., 2012; Robert S Wilson et al., 2011).
Two of these studies reported that anxiety was a significant predictor of decline
in cognitive state (Sinoff & Werner, 2003; Robert S Wilson et al., 2011). Specifically,
Sinoff and Werner (2003) reported that in a sample of 100 people, anxiety (assessed
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using Sinoff’s Short Anxiety Screening Test – SAST) had a strong direct and indirect
effect on predicting future decline in cognitive state over 3.2 years (B = 0.23, 95% CI
−0.03 to –3.95, p < 0.05). Similarly, Wilson et al (2011) found that in 785 older adults,
higher levels of anxiety symptoms (assessed using the anxiety subscale from the 48-
item Neuroticism scale) were significantly associated with more rapid decline in
cognitive state over a 3.4-year period (B = −0.003, S.E. = 0.001, p = 0.01).
Conversely, three of the eligible studies found no association between anxiety
symptoms and a decline in cognitive state (Bierman et al., 2008; Brodaty et al., 2012;
Bunce et al., 2012). Bierman et al (2008) found no evidence that anxiety (assessed using
the anxiety sub-scale from the Hospital Anxiety and Depression Scale – HADS-A)
predicted a linear decline in cognitive state in a sample of 2351 people over a period of
9 years. Instead, a significant negative quadratic trend for cognition was reported. The
authors state that this is suggestive of a curvilinear association between anxiety levels
and cognitive performance. Specifically, milder anxiety symptoms may be associated
with an improvement on the MMSE until it reaches an optimal level, beyond which the
beneficial influence reduces, so more severe anxiety is related to poorer cognitive
function. The authors posit that the Yerkes and Dodson law regarding the association
between arousal and cognitive performance (Mendl, 1999; Yerkes & Dodson, 1908)
may also apply to anxiety symptoms. Brodaty et al (2012) found that in a sample of 480
non-impaired people, the odds of decline in global cognitive state over a period of 2
years were not significantly higher for participants with anxiety (assessed using
Neuropsychiatric Inventory) at baseline than those without (OR 1.63, 95% CI 0.5–5.8, p
= 0.45). They did, however, find a significant effect of anxiety at baseline on the decline
in executive function (OR 3.54, 95% CI 1.3–9.9, p = 0.016). Finally, Bunce et al (2012)
found no evidence that anxiety (assessed using the Goldberg Anxiety Scale) affected
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change in cognitive state over a period of 12 years in a sample of 836 community-
dwelling individuals over the age of 70 (B = −0.14, S.E. = 0.19, p = 0.46).
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2.5. Discussion
The aim of the current study was to systematically investigate associations
between affective problems (depression and anxiety) present at baseline and subsequent
decline in cognitive state. Our findings revealed that individuals with depression
(measured as a binary or continuous predictor) were at an increased risk of a greater
decline in cognitive state. These findings are consistent with previous reviews which
have indicated an association between affective problems and development of dementia
(Bennett & Thomas, 2014; Byers & Yaffe, 2011; Cherbuin et al., 2015; Da Silva et al.,
2013; Gulpers et al., 2016; Jorm, 2001; Ownby et al., 2006). Our results extend these
findings by linking affective problems to a greater decline in cognitive state in samples
without dementia at baseline.
Strengths and limitations.
Several limitations of the current study must be acknowledged. They are subject
to the limitations of the included studies. Our analyses suggest that there are several key
methodological differences between studies which significantly affect the results
produced. For example, our results suggest that effects may differ based on length of
follow-up. As shown, this is unrelated to differences in publication year, age at baseline,
or method of depression assessment (self-report or diagnosis). It is possible that this is
more likely attributable to additional unobserved heterogeneity.
This review only included studies of decline in cognitive state as an outcome.
For this reason, it is not clear whether affective problems may differentially influence
decline in different cognitive domains. Additionally, the majority of included studies
assessed cognitive state using the MMSE. This measure has been criticised for lacking
sensitivity to subtle changes in cognition and for ceiling and floor effects (Tombaugh &
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McIntyre, 1992). Consistent with this, the meta-analysis of studies using depression as a
binary predictor revealed that effect sizes are significantly smaller for studies using the
MMSE than studies using neuropsychiatric batteries. It is therefore possible that the
widespread use of the MMSE may have resulted in an underestimation of the
association between affective disorders and decline in cognitive state in healthy older
adults over time. One further limitation is that excluding cognitive impairment and
dementia at baseline does not completely rule out the possibility of reverse causality.
Beyond this, included studies used different approaches and instruments to
assess affective problems. Research suggests that there is low overlap among different
scales of depression and anxiety, with content analysis suggesting that different types of
assessments may capture different symptoms (Fried, 2017). It is therefore possible that
studies included in this review are not entirely comparable on the basis that the methods
of assessing depression are heterogeneous and may each be capturing different kinds of
symptoms. Beyond this, there were also very few studies which met our inclusion
criteria which examined the association between anxiety and decline in cognitive state,
meaning that a quantitative meta-analysis was not possible. Moreover, an additional
limitation is that as there were no studies investigating comorbidity between anxiety and
depression. Finally, many of the studies did not report separate effect sizes for different
types of symptoms of affective problems (e.g. negative affect symptoms, somatic
symptoms, etc.), meaning we could not look at how different symptoms of affective
problems may influence decline in cognitive state in the current study.
Plausible mechanisms.
Three major hypotheses have been proposed to explain this observed
association. The first states that affective problems may act as an aetiological risk factor
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for the subsequent decline in cognitive state, perhaps by lowering the threshold for
manifesting decline (Bennett & Thomas, 2014; Butters et al., 2008). The second
hypothesis proposes that affective problems may act as a prodromal feature of dementia.
Specifically, affective problems may manifest as an early clinical presentation of this
disorder. Affective problems and decline in cognitive state may therefore be different
symptoms of the same underlying condition (Bennett & Thomas, 2014; Panza et al.,
2010). The third hypothesis posits that affective problems and decline in cognitive state
are separate processes but may share common risk factors and underlying
neurobiological substrates (Bennett & Thomas, 2014; Djernes, 2006; Enache, Winblad,
& Aarsland, 2011). These hypotheses are not necessarily mutually exclusive and it is
likely that multiple pathways and mechanisms underlie this relationship.
There are several biological and behavioural pathways which may be involved
in the association between affective problems and decline in cognitive state. These
include vascular disease, increased cortisol production leading to atrophy of the
hippocampus (Geerlings & Gerritsen, 2017), increased deposition of β-amyloid plaques 
(Byers & Yaffe, 2011), inflammatory changes (Byers & Yaffe, 2011) and a decline in
the levels and activities of neurotrophic factors (Royall, Al-Rubaye, Bishnoi, & Palmer,
2017). A multiple pathways model has also been proposed by Butters et al (2008),
which posits that depression-associated cerebrovascular disease and glucocorticoid
neurotoxicity may operate to decrease levels of brain and cognitive reserve, as well as
interact with pathology of Alzheimer’s disease, giving rise to the clinical manifestation
of Alzheimer’s disease and accelerated cognitive decline. Additional potential lifestyle
and behavioural pathways associated with affective problems include educational
attainment, social support, early life adversity and health behaviours such as exercise
regime, alcohol consumption, smoking status and medication status. It is more likely
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that a complex interaction of biological and sociobehavioural mechanisms are involved
in linking affective problems with cognitive decline, rather than one single aetiological
determinant (Da Silva et al., 2013).
Implications and future directions.
Future research should focus on investigating whether effective treatment and
management of affective problems may reduce risk of decline in cognitive state.
Additionally, future reviews could focus on how affective problems are associated with
decline in specific cognitive domains, such as memory, executive function and
information processing speed. This information can help to elucidate the pattern of
decline characteristic of individuals with a history of affective problems. The present
review could not address the issue of comorbidity between depression and anxiety and
how comorbidity is associated with subsequent decline in the mental state. Indeed,
comorbidity of depression and anxiety disorders is common. It is estimated that around
50–60% of individuals who have experienced depression also have a history of anxiety
disorder (Fava et al., 2000; Kessler et al., 1996). Additionally, it is believed that
comorbidity of anxiety and depression may be related to higher symptom severity and
persistence, as well as poorer functional outcomes (Kaufman & Charney, 2000; Roy-
Byrne et al., 2000). For this reason, it is important for future research to address how
comorbid depression and anxiety is associated with future cognitive decline, and
whether comorbidity of these conditions may result in poorer cognitive outcomes than
depression or anxiety in isolation. One additional question which remains unresolved is
whether affective problems act as a risk factor for the accelerated decline in cognitive
state or whether they are an early biomarker representing prodromal dementia. While
we excluded studies where cognitive impairment was present at baseline, it is also
known that dementia has a preclinical period of many decades (Sperling, Jack, & Aisen,
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2011). It is therefore possible that participants in included studies may have already
built up substantial dementia pathology at baseline, even if cognitive symptoms were
not yet apparent. Associations could therefore be due to reverse causality from subtle
cognitive changes short of dementia. Future research should focus on distinguishing
more clearly between these possibilities.
As average life expectancy lengthens and rapid demographic ageing occurs in
populations worldwide, there is a dramatic predicted increase in the number of older
adults living in our society (Lutz, Sanderson, & Scherbov, 2008; Oeppen & Vaupel,
2002). By 2030, it is estimated that approximately one in five people in England will be
over the age of 65 (House of Lords, 2013). Given the predicted increase in population
size of adults over the age of 65, as well as the poor outcomes and economic costs
associated with a decline in cognitive state and impairment, it is important to identify
life course risk factors for poorer late-life cognitive outcomes, for potential early
intervention. These findings may have value in identifying individuals who may be at a
greater risk of deterioration in cognitive function over time. It is possible that effective
management and treatment of depression may reduce risk and improve cognitive
outcomes within these individuals. However, there has also been some evidence to
suggest there may be persisting neurocognitive disturbances even after remission of
depression (Frasch et al., 2000; Paelecke-Habermann, Pohl, & Leplow, 2005; Weiland-
Fiedler et al., 2004). Additionally, cognition may be an important treatment target for
depression (Kaser, Zaman, & Sahakian, 2017). Due to the high prevalence of depression
in the population, these results are of great public health importance.
In conclusion, demographic ageing is occurring rapidly worldwide and the
number of people living with dementia is expected to grow substantially in prevalence
over the next thirty years. As such, focussing research on potentially modifiable life
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course risk factors, such as affective problems, is of increasing importance. This review
highlights the importance of affective problems, particularly depression, in this context.
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2.6. Tables & figures
Figure 2.6.1: Conceptual framework of Chapter 2
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Table 2.6.1: Key terms used for systematic search
Search Block 1
(Affective problems)
Search Block 2
(Cognitive decline)
Search Block 3
(Study design)
Depress* OR MDD OR Dysthymi*
OR Anxi* OR GAD OR worr* OR
Phobia OR Panic OR Agoraphobia
OR “Obsessive compulsive” OR
OCD OR PTSD OR “Post
traumatic stress” OR “Post-
traumatic stress” OR mood OR
affective OR psychiatric OR
neuropsychiatric
“Cognitive function” OR “Cognitive impairment” OR “Cognitive decline” OR
“Cognitive deficit” OR “Cognitive loss” OR “Cognition loss” OR “Cognitive
ability” OR “Cognitive abilities” OR “Cognitive status” OR “Cognitive
change” OR “Cognition change” OR “Cognitive performance” OR “Cognitive
dysfunction” OR “Cognitive complaints” OR “Cognitive capability” OR
“Cognitive ageing” OR “Cognitive aging” OR Memory OR Attention OR
“Reaction time” OR “Speed of processing” OR “Processing speed” OR
Intelligence OR “General mental ability” OR GMA OR “Executive function”
OR “Neuropsychological testing” OR “Mini mental state exam” OR MMSE
OR “Mental status”
Longitudinal OR
prospective OR
follow-up OR
cohort OR “life
course” OR
lifespan OR “life
span” OR lifelong
OR “life long”
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Table 2.6.2: Studies included in the systematic literature review and meta-analyses
Study
ID Author Year Country
%
Female
Mean
age at
baseline
Mean
length of
follow-up
Measure of
cognition
Type of
affective
problem
Measure of affective
problem
1 Bassuk 1998 USA 63 73.72 12
Short Portable
Mental Status
Questionnaire
(SPMSQ)
Depression
Center for Epidemiologic
Studies Depression Scale
(CES-D)
2 Brodaty 2012 Australia 59 78.41 2
Mean of other
cognitive
domain scores
Depression Neuropsychiatric Inventory
2 Brodaty 2012 Australia 59 78.41 2
Mean of other
cognitive
domain scores
Anxiety Neuropsychiatric Inventory
3 Chang 2015 Taiwan 49 63.34 4
Short Portable
Mental Status
Questionnaire
(SPMSQ)
Depression
Center for Epidemiologic
Studies Depression Scale
(CES-D)
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Study
ID Author Year Country
%
Female
Mean
age at
baseline
Mean
length of
follow-up
Measure of
cognition
Type of
affective
problem
Measure of affective
problem
4 Downer 2016 USA 58 73.18 14
Mini Mental
state
Examination
(MMSE)
Depression
Center for Epidemiologic
Studies Depression Scale
(CES-D)
5 Dufouil 1996 France 60 74.78 3
Mini Mental
state
Examination
(MMSE)
Depression
Center for Epidemiologic
Studies Depression Scale
(CES-D)
6 Ganguli 2006 USA 61 74.60 12
Mini Mental
state
Examination
(MMSE)
Depression
Modified Center for
Epidemiologic Studies
Depression Scale (CES-D)
7 Geerlings 2000 TheNetherlands 51 69.39 3
Mini Mental
state
Examination
(MMSE)
Depression
Center for Epidemiologic
Studies Depression Scale
(CES-D) (>16 vs. <16)
8 Han 2008 Canada 66 79.11 1
Mini Mental
state
Examination
(MMSE)
Depression Hamilton Depression RatingScale (HDRS)
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Study
ID Author Year Country
%
Female
Mean
age at
baseline
Mean
length of
follow-up
Measure of
cognition
Type of
affective
problem
Measure of affective
problem
9 Kohler 2010 TheNetherlands 48 69.40 6
Mini Mental
state
Examination
(MMSE)
Depression
Revised 90-item version of
the Symptom Checklist
(SCL-90)
10 Niti 2009 Singapore 64 65.40 1.5
Mini Mental
state
Examination
(MMSE)
Depression
Chinese version of the 15
item Geriatric Depression
Scale (GDS)
11 Paterniti 2002 France 43 64.96 4
Mini Mental
state
Examination
(MMSE)
Depression
Center for Epidemiologic
Studies Depression Scale
(CES-D)
12 Raji 2007 USA 59 72.70 7
Mini Mental
state
Examination
(MMSE)
Depression
Center for Epidemiologic
Studies Depression Scale
(CES-D)
13 Reyes-Ortiz 2008 USA 57 72.70 11
Mini Mental
state
Examination
(MMSE)
Depression
Center for Epidemiologic
Studies Depression Scale
(CES-D)
14 Rosenblatt 2003 USA 63 40.30 11.5
Mini Mental
state
Examination
(MMSE)
Depression Diagnostic InterviewSchedule (DIS)
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ID Author Year Country
%
Female
Mean
age at
baseline
Mean
length of
follow-up
Measure of
cognition
Type of
affective
problem
Measure of affective
problem
15 Sawyer 2012 USA 69 70.18 4
Mini Mental
state
Examination
(MMSE)
Depression Duke Depression EvaluationSchedule (DDES)
16 Sinoff 2003 Israel 63 77.64 3.1
Mini Mental
state
Examination
(MMSE)
Anxiety Sinoff’s Short AnxietyScreening Test (SAST)
17 Wilson 2016 USA 74 76.30 8
Battery of 19
cognitive
performance
tests
Depression
Subset of questions from the
Diagnostic Interview
Schedule
18 Yaffe 1999 USA 100 72.94 4
Mini Mental
state
Examination
(MMSE)
Depression Geriatric Depression Scale(GDS)
19 Bierman 2008 TheNetherlands 53 69.49 9
Mini Mental
state
Examination
(MMSE)
Anxiety
Hospital Anxiety and
Depression Scale-Anxiety
(HADS-A)
20 Bunce 2012 Australia 49 76.55 12
Mini Mental
state
Examination
(MMSE)
Depression Goldberg Depression Scale
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ID Author Year Country
%
Female
Mean
age at
baseline
Mean
length of
follow-up
Measure of
cognition
Type of
affective
problem
Measure of affective
problem
20 Bunce 2012 Australia 49 76.55 12
Mini Mental
state
Examination
(MMSE)
Anxiety Goldberg Anxiety Scale
21 Chen 2016 Taiwan 45 70.95 14
Short Portable
Mental Status
Questionnaire
(SPMSQ)
Depression
Center for Epidemiologic
Studies Depression Scale
(CES-D)
22 Chiao 2016 Taiwan 57 71.04 14
Short Portable
Mental Status
Questionnaire
(SPMSQ)
Depression
Center for Epidemiologic
Studies Depression Scale
(CES-D)
23 Dotson 2008 USA 40 75.38 4.4
Mini Mental
State Exam
(MMSE), and
Blessed
Information
Memory and
Concentration
Scale (BIMCS)
Depression
Center for Epidemiologic
Studies Depression Scale
(CES-D)
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Study
ID Author Year Country
%
Female
Mean
age at
baseline
Mean
length of
follow-up
Measure of
cognition
Type of
affective
problem
Measure of affective
problem
24 Gale 2012 England 55 64.07 6
Principal
components
analyses of 5
cognitive
outcomes
Depression
Center for Epidemiologic
Studies Depression Scale
(CES-D)
25 Geerlings 2000 TheNetherlands 51 69.39 3
Mini Mental
state
Examination
(MMSE)
Depression
Center for Epidemiologic
Studies Depression Scale
(CES-D) score (per point
increase)
26 Han 2006 Canada 66 79.11 1
Mini Mental
state
Examination
(MMSE)
Depression HDRS
27 Johnson 2013 USA 69 73.50 2
Mini Mental
state
Examination
(MMSE) &
Clinical
Dementia
Rating (CDR-
SB)
Depression Geriatric Depression Scale(GDS30)
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Study
ID Author Year Country
%
Female
Mean
age at
baseline
Mean
length of
follow-up
Measure of
cognition
Type of
affective
problem
Measure of affective
problem
28 Neubauer 2013 Germany 60 75.70 1
Mini Mental
state
Examination
(MMSE) and
Syndrome Short
Test (SKT)
Depression Geriatric Depression Scale(GDS30)
29 Panza 2009 Italy 36 71.90 3.5
Mini Mental
state
Examination
(MMSE)
Depression
Italian version of the
Geriatric Depression Scale
(GDS)
30 Rajan 2014 USA 63 72.41 9
Cognitive
battery of four
tests
Depression
Center for Epidemiologic
Studies Depression Scale
(CES-D)
31 Royall 2013
Japan,
Hawaii, and
the
mainland-
US
77.80 10
Cognitive
Abilities
Screening
Instrument
(CASI)
Depression
Center for Epidemiologic
Studies Depression Scale
(CES-D)
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Study
ID Author Year Country
%
Female
Mean
age at
baseline
Mean
length of
follow-up
Measure of
cognition
Type of
affective
problem
Measure of affective
problem
32 Turner 2015 USA 70 73.90 5
Measure derived
from 19
cognitive tests
Depression
Center for Epidemiologic
Studies Depression Scale
(CES-D) & Geriatric
Depression Scale (GDS)
33 Van denKommer 2013
The
Netherlands 53 69.25 13
Mini Mental
state
Examination
(MMSE)
Depression
Center for Epidemiologic
Studies Depression Scale
(CES-D)
34 Vinkers 2004 TheNetherlands 63 85.00 4
Mini Mental
state
Examination
(MMSE)
Depression Geriatric Depression Scale(GDS)
35 Wilson 2011 USA 76 80.70 3.4 Derived from 19cognitive tests Depression
48-item Neuroticism scale
from the NEO Personality
Inventory-Revised.
Depression sub-scale
35 Wilson 2011 USA 76 80.70 3.4 Derived from 19cognitive tests Anxiety
48-item Neuroticism scale
from the NEO Personality
Inventory-Revised. Anxiety
sub-scale
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Figure 2.6.2: Flowchart of study selection
Note: *One study assessed both binary and continuous assessments of depression,
meaning that although there are 17 studies using binary measures of depression and 16
studies using continuous measures of depression, in total there are only 32 studies
reporting on depression and cognitive decline.
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Figure 2.6.3: Forest plot of the association between binary depression and decline in
cognitive state
Notes for multiple effect sizes within studies: Bassuk* (1: High SPMSQ at baseline; 2:
Medium SPMSQ at baseline; 3: High or medium SPMSQ at baseline), Chang (1: Males
with persistent depressive symptoms; 2: Males with increasing depressive symptoms; 3:
Males with decreasing depressive symptoms; 4. Females with persistent depressive
symptoms; 5: Females with increasing depressive symptoms; 6: Females with
decreasing depressive symptoms), Geerlings* (1: CES-D threshold in high education
sample; 2: CES-D threshold in low education sample; 3: Felt depressed some of the
time vs never in high education sample; 4: Felt depressed some of the time vs never in
low education sample; 5: Felt depressed most of the time vs never in high education
sample; 6: Felt depressed most of the time vs never in low education sample), Han (1:
Major depression vs no depression; 2: Minor depression vs no depression), Kohler (1:
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Low depression vs no depression; 2: Middle depression vs no depression; 3: High
depression vs no depression), Wilson* (1: Major depression vs no depression; 2:
Elevated depression symptoms vs no depression), Yaffe (1: 3-5 depressive symptoms vs
0-2 depressive symptoms; 2: >6 depressive symptoms vs 0-2 depressive symptoms).
* represent effect sizes within studies where there may be some overlap in sample.
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Figure 2.6.4: Forest plot of the association between continuous depression and decline
in cognitive state
Notes for multiple effect sizes within studies: Chen 2016 (1: Cognition starting high and
declining; 2: Cognition starting low and declining), Chiao 2016* (1: Negative affect; 2:
Lack of positive affect), Dotson 2008* (1: Baseline CES-D on MMSE; 2: Average
CES-D on BIMCS; 3: Average CES-D on MMSE); Gale 2012 (1: Age 50-60; 2: Age
60-80; 3: Age 80-90), Geerlings 2000* (1: CES-D Score per point increase,
education>8 years; 2: CES-D Score per point increase, education<8 years; 3: Negative
affect score per point increase, education>8 years; 4: Negative affect score per point
increase, education<8 years), Johnson 2013* (1: MMSE; 2: CDR-SB), Neubauer 2013*
(1: Depression at T1 predicting cognition change from T1 to T2; 2: Depression at T2
predicting cognition change from T2 to T3; 3: Depression at T3 predicting cognition
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change from T3 to T4), Turner 2015* (1: CES-D; 2: CES-D Positive affect; 3: CES-D
Negative affect; 4: CES-D Somatic complaints; 5: CES-D Interpersonal problems; 6:
GDS; 7: GDS Positive affect; 8: GDS Negative affect; 9: GDS Positive and negative
affect).
* represent effect sizes within studies where there may be some overlap in sample.
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2.7. Supplementary material
Supplementary Figure 1: Begg’s funnel plot for publication bias of studies using
depression as a predictor of cognitive decline
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Supplementary Figure 1: Begg’s funnel plot for publication bias of studies using depression as a predictor of cognitive decline
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CHAPTER 3
Study 2: Effects of affective symptoms in adolescence
and adulthood on trajectories of cognitive function
from middle to late adulthood.
Study 2 is accepted for publication in Journal of Affective Disorders.
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3.1. Abstract
Little is known about the link between affective symptoms and cognitive
function across the life course. This study aims to investigate whether affective
symptoms in adolescence and adulthood predict trajectories of cognitive function from
middle to late adulthood. Data from the MRC National Survey of Health and
Development (NSHD), a cohort of 5362 individuals born in mainland UK in 1946, were
utilised. Linear mixed models were used to model cognitive trajectories (memory and
information processing speed) over a three decade period (from 43 to 69) and to test
effects of affective symptoms in adolescence (ages 13-15) and adulthood (ages 36 and
43) on baseline cognitive function (age 43) and decline in cognitive function (from 43
to 69). Models were adjusted for sex, childhood cognition, childhood socioeconomic
position, and education. A quadratic model best fitted memory and information
processing speed data. Models revealed that adolescent affective symptoms were
associated with lower memory (b = -1.11, SE = 0.53, p = .04) and information
processing speed (b = -18.17, SE = 7.53, p = .02) at baseline, but not with rates of
decline over time from 43 to 69. There were no significant associations between adult
affective symptoms and cognitive trajectories. Missing data is a potential limitation of
this study. This was dealt with using maximum likelihood estimation and multiple
imputation. Findings suggest that adolescent, but not adult, affective symptoms are
important predictors of cognitive function in midlife, but not rate of cognitive decline.
This highlights the importance of early intervention to manage mental health in
adolescence to protect later cognitive function.
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3.2. Introduction
Affective symptoms are common during adolescence and adulthood, with one in
six adults and adolescents in the UK reporting symptoms of depression and anxiety
(McManus et al., 2016; Patalay & Fitzsimons, 2017). Recent longitudinal studies have
confirmed long-lasting effects of affective disorders and symptoms on a wide range of
outcomes later in life, including lower educational attainment (Richards & Abbott,
2009), poorer physical and mental health (Colman, Wadsworth, Croudace, & Jones,
2007; Keenan-Miller, Hammen, & Brennan, 2007), and premature mortality (Archer,
Kuh, Hotopf, Stafford, & Richards, 2018). Affective symptoms have also been shown to
lead to worse cognitive outcomes, including dementia and faster cognitive decline (Da
Silva et al., 2013; James et al., 2018; John, Patel, Rusted, Richards, & Gaysina, 2018;
Livingston et al., 2017). However, the majority of existing studies have focused only on
the link between affective symptoms and cognitive function in late adulthood (John et
al., 2018; Singh-Manoux et al., 2010). Therefore, less is known about the effects of
affective symptoms in adolescence and early adulthood on cognitive ageing from
middle to late adulthood. The period of middle adulthood could be particularly
important for prevention of dementia in relation to depression, before dementia
pathology has built up to the clinical threshold for a diagnosis (Exalto et al., 2014). For
example, previous research has shown that post-menopausal women may be at
increased risk of depression, and this transition is also known to be an important period
of increased vulnerability to cognitive impairment and decline (Weber, Maki, &
Mcdermott, 2014). Specifically, research has shown that higher cognitive function from
childhood through to midlife is associated with later menopause (Kok et al., 2006; Kuh
et al., 2005; Richards, Kuh, Hardy, & Wadsworth, 1999) and that later menopause may
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be associated with better verbal memory (Richards, Cooper, Kuh, Moore, & Hardy,
2018).
Using data from the Medical Research Council National Survey of Health and
Development (MRC NSHD), Richards et al (2014) tested six life course profiles of
affective symptoms (from age 13 to 60-64) in relation to cognitive performance at age
60-64 and decline from 53 to 60-64 (Richards et al., 2014). No associations were found
between affective symptoms and cognitive outcomes. Additionally, using NSHD data,
Xu et al (2013) investigated adolescent mental health and memory function and decline
from age 43 to 60-64. They reported that adolescent self-organisation, but not conduct
problems or emotional problems, was associated with lower memory scores at age 43,
but not decline from age 43 to 60-64 (Xu et al., 2013). It is possible, however, that
participants may have still been relatively young for detection of significant cognitive
decline in both of these studies. Indeed, recent evidence shows that in the NSHD cohort,
rate of decline in verbal memory accelerates after age 60 (Davis et al., 2017). Therefore,
the aim of the present study was to extend existing research by testing associations of
affective symptoms in adolescence and adulthood with trajectories of verbal memory
and information processing speed from middle to late adulthood (from age 43 through
age 69). The conceptual framework for this chapter is presented in Figure 3.6.1. The
previous chapter showed that depression in older adulthood may be associated with
decline in cognitive state. This chapter extends those findings by testing whether
affective symptoms much earlier in the life course (i.e. adolescence and early
adulthood) are associated with cognitive trajectories from midlife to early old age.
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3.3. Method
Participants.
Participants were from the MRC NSHD, a nationally representative sample of
5362 individuals born in England, Scotland and Wales during one week of 1946. Since
birth, the cohort members have been followed up 24 times, most recently in 2015. At
age 69, 80% of participants who were currently alive and with a known address in the
UK, took part (N=2148). Of the target sample (N=2698) who were eligible but did not
take part (N=550), 298 (54%) refused to take part temporarily, 155 (28%) did not
respond, 55 (10%) completed postal questionnaire only, 31 (6%) withdrew from the
study, and 11 (2%) were unable to give informed consent. Detailed information about
participation patterns, respondent profiles and data collection methods have been
published elsewhere (Kuh et al., 2011a, 2016; Wadsworth, Kuh, Richards, & Hardy,
2006). All participants provided written informed consent at each wave of data
collection. Ethical approval for the latest data collection was obtained from NRES
Queen Square REC and Scotland A REC.
Measures.
Cognitive function.
Repeated assessments of verbal memory and information processing speed were
available at ages 43, 53, 60-64, and 69 (Davis et al., 2017; Rawle, Davis, et al., 2018;
Richards, Shipley, Fuhrer, & Wadsworth, 2004). Information processing speed was
measured using a letter cancellation task, which required cohort members to cross out as
many randomly distributed target letters as possible from a grid of other letters within a
timed period of 1 minute. Scores ranged from 0-600. Memory function was assessed
using a 15-item word recall task, which required participants to recall as many words as
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possible from a list shown visually at the rate of 1 word per second. Scores ranged from
0-45.
Previously, linear mixed models (linear and quadratic trends) were fit to verbal
memory and information processing speed data available from age 43 to age 69 (Davis
et al., 2017; Rawle, Davis, et al., 2018). The quadratic model was the best fit for both
cognitive domains (Davis et al., 2017; Rawle, Davis, et al., 2018), and therefore used in
the present study to test for associations between affective symptoms in adolescence
and adulthood (ages 13-15, 36 and 43) and cognitive trajectories.
Affective symptoms.
Affective symptoms were assessed at ages 13, 15, 36, 43, 53, 60-64, and 69
(Richards et al., 2014). For the present study, measures of affective symptoms at ages
13, 15, 36, and 43 were included in order to ensure forward temporal associations.
Psychological problems in adolescence (age 13 and age 15) were reported by teachers
using a forerunner of the Rutter A scale (Richards & Abbott, 2009). Previous research
used exploratory factor analysis on this scale at ages 13 and 15 (Xu et al., 2013), and ten
items which loaded strongly onto the factor representing emotional problems at ages 13
and 15 were included in the present study. Confirmatory factor analyses of these items
were run to derive latent affective symptoms scores at both ages, and then the mean of
these factor scores was calculated to represent the measure of adolescent affective
symptoms.
In adulthood, affective symptoms were assessed using the Present State
Examination (PSE) at age 36 (Wing, Cooper, & Sartorius, 1974), and the Psychiatric
Symptom Frequency scale (PSF) at age 43 (Lindelow, Hardy, & Rodgers, 1997). Latent
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trait scores of PSE at age 36, and PSF at age 43 were derived previously (Colman,
Ploubidis, Wadsworth, Jones, & Croudace, 2007).
The original latent scores were categorised into three percentile groups (1st-
50th, 51st-90th, 91th-100th percentiles), which represented no/low, moderate and severe
symptoms, as previously described using NSHD data (Archer et al., 2018), as a measure
of symptom severity. Both continuous and categorical measures of affective symptoms
were used for the analyses.
Covariates.
Key covariates were selected based on previous research: sex, childhood
socioeconomic position (SEP) (Kaplan et al., 2001), childhood cognition (McGurn,
Deary, & Starr, 2008), and educational attainment (Brayne et al., 2010). Childhood SEP
was represented by father’s occupation. This was coded to correspond to social classes
I-V in the Classification of Occupations (1970). Participants were classified by the
following: professional; intermediate; skilled non-manual; skilled manual; partly
skilled; unskilled. In order to maximise sample size, if SEP at age 4 was missing, this
was substituted with SEP at age 11. If SEP at age 4 and 11 were both missing, SEP at
age 15 was used. Educational attainment was represented by the highest qualification
achieved by age 26. This measure was coded according to the UK Burnham scale and
then grouped into 3 categories, including: no educational qualifications; vocational or
GCSE; A-Level or higher. Childhood cognition at age 8 was represented by a composite
score of four tests of verbal and nonverbal ability, including reading comprehension,
word reading, vocabulary, and picture intelligence (Hatch et al., 2007; Richards et al.,
2004). In order to maximise sample size, if cognitive function at age 8 was missing it
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was substituted with z scores of cognitive function at age 11. Where cognitive data was
not available at age 8 or 11, z scores of cognitive function at age 15 were used.
Additional covariates were: psychiatric medication use (Rawle, Cooper, Kuh, &
Richards, 2018) and externalising problems (Archer et al., 2018; Richards & Abbott,
2009). At ages 36, 43, 53, 60-64, and 69, participants were asked about use of
antidepressant and anxiolytic medications. A binary variable was derived, representing
participants who were prescribed these medications during at least one time-point
between ages 36 and 69 compared with participants who were never prescribed these
medications. Externalising problems were measured with the teacher rated forerunner of
the Rutter A scale at ages 13 and 15 (Xu et al., 2013).
Statistical Analyses.
Main analyses.
STATA version 14 (StataCorp, 2015) was used for all the analyses. Linear
mixed models were fitted to model memory and information processing speed
trajectories from middle to late adulthood. Intercepts (age 43) and slopes (from age 43
through age 69) were random and an unstructured covariance structure was assumed.
These models of cognitive trajectories using NSHD data have been described previously
(Davis et al., 2017; Rawle, Davis, et al., 2018). Latent scores of affective symptoms in
adolescence (ages 13-15), and adulthood (36 and 43) were used to predict cognitive
trajectory intercepts and slopes. In order to test for the effect of affective symptom
severity on cognitive trajectories, the ordinal measure based on percentile scores of
affective symptoms representing no/low, moderate and severe symptoms, were added
into the models.
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Initial models were unadjusted (Model 1) and subsequent models were adjusted
for key covariates: adjusted for sex (Model 2); adjusted for sex, childhood cognition,
childhood socioeconomic position, and education by age 26 (Model 3). Because there
was no significant interaction at the 5% level between sex and affective symptoms at
any of the time-points assessed (age 13-15, 36 and 43) for memory or information
processing speed (Supplementary Table 1), sex was used as a covariate, rather than a
moderator, in all subsequent analyses. Additionally, the models were adjusted for the
use of psychiatric medication (Model 4) and adolescent externalising problems (Model
5).
Sensitivity analyses.
The main analyses included participants with cognitive data available in at least
one time point between ages 43 and 69 (including participants who might die during
this period) with, missing data being accounted for using maximum likelihood
estimation. A sensitivity analysis was conducted in order to test whether results might
be affected by mortality. For this, the main models we reran on the sub-sample of
people who were alive by age 69.
In our main analyses, the sample size was restricted to those with data on all on
predictors and covariates available. Therefore, in order to maximise our sample size and
to determine that effects observed were not attributable to the method used to account
for missing data, an additional sensitivity analysis was conducted, in which a multiple
imputation approach was employed using MICE in R (Azur, Stuart, Frangakis, & Leaf,
2011; Buuren & Groothuis-Oudshoorn, 2011). Sixteen imputations were conducted
across 11 sweeps over the life course. Multiple imputation techniques have been used
frequently with NSHD data (Almoosawi, Prynne, Hardy, & Stephen, 2013; Jones et al.,
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2015; Silverwood et al., 2013). The inclusion of a larger number of auxiliary variables
in the model maximises the plausibility of the missing at random (MAR) assumption
(Coley et al., 2011). To determine whether method used to account for missing data had
an effect on our results, all main models were re-run on the imputed sample.
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3.4. Results
Available study sample and demographic information.
Table 3.6.1 shows demographic information for the samples included in the
main analyses with key covariates. A total of 3395 people had both cognitive measures
available in at least one time-point: Verbal memory N = 3404; Information processing
speed N = 3447 (Supplementary Table 2). Of this sample, 2648 (78%) people had
complete information on affective symptoms at each time-point assessed. Of this
number, 2543 (96%) people also had complete information for covariate data
(Supplementary Figure 1). The sample size was slightly larger for those with verbal
memory data (N = 2546) or information processing speed data (N = 2570) than for those
with both (N = 2543).
The sample with cognitive data (both verbal memory and information
processing speed) in at least one time-point and complete predictor and covariate data
(N = 2543) was compared with the sample with cognitive data in at least one time-point
and missing predictor and covariate data (N = 852). The sample with missing data did
not differ from the sample with complete information on sex (X2 = 1.29, p = .26),
education (X2 = 4.68, p = .10), childhood socioeconomic position (X2 = 9.07, p = .11),
childhood cognition (t = -0.96, p = .34), adolescent affective symptoms (t = -0.03, p =
.97), information processing speed scores at any age (Age 43: t = 1.58, p = .11; Age 53:
t = 1.95, p = .051; Age 60-64: t = 1.23, p = .22; Age 69: t = 1.36, p = .17), or verbal
memory scores at any age (Age 43: t = 1.44, p = .15; Age 53: t = 1.17, p = .24; Age 60-
64: t = 1.19, p = .23; Age 69: t = 1.24, p = .21). However, participants with missing
predictor and covariate data had significantly higher level of affective symptoms in
adulthood (Age 36: t = 3.06, p = .002; Age 42: t = 3.58, p < .001).
94
Effects of adolescent and adult affective symptoms on cognitive trajectories.
Fully adjusted models (Model 3, best fit according to AIC and BIC statistics)
revealed that adolescent affective symptoms were significantly associated with
cognitive function at baseline (Verbal Memory: b = -1.11, SE = 0.53, p = .04;
Information Processing Speed: b = -18.17, SE = 7.53, p = .02), but not with rate of
decline (Verbal Memory: b = 0.01, SE = 0.01, p = .30; Information Processing Speed: b
= 0.09, SE = 0.13, p = .50). There were no significant associations between affective
symptoms at ages 36 or 43 and cognitive trajectories between the ages of 43 and 69
(intercept or slope) in unadjusted or adjusted models (Table 3.6.2 & Table 3.6.3).
In order to investigate the effect of symptom severity, an ordinal variable based
on percentile cuts of the latent score of adolescent affective symptoms (0-50th, 51-90th,
91-100th percentile) was included in the models. Fully adjusted models revealed that
both groups with moderate and with severe adolescent symptoms differed significantly
in baseline memory performance from the group with no/low symptoms. Effect sizes
were largest for the highest percentile group of people with the most severe affective
symptoms in adolescence (Moderate symptoms: b = -0.87, SE = 0.42, p = .04; Severe
symptoms: b = -1.88, SE = 0.81, p = .02). Adolescent affective symptom percentile
groups were not significantly associated with the rate of memory decline between the
ages of 43 and 69 (b = 0.01, SE = 0.01, p = .14) (Table 3.6.4, Figure 3.6.2).
In information processing speed models, the moderate symptom group did not
differ significantly from the no/low symptom group on baseline information processing
speed performance (b = -9.25, SE = 5.97, p = .12), but the group with the most severe
symptoms were significantly poorer in baseline information processing speed than the
no/low symptom group (b = -23.42, SE = 11.55, p = .04). Adolescent affective symptom
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percentile groups were not significantly associated with the rate of processing speed
decline between the ages of 43 and 69 (b = 0.04, SE = 0.10, p = .72) (Table 3.6.4,
Figure 3.6.2).
When psychiatric medication use and externalising behaviour in adolescence
were controlled for, results were essentially unchanged for both memory and
information processing speed (Supplementary Tables 3 & 4).
Sensitivity analyses.
As a sensitivity analysis, participants who died before age 69 were excluded (N
= 1028), and main models were re-run on the sample of people who were still living up
to 2015 (N = 4334). From previous research using this data, it is already known that
both affective symptoms (Archer et al., 2018) and cognitive function (memory and
processing speed) (Davis et al., 2016; Kuh et al., 2009) are associated with mortality.
Fully adjusted models revealed that adolescent affective symptoms significantly
predicted baseline level of processing speed (b = -16.76, SE = 7.98, p = .04), but not
decline of processing speed between the age of 43 and 69 (b = 0.05, SE = 0.14, p = .71).
Affective symptoms at ages 36 and 43 did not significantly predict trajectories of
processing speed (intercept or slope). Models including verbal memory showed a
slightly different pattern. No effects were observed for affective problems at any age
across adolescence and adulthood on memory trajectories (intercept or slope) over the
period tested (Supplementary Tables 5 & 6).
Finally, main models were re-run on the imputed sample (N = 3404) to
maximise sample size and to determine whether effects observed were due to the
method used to account for missing data. Effect sizes from the models using the
imputed sample were substantially identical to those produced from the main models
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(Supplementary Tables 7 & 8). Affective symptoms in adolescence significantly
predicted lower cognitive scores at baseline (Memory: b = -1.03, SE = 0.47, p = .03;
Information processing speed: b = -16.81, SE = 6.65, p = .01), but not decline over the
time period tested. Adult affective symptoms did not predict cognitive trajectories.
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3.5. Discussion
Adolescent affective symptoms predicted lower memory and information
processing speed scores in middle adulthood (at age 43). However, adolescent affective
symptoms did not predict rate of cognitive decline over the period of three decades.
Overall, in this study no effects were observed for adult affective symptoms at ages 36
and 43 on cognitive function or decline from middle to late adulthood. Previous
research has reported that affective symptoms in adolescence can have a profound and
long-lasting effect on outcomes later in life, including educational attainment (Fletcher,
2010) and premature mortality (Archer et al., 2018). Findings from the current study
extend this to include lower memory and information processing speed level in midlife,
but not a faster rate of decline from fourth through sixth decade of life.
There was a dose-response between affective symptoms and memory at age 43.
Those with moderate and severe symptoms during adolescence differed significantly in
baseline memory function at age 43 from a group with no/low adolescent symptoms,
but effect sizes were largest for the group with severe adolescent symptoms. These
results also revealed that participants with moderate adolescent affective symptoms did
not differ significantly in baseline information processing speed performance from
participants with no/low adolescent symptoms. However, participants with severe
adolescent affective symptoms did show significantly poorer information processing
speed performance at baseline than participants with no/low adolescent symptoms. This
suggests that effects of adolescent affective symptoms on baseline information
processing speed performance may have been largely driven by cohort members with
more severe adolescent affective symptoms.
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After excluding participants who died before age 69 from the analysis, results
revealed that adolescent, but not adult, affective symptoms significantly predicted
baseline processing speed scores, but not decline over fourth to sixth decade. However,
after excluding deceased individuals from the analysis, the effect of adolescent affective
symptoms on memory was no longer significant. Previous research using NSHD has
shown that affective symptoms during adolescence are associated with premature
mortality (Archer et al., 2018). It is therefore not entirely surprising that when the
sample is restricted to only participants who are alive in 2015, the effects of adolescent
affective symptoms on cognitive outcomes is attenuated, as cohort members with the
most severe adolescent affective symptoms are more likely to have already died by the
time of cognitive assessment in adulthood.
These findings are consistent with those of Richards et al (2014), who reported
no associations between lifetime latent profiles of affective symptoms on cognitive
decline. The present study also found no effects of affective symptoms during adulthood
on cognitive performance and no effects of affective symptoms at any time-point on rate
of cognitive decline over the time period tested. However, in contrast to Richards et al
(2014), in the present study there were significant associations between adolescent
affective symptoms and memory and information processing speed level. This may be
due to differences in the baseline cognitive performance age between the studies.
Richards et al (2014) used cognitive scores at age 60-64 to determine effects of lifetime
affective symptoms on cognitive performance, whereas the present study used cognitive
scores at age 43 as the baseline. The latter is potentially a more stable baseline
uncontaminated by differential age-related decline and prodromal pathological
confounders emerging from mid-life. Additionally, the inclusion of additional waves
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with cognitive data at ages 43 and 69 may explain why these findings in adolescence
differ from those of Richards et al (2014).
Importantly, we did not see any effects of adult affective symptoms (age 36 and
43) on performance or rate of decline in either of the cognitive outcomes assessed. This
suggests that adolescence is an important sensitive period, during which the presence of
more severe affective symptoms may have more profound and lasting long term effects
on cognitive health than affective symptoms present during adulthood. Adolescence
may therefore be a sensitive period, during which the presence of more severe affective
symptoms can impact cognitive health across the life course. It is known that
adolescence is an important period of continued brain maturation, characterised by
major changes in both brain structure and function (Eiland & Romeo, 2013; Whittle et
al., 2014) with long-lasting effects on cognition function and ageing (Andersen, 2003;
Spear, 2000). Early developmental changes that accompany the experience of stress or
depression during adolescence may therefore be the source of cognitive impairment
observed later in life.
Strengths and limitations.
Key strengths of the present study include prospectively assessed measurements
of affective symptoms available across the life course, spanning from multiple time
points in adolescence through to midlife. Additionally, there are multiple repeated
assessments of memory and information processing speed from midlife to older
adulthood which are consistent over time, allowing for longitudinal modelling of
cognitive trajectories.
One potential limitation of the present study is that the NSHD has been
collecting data from cohort members for over 70 years, and as such missing data are
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inevitable. It is therefore possible that characteristics which predict attrition may also be
predictive of greater cognitive decline, and as such these individuals may be under-
represented in the study. In this analysis, we dealt with missing data using maximum
likelihood estimation, minimising issues associated with using a complete case analysis.
In order to determine whether this method influenced results, models were re-run on a
sample derived from a multiple imputation approach. Results from models including the
imputed sample were substantially identical to those without, suggesting that the
method used to account for missing data did not have a considerable impact on these
results. Limitations of the psychometric instruments used to assess cognitive and
affective symptoms should also be acknowledged. Specifically, although necessarily so,
different measures of affective symptoms were used in adolescence and adulthood
which may limit comparability of these measures. Additionally, in adolescence,
affective symptoms were reported by teachers, whereas for all other time points they
were reported directly by the cohort member. Beyond this, cognitive measures were
assessed using single assessments, rather than a more comprehensive cognitive battery,
and only memory and information processing speed were measured repeatedly over
time, although these are key cognitive domains that are sensitive to age- and morbidity-
associated decline. Finally, cognitive assessments were only available in adulthood at
ages 43, 53, 60-64 and 69, and subsequently associations between affective problems
and cognitive function before middle adulthood were not explored.
It is also important to note that affective symptoms were only considered from
ages 13 to age 43 in this study and it is possible that affective symptoms later in the life
course may also play an important role in predicting cognitive function and decline.
Specifically, research has shown that the menopause transition is associated with
approximately a 2- to 4- fold increased risk for major depression and that this effect is
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independent of history of depressive episodes (Bromberger et al., 2011). Additionally,
early cognitive ability is associated with age at menopause (Kok et al., 2006; Kuh et al.,
2005; Richards et al., 1999) and the menopausal transition has been associated verbal
memory function (Richards et al., 2018), and with increased vulnerability to cognitive
impairment (Weber et al., 2014). The menopausal transition may therefore be an
important period within the association between affective disorders and cognitive
function/decline. This is an interesting avenue for consideration in future research.
Implications.
With the high prevalence of mental health problems within adolescent
populations (24% of girls and 9% of boys report high depressive symptoms by the age
of 14 (Patalay & Fitzsimons, 2017), these findings are potentially of great importance
for public health. Additionally, there is evidence to suggest that the prevalence of
affective symptoms are increasing over time within this adolescent age-group, with
depressive symptoms increasing from 13.1% in 2009 to 20.3% in 2014 in adolescent
girls (Fink et al., 2015). This high and increasing prevalence is particularly concerning
when considered in the context of the results from this study, showing long-lasting
effects of adolescent affective symptoms on cognitive health into midlife and beyond, as
well as other recent studies demonstrating other negative adult outcomes of adolescent
affective symptoms, including educational attainment (Fletcher, 2010) and premature
mortality (Archer et al., 2018).
In conclusion, our findings suggest that adolescent affective symptoms are
important predictors of cognitive function in midlife, but they do not predict the rate of
cognitive decline from middle to late adulthood in cognitively healthy individuals.
Taken together, these findings highlight the importance of early intervention to prevent
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and manage mental health present during adolescence, in order to protect cognitive
function later in the life course.
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3.6. Tables & figures
Figure 3.6.1: Conceptual framework of Chapter 3
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Table 3.6.1: Demographic information for sample included in fully adjusted memory (n=2546) and information processing speed models
(n=2570)
Demographic information Verbal memory N = 2546 Information processing speed N =2570
Verbal Memory,
Mean (SD)
Age 43 24.65 (6.35) 24.66 (6.35)
Age 53 23.85 (6.34) 23.85 (6.34)
Age 60-64 24.17 (6.16) 24.17 (6.16)
Age 69 22.11 (6.05) 22.11 (6.05)
Processing Speed,
Mean (SD)
Age 43 340.94 (75.99) 340.69 (76.15)
Age 53 279.73 (75.07) 279.55 (75.24)
Age 60-64 265.74 (71.62) 265.74 (71.62)
Age 69 261.20 (73.29) 261.08 (73.28)
Continuous Measures of
Affective Symptoms,
Mean (SD)
Age 13-15 0.02 (0.50) 0.02 (0.49)
Age 36 0.23 (0.84) 0.23 (0.84)
Age 43 0.001 (0.64) 0.005 (0.64)
Categorical Measures of
Affective Symptoms, N
(%)*
- Low affective
symptoms
Age 13-15 1322 (51.92) 1327 (51.63)
Age 36 1323 (51.96) 1335 (51.95)
Age 43 1318 (51.77) 1323 (51.48)
- Moderate affective
symptoms
Age 13-15 994 (39.04) 1009 (39.26)
Age 36 987 (38.77) 995 (38.72)
Age 43 993 (39.00) 1009 (39.26)
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Demographic information (cont.) Verbal memory N = 2546 (cont.) Information processing speed N =
2570 (cont.)
- Severe affective
symptoms
Age 13-15 230 (9.03) 234 (9.11)
Age 36 236 (9.27) 240 (9.34)
Age 43 235 (9.23) 238 (9.26)
Number of episodes of
severe affective
symptoms between ages
13-42, N (%)
0 1970 (77.38) 1988 (77.35)
1 465 (18.26) 467 (18.17)
2 97 (3.81) 100 (3.89)
3 14 (0.55) 15 (0.58)
Sex
N (%)
Male 1262 (49.57) 1278 (49.73)
Female 1284 (50.43) 1292 (50.27)
Childhood Cognition,
Mean (SD) Cognitive score 0.05 (0.83) 0.04 (0.83)
Childhood Social Class,
N (%)
Professional 140 (5.50) 141 (5.49)
Intermediate 430 (16.89) 434 (16.89)
Skilled non-manual 472 (18.54) 474 (18.44)
Skilled manual 786 (30.87) 799 (31.09)
Partly skilled 556 (21.84) 560 (21.79)
Unskilled 162 (6.36) 162 (6.30)
Education,
N (%)
None attempted 934 (36.68) 950 (36.96)
Vocational or GCSE 731 (28.71) 736 (28.64)
A Level or Higher 881 (34.60) 884 (34.40)
Notes: * Low symptoms: 0-50th percentile; Moderate symptoms 51-90th percentile; Severe symptoms: 91-100th percentile.
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Table 3.6.2: Affective symptoms (at ages 13-15, 36, and 43) and verbal memory trajectories – Linear mixed models
Model 1: Model 2: Model 2:
Unadjusted Adjusted for sex
Adjusted for sex, education,
childhood cognition and
SEP
b SE p b SE p b SE p
INTERCEPT TERMS
Affective symptoms in adolescence -2.08 0.54 <.001 -2.29 0.54 <.001 -1.11 0.53 .04
Affective symptoms at age 36 -0.61 0.33 .07 -0.54 0.33 .11 -0.54 0.33 .10
Affective symptoms at age 43 0.87 0.44 .05 0.60 0.44 .18 0.48 0.43 .26
Gender 2.13 0.22 <.001 2.13 0.18 <.001
Childhood cognition 2.48 0.13 <.001
Childhood socioeconomic position -0.02 0.01 .10
Education 1.93 0.13 <.001
SLOPE TERMS
Decline per year (linear) 0.36 0.06 <.001 0.36 0.06 <.001 0.35 0.06 <.001
Decline per year (quadratic) -0.004 0.001 <.001 -0.004 0.001 <.001 -0.004 0.001 <.001
Affective symptoms in adolescence 0.01 0.01 .21 0.01 0.01 .19 0.01 0.01 .30
Affective symptoms at age 36 0.01 0.01 .18 0.01 0.01 .17 0.01 0.01 .31
Affective symptoms at age 43 -0.01 0.01 .08 -0.01 0.01 .07 -0.01 0.01 .12
N 2652 2652 2546
AIC 49763.34 49673.18 46636.31
BIC 49839.82 49755.55 46735.63
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Table 3.6.3: Affective symptoms (at ages 13-15, 36, and 43) and information processing speed trajectories – Linear mixed models
Model 1: Model 2: Model 2:
Unadjusted Adjusted for sex
Adjusted for sex, education,
childhood cognition and
SEP
b SE p b SE p b SE p
INTERCEPT TERMS
Affective symptoms in adolescence -19.66 7.38 .008 -21.56 7.33 .003 -18.17 7.53 .02
Affective symptoms at age 36 -1.04 4.56 .82 -0.21 4.53 .96 0.05 4.64 .99
Affective symptoms at age 43 2.95 6.02 .62 0.15 5.99 .98 0.46 6.10 .94
Gender 21.68 2.44 <.001 21.51 2.47 <.001
Childhood cognition 4.50 1.75 .01
Childhood socioeconomic position -0.36 0.14 .01
Education 8.44 1.75 <.001
SLOPE TERMS
Decline per year (linear) -21.68 0.84 <.001 -21.74 0.84 <.001 -22.02 0.85 <.001
Decline per year (quadratic) 0.17 0.01 <.001 0.17 0.01 <.001 0.17 0.01 <.001
Affective symptoms in adolescence 0.09 0.13 .46 0.09 0.13 .47 0.09 0.13 .50
Affective symptoms at age 36 -0.002 0.08 .98 -0.001 0.08 .99 -0.002 0.08 .98
Affective symptoms at age 43 -0.04 0.10 .68 -0.05 0.10 .66 -0.05 0.11 .62
2677 2677 2570
AIC 93702.93 93627.48 89796.77
BIC 93779.53 93709.98 89896.25
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Table 3.6.4: Effect of adolescent affective symptom percentiles on baseline memory and information processing speed function at age 43
Severity of adolescent
affective symptoms
Verbal Memory Information Processing Speed
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
b (SE), p b (SE), p b (SE), p b (SE), p b (SE), p b (SE), p
No/Low Reference Reference Reference Reference Reference Reference
Moderate -1.11 (0.44), 0.01 -1.30 (0.44), 0.003 -0.87 (0.42), 0.04 -8.63 (5.90), 0.14 -10.26 (5.86), 0.08 -9.25 (5.97), 0.12
High -3.21 (0.84), <.001 -3.51 (0.84), <.001 -1.88 (0.81), 0.02 -25.53 (11.39), 0.03 -27.98 (11.32), 0.01 -23.42 (11.55), 0.04
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Figure 3.6.2: Cognitive trajectories from ages 43 to 69 by exposure to affective symptoms in adolescence
Note: Adolescent affective symptoms split into three groups with either ‘no/low adolescent affective symptoms’, ‘moderate adolescent affective
symptoms’ or ‘high adolescent affective symptoms’ by dividing participants based on percentiles (0-50 th percentile, 51-90th percentile, and 91-
100th percentile).
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3.7. Supplementary material
Supplementary Table 1: Interaction effects of sex and affective symptoms on verbal
memory and processing speed trajectories.
Supplementary Table 2: Number of participants with cognitive data available.
Supplementary Table 3: Affective symptoms and cognitive trajectories, adjusting for
anxiolytic and antidepressant medication use.
Supplementary Table 4: Affective symptoms and cognitive trajectories, adjusting for
adolescent externalising behaviour.
Supplementary Table 5: Affective symptoms and verbal memory trajectories,
excluding participants who died before age 69.
Supplementary Table 6: Affective symptoms and information processing speed
trajectories, excluding participants who died before age 69.
Supplementary Table 7: Affective symptoms and verbal memory trajectories using
imputed sample (N=3404).
Supplementary Table 8: Affective symptoms and information processing speed
trajectories using imputed sample (N=3404).
Supplementary Figure 1: Flow chart of available sample.
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Supplementary Table 1: Interaction effects of sex and affective symptoms on verbal memory and processing speed trajectories.
Cognitive domain Interaction effect b SE p
Verbal Memory
Sex x Age 13-15 affective symptoms 0.05 0.44 .91
Sex x Age 36 affective symptoms -0.49 0.27 .08
Sex x Age 43 affective symptoms -0.29 0.36 .43
Processing Speed
Sex x Age 13-15 affective symptoms 3.50 4.91 .48
Sex x Age 36 affective symptoms -1.19 3.05 .70
Sex x Age 43 affective symptoms 3.81 4.04 .35
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Supplementary Table 2: Number of participants with cognitive data available.
Number of time points with cognitive data available Number of cohort members
Memory Processing Speed
0 1958 1915
1 495 487
2 654 648
3 657 675
4 1598 1637
Total with cognitive data at 1 or more time-points 3404 3447
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Supplementary Table 3: Affective symptoms and cognitive trajectories, adjusting for anxiolytic and antidepressant medication use.
Verbal Memory Information processing speed
b SE p b SE p
INTERCEPT TERMS
Affective symptoms in adolescence -1.12 0.53 .03 -18.04 7.53 .02
Affective symptoms at age 36 -0.54 0.33 .10 0.47 4.65 .92
Affective symptoms at age 43 0.51 0.43 .24 0.86 6.11 .89
Gender 2.16 0.18 <.001 21.61 2.48 <.001
Childhood cognition 2.46 0.13 <.001 4.55 1.76 .01
Childhood socioeconomic position -0.02 0.01 .11 -0.36 0.14 .01
Education 1.93 0.13 <.001 8.38 1.75 <.001
Anxiolytic medication use 0.51 0.46 .27 -8.23 6.24 .19
Antidepressant medication use -0.79 0.34 .02 -0.81 4.52 .86
SLOPE TERMS
Decline per year (linear) 0.35 0.06 <.001 -22.02 0.85 <.001
Decline per year (quadratic) -0.004 0.001 <.001 0.17 0.01 <.001
Affective symptoms in adolescence 0.01 0.01 .29 0.09 0.13 .51
Affective symptoms at age 36 0.01 0.01 .32 -0.003 0.08 .96
Affective symptoms at age 43 -0.01 0.01 .13 -0.05 0.11 .62
N 2546 2570
AIC 46634.28 89798.9
BIC 46745.28 89910.08
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Supplementary Table 4: Affective symptoms and cognitive trajectories, adjusting for adolescent externalising behaviour.
Verbal Memory Information processing speed
b SE p b SE p
INTERCEPT TERMS
Affective symptoms in adolescence -1.15 0.53 .03 -18.47 7.53 .01
Affective symptoms at age 36 -0.53 0.33 .11 0.08 4.64 .99
Affective symptoms at age 43 0.50 0.43 .24 0.60 6.10 .92
Gender 2.08 0.18 <.001 21.22 2.48 <.001
Childhood cognition 2.46 0.13 <.001 4.39 1.76 .01
Childhood socioeconomic position -0.02 0.01 .11 -0.36 0.14 .01
Education 1.86 0.13 <.001 8.00 1.79 <.001
Adolescent externalising behaviour -0.48 0.18 .008 -3.04 2.43 .21
SLOPE TERMS
Decline per year (linear) 0.35 0.06 <.001 -22.02 0.85 <.001
Decline per year (quadratic) -0.004 0.001 <.001 0.17 0.01 <.001
Affective symptoms in adolescence 0.01 0.01 .30 0.09 0.13 .51
Affective symptoms at age 36 0.01 0.01 .31 -0.001 0.08 .99
Affective symptoms at age 43 -0.01 0.01 .12 -0.05 0.11 .61
N 2546 2570
AIC 46631.26 89797.21
BIC 46736.42 89902.54
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Supplementary Table 5: Affective symptoms and verbal memory trajectories, excluding participants who died before age 69.
Model 1: Model 2: Model 2:
Unadjusted Adjusted for sex
Adjusted for sex, education,
childhood cognition and
SEP
b SE p b SE p b SE p
INTERCEPT TERMS
Affective symptoms in adolescence -1.92 .57 .001 -2.14 0.58 <.001 -0.99 0.56 .08
Affective symptoms at age 36 -0.48 0.35 .17 -0.41 0.35 .25 -0.38 0.34 .27
Affective symptoms at age 43 0.96 0.46 .04 0.67 0.46 .15 0.37 0.44 .41
Gender 2.11 0.23 <.001 2.13 0.19 <.001
Childhood cognition 2.52 0.14 <.001
Childhood socioeconomic position -0.02 0.01 .09
Education 1.92 0.14 <.001
SLOPE TERMS
Decline per year (linear) 0.40 0.06 <.001 0.40 0.06 <.001 0.39 0.06 <.001
Decline per year (quadratic) -0.004 0.001 <.001 -0.004 0.001 <.001 -0.004 0.001 <.001
Affective symptoms in adolescence 0.01 0.01 .24 0.01 0.01 .23 0.01 0.01 .33
Affective symptoms at age 36 0.01 0.01 .34 0.01 0.01 .33 0.003 0.01 .58
Affective symptoms at age 43 -0.01 0.01 .09 -0.01 0.01 .08 -0.01 0.01 .20
N 2339 2339 2248
AIC 46098.96 46019.66 43243.58
BIC 46173.81 46100.26 43340.78
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Supplementary Table 6: Affective symptoms and information processing speed trajectories, excluding participants who died before age 69.
Model 1: Model 2: Model 2:
Unadjusted Adjusted for sex
Adjusted for sex, education,
childhood cognition and
SEP
b SE p b SE p b SE p
INTERCEPT TERMS
Affective symptoms in adolescence -18.49 7.81 .02 -20.45 7.76 .008 -16.76 7.98 .04
Affective symptoms at age 36 -3.80 4.75 .42 -3.01 4.72 .52 -2.68 4.84 .58
Affective symptoms at age 43 3.65 6.27 .56 0.70 6.24 .91 0.79 6.36 .90
Gender 20.72 2.56 <.001 20.70 2.60 <.001
Childhood cognition 4.33 1.85 .02
Childhood socioeconomic position -0.36 0.15 .01
Education 8.26 1.84 <.001
SLOPE TERMS
Decline per year (linear) -21.33 0.86 <.001 -21.39 0.86 <.001 -21.63 0.88 <.001
Decline per year (quadratic) 0.16 0.01 <.001 0.16 0.01 <.001 0.17 0.01 <.001
Affective symptoms in adolescence 0.06 0.13 .64 0.06 0.13 .64 0.05 0.14 .71
Affective symptoms at age 36 0.03 0.08 .70 0.03 0.08 .69 0.03 0.08 71
Affective symptoms at age 43 -0.04 0.11 .69 -0.04 0.11 .69 -0.05 0.11 .65
N 2353 2353 2260
AIC 86913.68 86851.53 83314.71
BIC 86988.60 86932.21 83412.00
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Supplementary Table 7: Affective symptoms and verbal memory trajectories using imputed sample (N=3404).
Model 1: Model 2: Model 2:
Unadjusted Adjusted for sex Adjusted for sex, education,childhood cognition and SEP
b SE p b SE p b SE p
INTERCEPT TERMS
Affective symptoms in adolescence -1.79 0.49 <.001 -1.96 0.49 <.001 -1.03 0.47 .03
Affective symptoms at age 36 -0.21 0.30 .48 -0.14 0.30 .63 -0.22 0.29 .45
Affective symptoms at age 43 0.57 0.39 .15 0.30 0.40 .45 0.41 0.38 .28
Gender 2.08 0.19 <.001 2.20 0.16 <.001
Childhood cognition 1.96 0.11 <.001
Childhood socioeconomic position -0.19 0.07 .005
Education 2.14 0.11 <.001
SLOPE TERMS
Decline per year (linear) 0.35 0.06 <.001 0.34 0.06 <.001 0.35 0.06 <.001
Decline per year (quadratic) -0.004 0.001 <.001 -0.004 0.001 <.001 -0.004 0.001 <.001
Affective symptoms in adolescence 0.01 0.01 .20 0.01 0.01 .20 0.01 0.01 .19
Affective symptoms at age 36 0.001 0.005 .83 0.001 0.005 .80 0.0001 0.005 .98
Affective symptoms at age 43 -0.01 0.01 .18 -0.01 0.01 .18 -0.01 0.01 .12
N 3404 3404 3404
AIC 61548.6 61436.6 60233.0
BIC 61628.3 61522.5 60337.3
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Supplementary Table 8: Affective symptoms and information processing speed trajectories using imputed sample (N=3447).
Model 1: Model 2: Model 2:
Unadjusted Adjusted for sex
Adjusted for sex, education,
childhood cognition and
SEP
b SE p b SE p b SE p
INTERCEPT TERMS
Affective symptoms in adolescence -18.91 6.69 .005 -20.16 6.65 .002 -16.81 6.65 .01
Affective symptoms at age 36 -0.61 4.09 .88 0.08 4.07 .98 -0.04 4.06 .99
Affective symptoms at age 43 3.08 5.43 .57 0.50 5.41 .93 0.88 5.40 .87
Gender 20.20 2.18 <.001 20.99 2.16 <.001
Childhood cognition 3.29 1.49 .03
Childhood socioeconomic position -2.15 0.89 .02
Education 9.40 1.48 <.001
SLOPE TERMS
Decline per year (linear) -22.01 0.77 <.001 -22.07 0.77 <.001 -22.02 0.77 <.001
Decline per year (quadratic) 0.17 0.01 <.001 0.17 0.01 <.001 0.17 0.01 <.001
Affective symptoms in adolescence 0.15 0.12 .19 0.15 0.12 .21 0.14 0.12 .22
Affective symptoms at age 36 -0.004 0.07 .96 -0.002 0.07 .97 -0.01 0.07 .90
Affective symptoms at age 43 -0.07 0.09 .49 -0.07 0.09 .48 -0.07 0.09 .45
N 3447 3447 3447
AIC 115826.7 115744.3 115643.8
BIC 115906.6 115830.3 115748.2
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Supplementary Figure 1: Flow chart of available sample.
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CHAPTER 4
Study 3: Bidirectional relation between affective
symptoms and cognitive function from middle to late
adulthood: a prospective population-based birth
cohort study.
Study 3 is under review in British Journal of Psychiatry (BJP).
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4.1. Abstract
The aim of this study was to test for possible bidirectional relationships between
affective symptoms and cognitive function (memory and information processing speed)
from middle to late adulthood. Data were available from the MRC National Survey of
Health and Development (NSHD), a prospective birth cohort of 5362 people born in
1946. Affective symptoms and cognition were measured at ages 53, 60-64, and 69.
Latent scores of affective symptoms were derived at each time point and cross-lagged
models were fitted for affective symptoms with memory and information processing
speed separately to model bidirectional relationships. Models were adjusted for sex,
childhood socioeconomic position, education, and National Adult Reading Test score.
Results revealed an inverse cross-sectional association between affective symptoms and
memory (β = -0.18, SE = 0.04, p < .001) and information processing speed (β = -0.13, 
SE = 0.06, p = .05) at age 53, but not at ages 60-64 or 69. Affective symptoms at age 53
significantly predicted lower memory at age 60-64 (β = -0.58, SE = 0.27, p = .03), and
affective symptoms at age 60-64 was associated with lower memory (β = -0.64, SE = 
0.29, p = .03) and information processing speed (β = -1.27, SE = 0.41, p = .002) at age
69. Memory and information processing speed did not predict subsequent affective
symptoms. Affective symptoms predict poorer memory and information processing
speed over a period of 16-years, but the association does not operate in the opposite
direction. Future research should test whether treatment of affective disorders can
reduce risk of poorer cognitive outcomes.
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4.2. Introduction
Affective disorders are common in midlife, with 19% of women and 14.9% of
men between the age 55-64 reporting symptoms of depression (Stansfeld et al., 2014).
Additionally, research shows that affective symptoms in older age are highly comorbid
with cognitive impairment. It has been estimated that around 32% of people with
dementia present with high depressive symptoms compared with only 7% of people in
the general population (Lyketsos et al., 2002).
Previous research has also shown that a longitudinal association may exist
between affective symptoms and cognitive function over time, although the precise
temporal order remains unclear. There has been some evidence that affective symptoms
can precede subsequent development of dementia (Da Silva et al., 2013; Gulpers et al.,
2016; Jorm, 2001; Ownby et al., 2006), cognitive decline (John et al., 2018), and poorer
cognitive level (John et al., 2019). However, other research has suggested that cognitive
function can predict subsequent level of affective symptoms (Jajodia & Borders, 2011).
A bi-directional longitudinal association between affective symptoms and cognitive
function is therefore possible, but evidence is inconsistent. For example, Jajodia and
Borders, (2011) reported that in 14000 adults over the age of 50, memory performance
predicted increases in depressive symptoms over a follow-up period of 8-years, but not
vice versa. Vinkers et al (2004) studied 500 people aged 85 over a 4-year follow-up.
Similarly, it was concluded that poorer attention and memory function at baseline were
related to faster increases in depressive symptoms. No associations were observed
between baseline depression and change in cognitive function. Gale, Allerhand, &
Deary (2012) reported that in a sample of 8611 people over the age of 50, higher levels
of depression were associated with faster cognitive decline over a follow-up period of 7-
years, but only in people aged 60-80 years old. However, cognitive function was not
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associated with change in depressive symptoms over time. In these studies, samples
were based on people over the age of 50 at baseline, and therefore the analyses was
unable to account for earlier life influences which may be pertinent within this
association. Additionally, follow-up periods were relatively short (<10 years), so it is
unclear how affective symptoms and cognitive function may interact with each other
over a longer period of time.
The aim of the present study is to clarify and extend previous research by testing
bidirectional relationships between affective symptoms and cognition function (memory
and information processing speed) over a period of 16-years: from middle age (53),
through late middle age (60-64) to older age (69). The conceptual framework for this
chapter is presented in Figure 4.6.1. The previous chapters showed that affective
symptoms in older adulthood are associated with subsequent decline in cognitive state
and that affective symptoms in adolescence are associated with cognitive intercept, but
not slope from midlife to early old age. This chapter extends those findings by testing
bidirectional associations between affective symptoms and cognitive function across
midlife to early old age.
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4.3. Method
Participants.
Data from the MRC National Study of Health and Development (NSHD) were
used. The sample originally comprised 5362 males and females born in mainland UK in
1946. Data has been collected from participants at 24 time points, most recently when
participants were aged 69. At the latest sweep, 80% (N=2148) of participants who were
alive and with a known UK address, participated (Kuh et al., 2016). Reasons for non-
participation at age 69 varied; 155 cohort members did not respond to the invitation, 55
people only took part in the postal questionnaire, 298 people refused to participate, 31
people withdrew from the study, and 11 were not able to provide informed consent.
Further information about data collection and participation rates in NSHD is available
elsewhere (Kuh et al., 2011b, 2016; Wadsworth et al., 2006). Informed consent was
provided by participants at every wave and the latest ethical approval was obtained from
NRES Queen Square REC and Scotland A REC. Further ethical approval for the current
study has been received from the University of Sussex (ER/AJ316/1).
Measures.
Cognitive function.
The current study focuses on measures of verbal memory and information
processing speed measured three times, at ages 53, 60-64, and 69. Memory was
assessed using a word recall test with 3 administrations. At each administration
participants were asked to recall as many words from the list as they could, with
possible scores ranging from 0-45. A letter cancellation task was used to capture
information processing speed. For this task, participants were asked to cross out the
target letters P and W from a letter grid within a 1 minute time limit, as quickly and
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accurately as possible, with possible scores ranging from 0-600. These measures have
been described in detail elsewhere (Davis et al., 2017; Rawle, Davis, et al., 2018;
Richards et al., 2004).
Affective symptoms.
Affective symptoms were measured at multiple time points across the life course
(ages 13, 15, 36, 43, 53, 60-64, and 69). For the current study, measures of affective
symptoms assessed at ages 53, 60-64, and 69 were included in main analyses. At all
three of these latter time points, the 28 item General Health Questionnaire (GHQ-28)
was used. Research has shown that the GHQ is a consistent and reliable measure in
detecting psychiatric symptoms in a general population across multiple time points with
long intervals between testing (Pevalin, 2000).
Covariables.
The covariables selected for the analysis were sex, childhood socioeconomic
position (SEP) (Kaplan et al., 2001), education (Hatch, Feinstein, Link, Wadsworth, &
Richards, 2007), and score on the National Adult Reading Test (NART) at age 53
(James et al., 2018). Score on the National Adult Reading Test was adjusted for to
account for crystallised intelligence and to isolate associations between affective
symptoms and fluid cognitive abilities (James et al., 2018). Details about how
covariables were derived is presented in Supplementary Material 1A
Statistical Analyses.
The GHQ-28 measure of affective symptoms comprises four sub-scales
measuring depression, anxiety, social dysfunction, and somatic symptoms. To take
account of the four factor structure within the GHQ at each time point, second order
confirmatory factor analysis (CFA) was conducted to derive latent scores of affective
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symptoms at each time point. Model fit was assessed and measurement invariance was
tested to check that the same latent construct was captured over time (Supplementary
Figure 1).
To explore bidirectional relationships between affective symptoms and cognitive
function across middle to late adulthood, cross-lagged models were fitted for memory
and processing speed separately. This method allows directional relationships between
two variables to be estimated across multiple time points. Benefits of cross-lagged
methods are that lagged associations between variables can be estimated, while
simultaneously allowing for cross-sectional associations and auto-correlations across
repeated measures over time (Kearney, 2017). Models included affective symptoms and
cognitive function at ages 53, 60-64 and 69. Two main models were fitted, including:
Model 1: Unadjusted; Model 2: Adjusted for covariables: sex, childhood socioeconomic
position, education by age 26, score on NART. Model fit did not significantly improve
when the analysis was stratified by sex (Supplementary Table 1), suggesting that
patterns of association did not differ significantly between men and women. For this
reason, sex was used as a covariable in all subsequent analyses, rather than as a
stratifying variable.
As a sensitivity analysis, main models were re-run on the sample of people who
were still alive by age 69, to ensure that our results were not affected by mortality. As
an additional sensitivity analysis, main models were re-run excluding participants using
anxiolytic and antidepressant medications at ages 36, 43, 53, 60-64, and 69. Finally to
maximise sample size available for the analyses, we ran a final sensitivity analysis using
multiple imputation with MICE in R (Azur et al., 2011; Buuren & Groothuis-
Oudshoorn, 2011) to impute covariate data for the adjusted models. Multiple imputation
operates by deriving multiple plausible complete datasets, where missing values are
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replaced by imputed values. Results from the generated complete datasets are then
pooled into one (Sterne et al., 2009). Due to the multiple estimations, this analysis can
create plausible standard error estimates (Patrician, 2002). The multiple imputation
approach maximises plausibility of the missing at random assumption, as it allows for
the inclusion of auxiliary variables and covariates in the models (Coley et al., 2011). For
the current analysis, eighteen imputations were conducted over 12 sweeps in NSHD
data. Further information about the multiple imputation process is presented in
Supplementary Material 1B.
Mplus version 8 (Muthén & Muthén, 2017) was used for analyses, and missing
data were dealt with using full information maximum likelihood (FIML) methods for
cognitive and GHQ data, and using multiple imputation for covariables.
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4.4. Results
Available sample and missing data.
The available sample included all participants with at least one measure of
affective symptoms or cognitive function. Slightly different sample sizes were available
for memory and processing speed. Specifically, 3125 survey members had at least one
measure of memory or affective symptoms (58.3% of the original birth sample) and of
this group, 2028 (64.9%) also had complete information for all covariables. In total,
3127 (58.3%) people had data for processing speed or affective symptoms in at least
one time point of the total sample available at birth. Of this group, 2028 (64.9%) also
had data for all covariables. For more information about available data, see Figure 4.6.2.
The sample with at least one measure of affective symptoms or cognition
available at any time point (Memory: N = 3125; Processing speed: N = 3127) was
compared on key childhood and adulthood variables with the sample with missing data
on all assessments of cognition and affective symptoms (Memory: N = 2237;
Processing speed: N = 2235). The sample with key data available did not differ from the
sample with missing data on anxiolytic medication use (p = .08). However, the sample
with missing data had significantly more males and fewer females than the sample with
complete data available (p < .001). The sample with missing data also had significantly
lower socioeconomic position at age 15 (p = .02), lower cognitive scores at age 15 (p <
.001), lower educational level (p < .001), higher affective symptom scores at age 36 (p =
.01), higher affective symptom scores at age 43 (p = .03), and lower antidepressant
usage in adulthood (p < .001). Due to differences between the sample with complete
covariate data and the sample with missing data, a sensitivity analysis was conducted
using a multiple imputation approach to impute all covariate data. Further information
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about the multiple imputation process is available in Supplementary Material 1B. Table
4.6.1 shows demographic information for the samples included in the analysis.
Longitudinal measurement model for affective symptoms.
Before fitting the cross-lagged model, the second order confirmatory factor
analysis of the GHQ measurements over time was fitted to ensure this was an
appropriate fit to the data for subsequent analysis. The second order CFA fit the data
well (χ2 (3387) = 17138.88, p < .001; CFI = .915; TLI = .912; RMSEA = .036).
Indicators all loaded significantly onto the factors (p < .001). Measurement invariance
of the first order factors was assessed by constraining factor loadings to be equal across
time over the first order. There was not a significant deterioration in model fit after
constraining according to a chi square difference test (Supplementary Table 2). Next,
factor loadings were constrained to be equal over the first and second order factors.
Again, model fit did not significantly deteriorate (Supplementary Table 2). Therefore, it
was concluded that the GHQ measure captured the same latent construct over the three
waves for both the first and second order factors.
Cross-lagged models.
Memory.
The cross-lagged memory model showed excellent fit to the data (χ2 (2) = 5.39, p
= .07; CFI = 1.00, TLI = 1.00; RMSEA = 0.02). The unadjusted model showed that all
autoregressive pathways were significant, demonstrating stability in constructs over
time for both memory and affective symptoms. There were significant cross-sectional
associations between memory and affective symptoms at all ages (Age 43: β = -0.09, SE 
= 0.05, p = .05; Age 60-64: β = -0.04, SE = 0.02, p = .03; Age 69: β = -0.03, SE = 0.01, 
p = .04). Poorer memory function at age 53 significantly predicted higher affective
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symptoms at age 60-64 (β = -0.002, SE = 0.001, p = .004). Additionally, higher
affective symptoms at age 60-64 was significantly associated with poorer memory
function at age 69 (β = -0.60, SE = 0.25, p = .02) (Supplementary Figure 2).
The fully adjusted model also fit the data very well (χ2 (2) = 7.03, p = .03; CFI =
1.00, TLI = 0.99; RMSEA = 0.03). The fully adjusted model showed that all
autoregressive pathways were significant. Results also revealed that there was a
significant association between memory and affective symptoms at age 53 (β = -0.18, 
SE = 0.04, p < .001), but this cross-sectional effect no longer persisted over time at ages
60-64 (β = -0.03, SE = 0.02, p = .20) and age 69 (β = -0.03, SE = 0.02, p = .06).
Additionally, higher affective symptoms at age 53 significantly predicted lower memory
performance at age 60-64 (β = -0.58, SE = 0.27, p = .03), and higher affective
symptoms at age 60-64 were significantly associated with poorer memory at age 69 (β = 
-0.64, SE = 0.29, p = .03). There were no significant longitudinal associations between
memory scores and subsequent level of affective symptoms (Figure 4.6.3).
Processing Speed.
The cross-lagged processing speed model was also an excellent fit to the data (χ2
(2) = 0.81, p = 67; CFI = 1.00, TLI = 1.00; RMSEA = 0.00). The unadjusted model
revealed that as with the memory model, all autoregressive pathways were statistically
significant, showing stability in constructs over time. In this unadjusted model, there
were no cross-sectional or longitudinal associations between affective symptoms and
processing speed (Supplementary Figure 3).
The fully adjusted model was also a good fit to the data (χ2 (2) = 1.76, p = .41;
CFI = 1.00, TLI = 1.00; RMSEA = 0.00). In the fully adjusted model, all of the
autoregressive pathways remained significant. There was a significant association
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between affective symptoms and processing speed present at age 53 (β = -0.13, SE = 
0.06, p = .05), but not at ages 60-64 (β = -0.02, SE = 0.03, p = .52) or 69 (β = -0.02, SE 
= 0.02, p = .31). Additionally, results from the fully adjusted model showed that higher
level of affective symptoms at age 60-64 significantly predicted worse processing speed
performance at age 69 (β = -1.27, SE = 0.41, p = .002). No other cross lagged pathways
were statistically significant (Figure 4.6.4).
Sensitivity analysis.
As a sensitivity analysis, the main models were re-run after excluding
participants who died by age 69 from the analysis, to ensure results were not influenced
by mortality. These models fit the data well (Memory: χ2 (2) = 6.86, p = .03; CFI =
1.00; TLI = 0.99; RMSEA = 0.04. Processing speed: χ2 (2) = 1.76, p = .42; CFI = 1.00;
TLI = 1.00; RMSEA = 0.00). Results from memory models including the sample alive
by age 69 remained consistent. The fully adjusted model showed a significant cross-
sectional association between affective symptoms and memory at age 53 (β = -0.16, SE 
= 0.05, p = .001), and significant lagged pathways between affective symptoms at age
53 and memory at age 60-64 (β = -0.65, SE = 0.28, p = .02) and between affective
symptoms at age 60-64 and memory at age 69 (β = -0.64, SE = 0.29, p = .03). No other
pathways reached statistical significance (Supplementary Figure 4). Results from
processing speed models excluding people who died by age 69 were also similar to
those from the main models. Specifically, affective symptoms at age 60-64 significantly
predicted poorer processing speed at age 69 (β = -1.27, SE = 0.41, p = .002). Again, no
other pathways were statistically significant (Supplementary Figure 5).
Main models were re-run excluding people taking anxiolytic or antidepressant
medication. Results from this analysis were similar to main models. The models fit the
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data well (Memory: χ2 (2) = 4.82, p = .09; CFI = 1.00; TLI = 0.99; RMSEA = 0.03.
Processing speed: χ2 (2) = 1.22, p = .54; CFI = 1.00; TLI = 1.00; RMSEA = 0.00).
Results from memory models show that there is a cross-sectional association between
affective symptoms and memory function at age 53 (β = -0.14, SE = 0.05, p = .002), and
a longitudinal association between affective symptoms at age 53 and memory function
at age 60-64 (β = -0.63, SE = 0.31, p = .04). No other cross-sectional or lagged
pathways reached statistical significance (Supplementary Figure 6). Results from
processing speed models showed no significant cross-sectional associations between
affective symptoms and processing speed function. However, affective symptoms at age
60-64 significantly predicted lower processing speed scores at age 69 (β = -1.38, SE = 
0.46, p = .003). No other longitudinal pathways were significant (Supplementary Figure
7).
Finally, to check whether results were affected by missing data, a sensitivity
analysis was run using multiple imputation to impute covariate data. Models fit the data
well (Memory: χ2 (2) = 2.88, p = .24; CFI = 1.00; TLI = 1.00; RMSEA = 0.01.
Processing speed: χ2 (2) = 1.29, p = .53; CFI = 1.00; TLI = 1.00; RMSEA = 0.00) and
results were consistent with main models. The fully adjusted memory model showed
significant cross sectional associations between affective symptoms and memory
function at age 53 (β = -0.15, SE = 0.04, p < .001) and age 60-64 (β = -0.04, SE = 0.02, 
p = .03), but not at age 69 (β = -0.02, SE = 0.01, p = .10). Affective symptoms at age
60-64 also significantly predicted poorer memory at age 69 (β = -0.73, SE = 0.25, p =
.004). No other longitudinal pathways were significant (Supplementary Figure 8). The
fully adjusted processing speed model revealed a significant cross-sectional association
between affective symptoms and processing speed at age 53 (β = -0.16, SE = 0.05, p =
.003) but not at ages 60-64 (β = -0.01, SE = 0.02, p = .68) or age 69 (β = -0.03, SE = 
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0.02, p = .12). Affective symptoms at age 60-64 significantly predicted poorer
processing speed at age 69 (β = -0.73, SE = 0.36, p = .04), but no other pathways
reached statistical significance (Supplementary Figure 9).
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4.5. Discussion
There was a cross-sectional inverse association between affective symptoms and
cognitive function (both memory and processing speed) in mid-life (age 53), but not at
ages 60-64 or 69. Additionally, higher affective symptoms at age 53 significantly
predicted lower memory scores at age 60-64, and affective symptoms at age 60-64 also
predicted lower memory at age 69. However, memory function did not predict
subsequent affective symptoms at any time-point. Results for processing speed models
were similar; higher affective symptoms at age 60-64 significantly predicted poorer
processing speed at age 69. Processing speed did not predict later affective symptoms at
any time-point assessed. Overall, these results are consistent with previous research
showing that affective symptoms can predict subsequent cognitive function (James et
al., 2018; John et al., 2019, 2018). Our findings extend previous evidence by
demonstrating that this relationship does not operate in the opposite direction over the
period of 16-years.
There are four primary hypotheses that can explain associations between
affective symptoms and cognitive function over time. First, it has been proposed that
affective symptoms be a risk factor for poorer cognitive outcomes (Bennett & Thomas,
2014; Butters et al., 2008). Second, it is possible that affective symptoms may be a
prodromal symptom of cognitive impairment (Bennett & Thomas, 2014; Butters et al.,
2008; Byers & Yaffe, 2011). Third, there may be some common cause factor which
increases risk for both affective disorders and poorer cognitive function (Bennett &
Thomas, 2014; Djernes, 2006; Enache et al., 2011). Finally, it has also been proposed
that affective symptoms may emerge as a response to subjective awareness of memory
impairment (Vinkers et al., 2004). The temporal sequencing over an extended time
frame which emerges in this study does not support the fourth possibility that affective
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symptoms reflect a subjective response to cognitive impairments. Instead, these results
indicate that affective symptoms may precede cognitive impairments by several years
and that increased affective symptoms predict later cognitive function.
Our finding that affective symptoms predicted subsequent processing speed at
the later time-point only (age 69) suggests that the effects of affective symptoms on
lower processing speed, may not be observed until later in the life course. This is
consistent with previous research showing that adult affective symptoms can predict
poorer mid-life memory function at age 50, but no effects were observed on information
processing speed at this age (John et al., 2019). This finding is inconsistent with work
that suggests processing speed may be an important component in memory processing
(Salthouse, 1996). This can potentially be explained by the digit checking task
containing a motor component, compared to the verbal component within the memory
task.
Future research should focus on identifying biological and socio-behavioural
pathways and mechanisms of the longitudinal association between affective disorders
and cognitive function. An additional important avenue for future research is to
investigate whether effective treatment of affective symptoms can reduce risk of poorer
cognitive outcomes later in life.
The key strength of the study is a large, nationally representative, and
prospective sample, with 16-years follow-up period. An additional strength of the study
is the use of consistent measures of affective symptoms and cognitive function.
However, sample attrition is a problem in all long-running cohort studies. In the present
study, missing data was addressed using full information maximum likelihood (FIML)
methods and an additional supplementary analysis was conducted using multiple
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imputation to deal with missing data. Another limitation of the study is that single
cognitive tests were used to measure memory and processing speed, rather than more
comprehensive cognitive batteries. Additionally, other cognitive domains, such as
attention and inhibitory processes, could not be assessed.
Results from the present study show that affective symptoms can predict poorer
cognitive outcomes over a 16-year period: from middle to late adulthood. These
findings have significant value for public health. Understanding longitudinal
associations between affective symptoms and cognitive function offers insights into
maintaining better cognitive health for longer.
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4.6. Tables & figures
Figure 4.6.1: Conceptual framework of Chapter 4
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Table 4.6.1: Demographic information for analysed sample
Demographic Information Memory(N=3125)
Processing Speed
(N=3127)
Sex
N (%)
Male 1557 (49.8) 1559 (49.9)
Female 1568 (50.2) 1568 (50.1)
Childhood socioeconomic position
N (%)
Professional 209 (6.7) 209 (6.7)
Intermediate 725 (23.2) 725 (23.2)
Skilled non-manual 468 (15.0) 468 (15.0)
Skilled manual 962 (30.8) 963 (30.8)
Partly skilled 570 (18.2) 570 (18.2)
Unskilled 191 (6.1) 192 (6.1)
Educational attainment
N (%)
None attempted 1149 (36.8) 1151 (36.8)
A-Level or below 1670 (53.4) 1670 (53.4)
Degree or above 306 (9.8) 306 (9.8)
National Adult Reading Test score
Mean (SD) NART Score 17.2 (9.8) 17.2 (9.8)
Antidepressant medication use
N (%)
Yes 292 (9.3) 293 (9.4)
No 2833 (90.7) 2834 (90.6)
Anxiolytic medication use
N (%)
Yes 157 (5.0) 157 (5.0)
No 2968 (95.0) 2970 (95.0)
Cognitive score
Age 53 23.93 (6.30) 281.07 (76.09)
Age 60-64 24.26 (6.11) 266.71 (71.74)
Age 69 22.20 (6.02) 262.30 (74.15)
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Figure 4.6.2: Flow chart showing available sample size
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Figure 4.6.3: Cross lagged model of affective symptoms and memory from age 53 to 69. Fully adjusted model
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Figure 4.6.4: Cross lagged model of affective symptoms and processing speed from age 53 to 69. Fully adjusted model
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4.7. Supplementary material
Supplementary Material 1A: Details about covariables
Supplementary Material 1B: Technical details for the multiple imputation process
Supplementary Table 1: Model fit for memory and processing speed data stratified by
sex
Supplementary Table 2: Measurement invariance for GHQ over time
Supplementary Figure 1: Diagram of second order confirmatory factor analysis of
GHQ measurements from age 53 to 69
Supplementary Figure 2: Unadjusted memory model
Supplementary Figure 3: Unadjusted processing speed model
Supplementary Figure 4: Memory model excluding participants who died by age 69
Supplementary Figure 5: Processing speed model excluding participants who died by
age 69
Supplementary Figure 6: Memory model excluding participants using psychotropic
medications
Supplementary Figure 7: Processing speed model excluding participants using
psychotropic medications
Supplementary Figure 8: Memory model using imputed data
Supplementary Figure 9: Processing speed model using imputed data
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Supplementary Material 1A: Details about covariables
Fathers’ occupation was used as a measure of childhood SEP for each
participant. This was coded into 6 categories based on social classes I-V in the
Classification of Occupations: professional; intermediate; skilled non manual; skilled
manual; partly skilled; unskilled. The highest qualification achieved by the participant
at age 26 was used as a measure of education. This was coded based on the UK
Burnham Scale into 9 categories: None attempted; Vocational course; Sub GCE or sub
Burnham C; GCE O Level or Burnham C; GCE A Level or Burnham B; Burnham A2;
1st degree; higher degree (Masters); higher degree (doctorate).
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Supplementary Material 1B: Technical details for the multiple imputation process
For this analysis, eighteen imputations were conducted over 12 sweeps. Firstly
data collected at birth was imputed (birthweight, mother’s age when cohort member was
born, father’s age when cohort member was born). Next, the measures collected at birth
were used as auxiliary variables to impute socioeconomic position at age 4. As a next
step, all birth and age 4 variables described above were used to impute variables at age
6 (mother’s educational level and father’s educational level). Next, all birth, age 4 and 6
variables were used to impute cognitive function at age 8. Cognitive function at age 11
was then imputed using the data from birth, age 4, 6, and 8. Data from birth, age 4, 6, 8,
and 11 were used to impute adolescent affective symptoms at age 13. Measures from
birth, age 4, 6, 8, 11, and 13 were used to impute age 15 variables (adolescent affective
symptoms, cognitive function, and socioeconomic position). Educational attainment at
age 26 was imputed using data from birth, age 4, 6, 8, 11, 13, and 15. Psychiatric
symptoms at age 36 were imputed using the data from birth, age 4, 6, 8, 11, 13, 15, and
26. These variables at birth, age 4, 6, 8, 11, 15, 26, and 36 were next used to impute
psychiatric symptoms at age 43. The data from birth, age 4, 6, 8, 11, 15, 26, 36, and 43
were then used to impute National Adult Reading Test score at age 53. Finally, lifetime
use of antidepressant and anxiolytic medications was imputed using data from birth, age
4, 6, 8, 11, 13, 15, 26, 36, 43, and 53.
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Supplementary Table 1: Comparison of fit statistics for memory and processing speed
models stratified by sex
Model χ2 χ2 difference test 
Model 1* χ2 (2) = 5.39, p = .07 Reference
Model 2 χ2 (4) = 7.10, p = .13 p = .43(Neither model is better)
Model 3* χ2 (2) = 0.81, p = .67 Reference
Model 4 χ2 (4) = 1.40, p = .84 p = .74(Neither model is better)
*Reference models
Model 1: Un-stratified memory model; Model 2: Memory model stratified by sex;
Model 3: Un-stratified processing speed model; Model 4: Processing speed model
stratified by sex
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Supplementary Table 2: Measurement invariance for GHQ over time
Model χ2 Model fit χ2 difference test 
Model 1* χ2 (3387) = 17138.88, p < .001 Reference
Model 2 χ2 (3435) = 16208.54, p < .001 χ2 (48) = 930.33, p = .00(Model 2 is better)
Model 3 χ2 (3441) = 15549.97, p < .001 χ2 (54) = 1588.91, p = .00(Model 3 is better)
*Reference model
Model 1: Unconstrained model (reference); Model 2: First order factor loadings
constrained to be equal; Model 3: First and second order factor loadings constrained to
be equal
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Supplementary Figure 1: Diagram of second order confirmatory factor analysis of GHQ measurements from age 53 to 69
148
Supplementary Figure 2: Unadjusted memory model
149
Supplementary Figure 3: Unadjusted processing speed model
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Supplementary Figure 4: Memory model excluding participants who died by age 69
* Adjusted for sex, childhood socioeconomic position, education, and National Adult Reading Test (NART) score.
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Supplementary Figure 5: Processing speed model excluding participants who died by age 69
* Adjusted for sex, childhood socioeconomic position, education, and National Adult Reading Test (NART) score.
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Supplementary Figure 6: Memory model excluding participants using psychotropic medications
* Adjusted for sex, childhood socioeconomic position, education, and National Adult Reading Test (NART) score.
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Supplementary Figure 7: Processing speed model excluding participants using psychotropic medications
* Adjusted for sex, childhood socioeconomic position, education, and National Adult Reading Test (NART) score.
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Supplementary Figure 8: Memory model using imputed data
* Adjusted for sex, childhood socioeconomic position, education, and National Adult Reading Test (NART) score.
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Supplementary Figure 9: Processing speed model using imputed data
* Adjusted for sex, childhood socioeconomic position, education, and National Adult Reading Test (NART) score.
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CHAPTER 5
Study 4: Longitudinal associations of affective
symptoms with midlife cognitive function: evidence
from a British birth cohort.
Study 4 is published in British Journal of Psychiatry as:
John, A., James, S. N., Patel, U., Rusted, J., Richards, M., & Gaysina, D. (2019).
Longitudinal associations of affective symptoms with midlife cognitive function:
evidence from a British birth cohort. British Journal of Psychiatry.
Doi: 10.1192/bjp.2019.24.
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5.1. Abstract
Affective disorders are associated with poorer cognition in older adults;
however, whether this association can already be observed in midlife remains unclear.
This study investigated effects of affective symptoms over a period of 30 years on
midlife cognitive function. First, we explored whether timing (sensitive period) or
persistence (accumulation) of affective symptoms predicted cognitive function. Second,
we tested how different longitudinal trajectories of affective symptoms were associated
with cognitive function. The study used data from the National Child Development
Study. Memory, verbal fluency, information processing speed and accuracy were
measured at age 50. Affective symptoms were measured at ages 23, 33, 42, and 50 and
used to derive longitudinal trajectories. A structured modelling approach compared a set
of nested models in order to test accumulation versus sensitive period hypotheses.
Linear regressions and structural equation modelling were used to test for longitudinal
associations of affective symptoms with cognitive function. Accumulation of affective
symptoms was found to be the best fit for the data, with persistent affective symptoms
being associated with poorer immediate memory (b = -0.07, SE = 0.03, p = .01),
delayed memory (b = -0.13, SE = 0.04, p < .001), and information processing accuracy
(b = 0.18, SE = 0.08, p = .03), but not with information processing speed (b = 3.15, SE
= 1.89, p = .10). Longitudinal trajectories of repeated affective symptoms were
associated with poorer memory, verbal fluency, and information processing accuracy.
Persistent affective symptoms can affect cognitive function in midlife. Effective
management of affective disorders to prevent recurrence may reduce risk of poor
cognitive outcomes and promote healthy cognitive ageing.
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5.2. Introduction
Affective disorders, such as depression and anxiety, have been associated with
impaired cognition, dementia and accelerated cognitive decline in late adulthood (Da
Silva et al., 2013; Gulpers et al., 2016; John et al., 2018). However, there are significant
gaps in our understanding of this association. The majority of studies have been
conducted in older adults, usually over the age of 60 and have only considered this
association in the context of short follow-up periods (<10 years) (Singh-Manoux et al.,
2010). Therefore, it is unclear how affective symptoms are associated with cognitive
function over time. There is some evidence that risk of dementia increases with the
number of affective episodes experienced over the life course; whereby rate of dementia
is estimated to increase by around 13% with each additional depressive episode
(Kessing & Andersen, 2004). Additionally, evidence shows that individuals with
persistent depressive symptoms may be at greater risk for subsequent cognitive deficits
than individuals with fewer episodes (Singh-Manoux et al., 2010). Another line of
evidence suggests that timing, rather than frequency, of affective symptoms can be an
important predictor of cognitive outcomes. For example, depressive symptoms in older
age only were shown to be associated with increased risk of dementia (Singh-Manoux et
al., 2017). However, there is limited inconsistent evidence for associations between
affective disorders and cognitive function before old age in two studies using data from
the MRC National Survey of Health and Development (NSHD). The first study
(Richards et al., 2014) found no associations of affective symptoms measured between
ages 13 to 53 with objectively measured cognitive outcomes at age 60-64, whereas the
most recent study reported that persistent case-level affective symptoms were associated
with poorer cognitive state, verbal memory, and letter search speed and accuracy at age
69 (James et al., 2018). The current study tested for associations of affective symptoms
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across adulthood (ages 23, 33, 42 and 50) with aspects of cognitive function at age 50.
Specifically, two complementary advanced statistical approaches were employed. First,
a structured modelling approach comparing a set of nested models was used to
investigate whether accumulation or timing of case-level affective symptoms can
predict midlife cognition. Second, a latent growth mixture modelling approach was
employed to derive longitudinal trajectories of affective symptoms and to examine how
different longitudinal trajectories of affective symptoms were associated with midlife
cognition.
The conceptual framework for this chapter is presented in Figure 5.6.1. The
previous chapters showed that: 1.) Affective symptoms in older adulthood are
associated with decline in cognitive state; 2.) Affective symptoms in adolescence are
associated with cognitive intercept but not slope from midlife to early old age; 3.)
Affective symptoms are associated with poorer subsequent cognitive scores from
midlife to early old age, but the association did not operate in the opposite direction.
This chapter extends those findings by testing whether accumulation or timing of
affective symptoms are associated with midlife cognition and whether particular
trajectories of affective symptoms predict midlife cognition.
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5.3. Method
Participants.
Participants were from the National Child Development Study (NCDS), a
population representative sample of 18,558 people born during one week of 1958 in
England, Scotland and Wales (i.e., British 1958 birth cohort). This sample comprised
98.2% of total births that week. Data were subsequently collected from participants at
ages 7, 11, 16, 23, 33, 42, 46, and 50 years. Further information about the study sample,
respondent profiles, and data collection methods are described in depth by Power &
Elliott (2006) (Power & Elliott, 2006). Data are available from the UK Data Service
(University of London,. Institute of Education,. Centre for Longitudinal Studies, 2008a,
2008b, 2012, University of London, Institute of Education, & Centre for Longitudinal
Studies, 2008, 2014). Cohort members gave written informed consent to participate.
Ethical approval for the data collection in 2008 was provided by London MREC (REC
reference: 08/H0718/29). Ethical approval for the present study was also provided by
the University of Sussex (Reference number: ER/AJ316/1).
Detailed information about the sample analysed in the present study is presented
in Supplementary Material 1A; Supplementary Figure 1; Supplementary Table 1. There
were 9790 people who participated in 2008 data collection (at age 50). A total of 9385
people of this sample completed the cognitive tests at this time point (95.9%). Of the
9385 participants who completed the cognitive tests at age 50, 4625 had complete
information for all predictors and covariates (49.3% of those with cognitive measures).
Measures.
Cognitive function.
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Cognitive measures collected at age 50 were verbal memory, verbal fluency,
information processing speed and accuracy (Brown & Dodgeon, 2010). Memory was
assessed using a word-recall test with immediate and delayed components. Verbal
fluency was assessed using an animal naming task, in which participants named as
many animals as possible in a 1-minute period. Information processing was assessed
using a letter cancellation task. In this task, cohort members crossed as many target
letters as possible from a grid of letters in a 1 minute period. The results of this task
were split into two scores. The total number of letters scanned represented information
processing speed, and the number of target letters missed up to the final letter searched
represented information processing accuracy. Accuracy was negatively scored, so
higher scores represent poorer performance.
Affective symptoms.
Affective symptoms were assessed using the Malaise Inventory Scale,
administered at ages 23, 33, 42, and 50. This is a measure of psychological distress and
comprises 24 self-completion items, which are combined to assess levels of emotional
disturbance and associated somatic symptoms. The total number of questions answered
‘yes’ was summed, creating a sum score of affective symptoms out of 24. This score
was dichotomised using a standard cut-off threshold score of 7 out of 24 to represent
‘case-level’ affective symptoms, indicating clinically relevant affective symptoms
(Hope, Power, & Rodgers, 1999; Lacey et al., 2012; Sacker & Cable, 2006). At age 50,
a short form of the Malaise Inventory Scale was administered, comprising 9 items. For
this time-point, a recommended cut-off score of 3 was used to categorise case-level
affective symptoms (Bowling, Pikhartova, & Dodgeon, 2016).
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As the short form of the Malaise Inventory Scale was used at age 50, the 9 items
from this short form were extracted from the longer forms used at ages 23, 33, and 42,
in order to make malaise scores over time more comparable to be used for modelling
longitudinal trajectories.
Covariates.
Based on previous research, the following factors were included as potential
confounders: sex, childhood cognition (McGurn et al., 2008), childhood emotional
adjustment (Lupien, McEwen, Gunnar, & Heim, 2009), childhood socio-economic
position (Kaplan et al., 2001), adult socio-economic position (Sattler, Toro,
Schönknecht, & Schröder, 2012), and education (Brayne et al., 2010). Childhood
cognition was assessed at age 11, using a general ability test administered at the child’s
school. Childhood emotional adjustment was assessed at age 11 using the Bristol Social
Adjustment Guides (BSAG) (Mcdermott & Watkins, 2017). This questionnaire was
completed by teachers and is designed to assess behaviour that may be indicative of
maladjustment and emotional disturbance. A measure of household socio-economic
position at age 11 was derived using guidelines from the Centre for Longitudinal
Studies (CLS) (Elliott & Lawrence, 2014), based on measures of father’s occupation,
mother’s occupation, and household tenure. Highest educational attainment was derived
by combining education data from 1991, 2000, 2004, and 2008 to ascertain the highest
academic qualification the cohort member had achieved by age 50. Adult socio-
economic position was based on occupation, with three categories (working,
intermediate and middle class). Additional information about these covariates are
included in Supplementary Material 1B.
Analytical procedure.
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First, a structured modelling approach was used to compare a set of nested
models corresponding to accumulation and sensitive period hypotheses to a saturated
model including all main effects and all possible interactions (James et al., 2018; Mishra
et al., 2009; Murray et al., 2011). The sensitive period model included three measures
indicating whether an individual experienced case-level affective symptoms at three
time windows across the life course: early adulthood (age 23); middle adulthood (ages
33 and/or 42); midlife (age 50). The accumulation model included a measure of the
number of time-points (of the three time windows described above) in which each
individual experienced case-level affective symptoms. The saturated model was also
compared with a ‘null’ model that assumed no effect of affective symptoms on midlife
cognition. Partial F tests were used to compare each hypothesis to the fully saturated
model. Where multiple P values were > .05, the model with the highest P value and
lowest F statistic were selected as the best fit for the data. This analysis was conducted
in STATA V14.2.
Four variables with case-level affective symptoms were summed up to create a
variable for accumulation of adult affective symptoms (ranging from 0 to 4). Linear
regression models were fitted to test for associations of accumulation of adult affective
symptoms and cognitive function at age 50. For these analyses, four models were fitted:
unadjusted (Model 1); adjusted for sex only (Model 2); additionally adjusted for child
cognition, emotional disturbance and socio-economic position (Model 3); and
additionally adjusted for highest educational attainment, and adult socio-economic
position (Model 4). This analysis was conducted in R V3.5.1.
To account for missing data, multiple imputation analysis was conducted on the
sample with cognitive data. All analyses described above were re-run using imputed
variables for the key predictors. Multiple imputation was conducted in R using the
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MICE package (Azur et al., 2011; Buuren & Groothuis-Oudshoorn, 2011). Twenty
imputations were conducted using data across 7 sweeps over the life course. This
multiple imputation approach includes a large number of covariates and auxiliary
variables in the models, which maximises the plausibility of the missing at random
(MAR) assumption, and limits possibility of missing not at random (MNAR) data
(Coley et al., 2011). These multiple imputation techniques have been used extensively
to address missing data in the National Child Development Study (Barboza Solís et al.,
2015; Blane, Wahrendorf, Webb, & Netuveli, 2012; Kelly-irving et al., 2013).
Technical details of the multiple imputation process are reported in Supplementary
Material 1C.
Second, a confirmatory factor analysis was conducted to generate latent factor
scores of affective symptoms at each time-point (see Supplementary Table 2 for details
about model fit). Linear mixed models were then used to examine trajectories of
affective symptoms over time, using factor scores from each time-point. Linear and
quadratic models were fitted and compared and the model with the best fit according to
the Akaike information criterion (AIC) and Bayesian information criterion (BIC) was
selected for subsequent analyses. Next, growth mixture models (GMM) were fit to the
data to identify trajectory classes. Models with a 2-class, 3-class, 4-class, and 5-class
solution were fitted and compared using AIC, BIC, and the Lo-Mendel-Rubin Adjusted
likelihood ratio test (Lo-Mendel-Rubin Adjusted LRT). Once longitudinal trajectories
were identified using GMM, a structural equation model was used to investigate
whether class membership predicted cognitive outcomes at age 50, after controlling for
key covariates. One-step estimation approaches have been criticised in recent years on
the basis that including distal outcomes into the measurement model in one step may
lead to an unintended and problematic circular relationship in which the classes from
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the trajectory modelling are determined in part by the distal outcome which they are
meant to be predicting (Bakk & Vermunt, 2015; Vermunt, 2010; Zhu, Steele, &
Moustaki, 2017). This analysis was therefore conducted in a step-wise fashion to avoid
drawbacks associated with one-step estimation methods. Missing data were dealt with
using full information maximum likelihood estimation (FIML). Analysis was conducted
in Mplus V.8. According to Mplus defaults, variances across classes were held equal
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5.4. Results
Missing data and descriptive statistics.
Of the sample who completed the cognitive tests at age 50 (n = 9,385),
participants with complete information (n = 4625) were compared to the sample with
missing data (n = 4,760). Results revealed that participants with missing data did not
differ by sex (p = .54). However, participants with missing data had significantly lower
childhood cognitive scores (p < .001), higher levels of childhood psychological
maladjustment (p < .001), lower level of education (p < .001), lower SEP in childhood
(p < .001) and adulthood (p < .001), and more case-level affective symptoms at ages 23
(p < .001), 33 (p < .001), 42 (p < .001), and 50 (p < .001).
The imputed dataset was created for the sample of 9385 participants. Socio-
demographic information for the sample with complete information for cognitive
outcomes, main predictors and covariates (n = 4,625; 50.5% women) and the imputed
sample (n = 9,385; 50.8% women) is presented in Supplementary Table 3.
Accumulation of affective symptoms and midlife cognitive function.
Results from the analysis using a structured modelling approach revealed that
the accumulation model was the best fit for the data. For this model, there were no
significant differences observed from the saturated model for any of the cognitive
outcomes (Table 5.6.1). This was particularly prominent for memory outcomes
(immediate memory: F = 1.81; p = .09; delayed memory: F = 1.39, p = .22), for which
none of the other models (i.e., ‘no effect’ model, or sensitive period models) fit the data
well (p < .05 for all other models).
Fully adjusted regression models revealed significant linear associations,
whereby as the number of case-level affective symptoms increased over the life course,
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midlife immediate memory (b = -0.07, SE = 0.03, p = .01), delayed memory (b = -0.13,
SE = 0.04, p < .001) and information processing accuracy (b = 0.18, SE = 0.08, p = .03)
decreased (Table 5.6.2). No effects were apparent for verbal fluency or information
processing speed in fully adjusted models. Results of the analyses using imputed data
were similar (Supplementary Tables 4 & 5).
Trajectories of affective symptoms and midlife cognitive function.
Linear mixed models revealed that a linear trajectory (AIC = 9020.291; BIC =
9065.883), rather than a quadratic trajectory (AIC = 9021.989; BIC = 9075.18), fitted
adult affective symptom latent variables scores better and were therefore used to
identify trajectory classes. When comparing models with a 2-class, 3-class, 4-class, and
5-class solution, the 5-class solution was found to be the best fit for the data
(Supplementary Table 6). Therefore, five different trajectories of adult affective
symptoms were identified (Figure 5.6.2): Class 1) no affective symptoms (51.4%);
Class 2) consistent mild/moderate affective symptoms (28.3%); Class 3) initially low
and increasing to high affective symptoms (5.4%); Class 4) initially high and
persistently increasing affective symptoms (7.3%); Class 5) initially high and
decreasing to low affective symptoms (7.5%).
A fully adjusted structural equation model revealed that class membership
predicted cognitive function at age 50 (Table 5.6.3). Belonging to a trajectory with
initially high and increasing affective symptoms was associated with lower midlife
immediate memory (b = -0.25, SE = 0.07, p < .001), delayed memory (b = -0.23, SE =
0.09, p = .006), and verbal fluency scores (b = -0.79, SE = 0.30, p = .01), as compared
to the trajectory with no affective symptoms. Belonging to a trajectory with initially low
and increasing affective symptoms was associated with significantly lower midlife
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immediate (b = -0.16, SE = 0.07, p = .03) and delayed memory (b = -0.23, SE = 0.09, p
= .007), and information processing accuracy (b = 0.50 SE = 0.21, p = .02). Belonging
to a trajectory with initially high and decreasing affective symptoms was associated
with poorer immediate memory (b = -0.15, SE = 0.07, p = .04). Finally, belonging to a
trajectory with consistently mild/moderate affective symptoms was associated with
poorer immediate memory (b = -0.09, SE = 0.04, p = .03). No associations were found
for information processing speed and accuracy. Unadjusted and partially adjusted
models are reported in Supplementary Table 7.
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5.5. Discussion
The present study found that accumulation of affective symptoms across three
decades of adulthood (from age 23 through age 50) was associated with poorer
cognitive function in midlife: a greater number of case-level affective symptoms was
linearly associated with poorer memory and information processing accuracy in midlife.
Analysis of longitudinal trajectories of affective symptoms showed that belonging to a
trajectory with high and increasing level of affective symptoms across adulthood was
significantly associated with poorer verbal memory and fluency in midlife. Belonging to
a trajectory with low and increasing affective symptoms was associated with lower
verbal memory and information processing accuracy scores at age 50. Belonging to a
trajectory with initially high and decreasing affective symptoms or a trajectory with
consistently mild/moderate affective symptoms was associated with lower immediate
memory scores in midlife.
These findings suggest that associations between affective symptoms and
cognitive function may be evident even by midlife, an earlier stage in the life course
than considered by many previous studies (Ganguli et al., 2006). It is now believed that
for those experiencing dementia in later life, there is a long pre-clinical period before
cognitive impairment becomes evident (Morris, 2005). It is possible that older
participants may have already developed cerebral pathology by the time of baseline
assessment, even if they are not yet displaying symptoms of cognitive impairment. It is
plausible that associations between affective disorders and cognition in older adults may
be the result of reverse causality from subtle cognitive changes short of dementia. For
this reason, it is important to explore this association earlier in the life course and in a
population who have not developed dementia pathology. Midlife may prove a better age
to guarantee forward temporal associations between risk factors, such as affective
170
disorders, and subsequent cognitive impairments (Exalto et al., 2014; Lancaster, Tabet,
& Rusted, 2017). Additionally, if associations between affective disorders and cognitive
function are already apparent by midlife, this may be an important window for early
intervention (Sperling et al., 2011). These results advance previous findings,
demonstrating for the first time that effects may be apparent even many years prior to
development of any substantial cognitive deficits and also may be apparent even if no
dementia develops. This observation has value in clarifying the temporal order of this
association and minimises the issue of reverse causality inherent in studies focussing
exclusively on older adults.
These results also suggest that accumulation of multiple, repeated affective
episodes can predict poorer cognitive function in midlife. While the late-life trajectory
of cognitive decline in this current cohort cannot be modelled, the findings add to
previous research which reports a monotonic increase in dementia risk with each
additional affective episode, by demonstrating that the pattern of accumulating affective
episodes is important in predicting midlife cognitive function in a general population
(Kessing & Andersen, 2004). Singh-Manoux et al (2017) (Singh-Manoux et al., 2017)
investigated depression trajectories over a period of 28 years for a population of
individuals who developed dementia up to 2015 (participants aged 65-85 in 2015), and
those who remained cognitively healthy, and found an accelerated growth in depressive
symptoms during the decade before dementia diagnosis. Our results complement
findings from recent studies using data from the NSHD cohort born in 1946, which
reported that recurrent case-level affective symptoms were associated with poorer
cognitive state (as measured with Addenbrooke's Cognitive Examination third edition),
verbal memory, and search speed and accuracy in early old age (James et al., 2018), but
not with objectively measured cognitive outcomes in late mid-adulthood (Richards et
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al., 2014). Because prevalence of depression and psychological distress has been
increasing in the UK over the past few decades (Fink et al., 2015) it is possible that the
effect of mental health problems on cognitive ageing can manifest earlier (by midlife) in
younger cohorts, such as NCDS born in 1958.
Taken together, these results suggest that verbal memory is affected by the
number of affective episodes experienced and by longitudinal trajectories of affective
symptoms. Information processing accuracy is affected by the number of affective
episodes experienced and by a trajectory of initially low and increasing affective
episodes. Verbal fluency scores are affected by a pattern of initially high and increasing
accumulation affective episodes. Strongest effects of affective symptoms were therefore
observed on midlife verbal memory, verbal fluency, and information processing
accuracy, while information processing speed was consistently unaffected by affective
symptoms. Several studies have found untreated depressive symptoms persistent over
the entire life course may lead to cumulative hippocampal volume loss (Sheline, Gado,
& Kraemer, 2003); a key structure associated with verbal memory (Bird & Burgess,
2008). This could potentially explain effects of affective problems on memory. It is
possible that midlife may be too early for effects to be observed in information
processing speed, and that effects of affective disorders may become apparent on this
cognitive domain as individuals transition from midlife into older adulthood.
Strengths & limitations.
The key strength of the study is a large nationally-representative sample with a
long follow-up period (three decades). Moreover, multiple cognitive domains were
assessed in midlife, and prospective assessments of affective symptoms using the same
instrument from early adulthood through midlife were available for the analyses.
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However, results should be interpreted with consideration of a number of limitations.
Cognitive function was only assessed at one time-point in adulthood (age 50) in the
NCDS, and therefore it was not possible to investigate the effects of affective problems
on cognitive change over time. Cognitive assessments at this time point were also
limited in breadth; single, rather than multiple, cognitive tests were used for each
domain (immediate and delayed memory, verbal fluency, information processing speed
and accuracy); and functions in other cognitive domains (e.g., inhibitory processes,
attention) known to be affected in people with affective disorders, were not assessed in
NCDS. Additionally, although cognitive ability in childhood was controlled for, this
does not completely eliminate the possibility of reverse causality, whereby the
association may operate in the opposite direction with lower cognitive function leading
to higher affective symptoms across adulthood (Hatch, Jones, et al., 2007). We were
also unable to take the effect of medications into account, which may play an important
role in this association.
Missing data are inevitable in the long-running cohorts such as NCDS, and
indeed there was a lot of missing data that could potentially lead to biased estimates.
We have dealt with this by imputing missing data using a multiple imputation approach.
The benefits of the multiple imputation approach are that missing data can be dealt with
prior to analysis (Schafer & Graham, 2002) using a large amount of additional
information from other variables available in the dataset. Specifically, this allows extra
information that isn’t included in our main models (such as birthweight, parental
education etc.) to be used as auxiliary variables to aid with imputing the missing data.
This maximises plausibility of the missing at random assumption (Coley et al., 2011).
Notably, the results using imputed data were substantially identical to the ones obtained
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using a complete dataset and also were consistent and complementary with the analysis
using FIML to account for missing data.
Plausible mechanisms.
Both biological and socio-behavioural pathways have been proposed to explain
the link between affective disorders and cognitive function. Specifically, hypothalamic
pituitary adrenal (HPA) axis function has been proposed as one potential mechanism
linking affective problems and subsequent cognitive dysfunction (Byers & Yaffe,
2011). Affective symptoms and chronic stress may give rise to HPA axis activity and
lead to increased glucocorticoid production, which in turn may lead to hippocampal
atrophy and cognitive dysfunction. Animal studies exploring response to stress have
proposed that conditions of high stress and exogenous glucocorticoids can lead to
cognitive impairment (Park, Zoladz, Conrad, Fleshner, & Diamond, 2008).
Another potential pathway involves cardio-metabolic risk factors. Affective
problems and psychological distress across the life course have been associated with
higher cardio-metabolic risk (Winning, Glymour, McCormick, Gilsanz, & Kubzansky,
2015). Additionally, cardio-metabolic disorders have also been linked with Alzheimer’s
disease and cognitive decline (Bhat, 2010). Related to this, physical health and health
behaviours (Ströhle, 2009), including physical activity and exercise may also play an
important role in the association between affective problems and cognitive ageing.
Beyond this, chronic inflammation plays a role in both depression and dementia, and as
such may act as an important pathway between the two. Moreover, Aβ deposition is 
known to play an important role in the pathogenesis of dementia (Hardy & Selkoe,
2002) and has additionally been associated with major depression (Wu et al., 2014).
Educational attainment (Geerlings, Schmand, Braam, & Jonker, 2000) and socio-
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economic position (Sattler et al., 2012) may also play a role in the association between
affective problems and cognitive ageing. It is plausible that the association between
affective problems and cognitive ageing is underpinned by a complex interaction of
biological and socio-behavioural mechanisms, rather than by one single aetiological
determinant (Da Silva et al., 2013).
Conclusions.
In conclusion, the present study suggests that individuals with affective
symptoms in adulthood are at increased risk of poorer cognitive outcomes by midlife.
This finding has implications for prevention efforts, as the asymptomatic phase before
development of dementia pathology may be a critical window to target for early
intervention (Sperling et al., 2011). Additionally, in the absence of pathological change,
one further important avenue of research is to investigate whether effective treatment
and management of affective problems early in life can reduce risk of poor cognitive
outcomes and promote healthy cognitive ageing. Future research should also focus on
determining the biological and socio-behavioural mechanisms that underpin the
association between affective and cognitive factors. All interventions to promote and
sustain healthy ageing are important to health policy development in an ageing
population.
175
5.6. Tables & figures
Figure 5.6.1: Conceptual framework of Chapter 5
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Table 5.6.1: A structured modelling approach comparing life course hypotheses of the association between lifetime affective symptoms and
midlife cognitive function (no effect hypothesis, accumulation hypothesis, sensitive period hypothesis)
Models
Immediate Memory Delayed Memory Verbal Fluency Processing Speed Processing Accuracy
F P F P F P F P F P
Saturated model Reference Reference Reference Reference Reference Reference Reference Reference Reference Reference
No effect 4.15 .0001 5.1 <.0001 2.97 .004 1.24 .28 2.58 .01
Accumulation 1.81a .09 1.39 .22 0.56 .76 0.88 .51 0.66 .68
Sensitive period 1 (age 23) 2.97 .01 3.46 .002 1.86 .08 1.15 .33 2.19 .04
Sensitive period 2 (age 33-42) 3.51 .002 3.89 .001 1.35 .23 1.14 .34 1.8 .10
Sensitive period 3 (age 50) 3.14 .01 3.23 .004 2.46 .02 1.12 .33 1.4 .21
Best fitting model Accumulation Accumulation Accumulation Accumulation Accumulation
a Bold values represent estimates which are non-significant at the p < .05 level. Non-significant P values represent a good fit for the data. The
hypothesis with the smallest F statistic is taken as the hypothesis with the best fit for the data.
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Table 5.6.2: Life course accumulation of affective symptoms and cognitive function at age 50
Cognitive Functions
Model 1a Model 2 Model 3 Model 4 Model 5
b SE P b SE P b SE P b SE P b SE P
Immediate Memory -0.14b 0.03 <.001 -0.17 0.03 <.001 -0.09 0.03 .003 -0.07 0.03 .01 -0.08 0.03 .01
Delayed Memory -0.2 0.04 <.001 -0.25 0.04 <.001 -0.14 0.04 <.001 -0.13 0.04 <.001 -0.13 0.04 <.001
Verbal Fluency -0.51 0.13 <.001 -0.52 0.13 <.001 -0.13 0.13 .31 -0.06 0.12 .61 -0.07 0.12 .59
Processing Speed 3.82 1.87 .04 1.45 1.88 .44 2.78 1.89 .14 3.15 1.89 .10 3.25 1.89 .09
Processing Accuracy 0.32 0.08 <.001 0.3 0.08 <.001 0.17 0.08 .04 0.18 0.08 .03 0.19 0.08 .02
a Results are presented for model 1 (unadjusted estimates), model 2 (estimates adjusted for sex), model 3 (estimates adjusted for sex, childhood
socio-economic status, childhood emotional adjustment, and childhood cognition), and model 4 (estimates adjusted for sex, childhood socio-
economic status, childhood emotional adjustment, childhood cognition, adult socio-economic status, and highest educational attainment at age
50). Model 5 is a sensitivity analysis, using all the covariates in Model 4, but excluding childhood emotional adjustment.
b Bold values represent estimates significant at the p < .05 level. Estimates are based on sample with complete data for all key factors and
covariates (N = 4,625).
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a Bold values represent estimates significant at the p < .05 level.
Table 5.6.3: Fully adjusted structural equation model output for class membership predicting midlife cognitive function
Predictors
Immediate memory Delayed memory Verbal fluency Processing Speed Accuracy
b SE P b SE P b SE P b SE P b SE P
Affective symptom trajectories:
No affective symptoms Reference Reference Reference Reference Reference
Mild/moderate affective
symptoms -0.09 0.04 .03
a 0.03 0.05 .58 -0.32 0.18 .08 0.96 2.66 .72 0.10 0.12 .41
Initially low and rapidly
increasing affective symptoms -0.16 0.07 .03 -0.23 0.09 .007 -0.23 0.30 .45 7.02 4.50 .12 0.50 0.21 .02
Initially high and persistently
increasing affective symptoms -0.25 0.07 <.001 -0.23 0.09 .006 -0.79 0.30 .01 -2.80 4.48 .53 0.17 0.21 .42
Initially high and steadily
decreasing affective symptoms -0.15 0.07 .04 -0.17 0.09 .05 -0.59 0.31 .06 3.95 4.69 .40 0.24 0.22 .26
Sex 0.19 0.04 <.001 0.35 0.04 <.001 -0.33 0.16 .03 23.66 2.32 <.001 0.40 0.11 <.001
Childhood affective problems <.001 0.002 .87 -0.002 0.003 .50 -0.01 0.10 .55 0.05 0.15 .75 0.02 0.01 .001
Childhood cognition 0.02 0.001 <.001 0.03 0.002 <.001 0.09 0.01 <.001 0.29 0.09 .001 -0.05 0.004 <.001
Child socio-economic position -0.01 0.02 .60 0.002 0.03 .94 -0.40 0.10 <.001 0.53 1.56 .73 -0.02 0.07 .82
Adult socio-economic position -0.08 0.02 .001 -0.07 0.03 .02 -0.23 0.11 .03 -5.83 1.57 <.001 -0.09 0.07 .24
Education 0.08 .009 <.001 0.11 0.01 <.001 0.37 0.04 <.001 1.96 0.58 .001 0.07 0.03 .007
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Figure 5.6.2: Life course trajectories of affective symptoms (estimated from 5-class growth mixture model)
Class 1: No affective symptoms (51.4%)
Class 2: Mild/moderate affective symptoms (28.3%)
Class 3: Initially low and rapidly increasing affective symptoms (5.4%)
Class 4: Initially high and persistently increasing affective symptoms (7.3%)
Class 5: Initially high and steadily decreasing affective symptoms (7.5%)
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5.7. Supplementary material
Supplementary Material 1A: Details of available study sample and sample selection
process.
Supplementary Figure 1: Flow chart showing available study sample.
Supplementary Table 1: Missing data for each key variable (N=9385).
Supplementary Material 1B: Additional information on covariates.
Supplementary Material 1C: Technical details of multiple imputation process.
Supplementary Table 2: Model fit statistics for confirmatory factor analysis of items
in Malaise Inventory Scale at ages 23, 33, 42, 50 (N=14,745).
Supplementary Table 3: Demographic information of the complete case and imputed
sample (N = 9,385).
Supplementary Table 4: A structured modelling approach comparing life-course
hypotheses of the association between lifetime affective problems and midlife cognitive
function (no effect hypothesis, accumulation hypothesis, sensitive period hypothesis)
using imputed data (N=9,385).
Supplementary Table 5: Linear regressions of number of time-point with case-level
affective symptoms (Range 0-4) on cognitive outcomes at age 50 using imputed data
(N=9,385).
Supplementary Table 6: Comparison of 2-class, 3-class, 4-class, and 5-class growth
mixture models.
Supplementary Table 7: Unadjusted and partially adjusted structural equation model
output for class membership predicting midlife cognitive test scores.
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Supplementary Material 1A: Details of available study sample and sample selection
process
During the sweep in 2008 (cohort members aged 50), the target sample was all
cohort members in Great Britain, excluding permanent refusals and participants who
had been excluded for specific reasons (n = 12,369). It was possible to issue 12,316 of
the original 18,558 participants to interviewers. These 12,316 participants either had
participated in sweeps in 2000, 2002 or 2004 and were still alive and residing in Great
Britain with a known address (n = 11,320), or had not participated in the above sweeps
but had confirmed their current address since 2000 (n=387), or had not participated in
any of the above but contact details had been obtained through tracing exercises (n =
609). Of the total issued sample in 2008 (n = 12,316), 11,461 (93.1%) were confirmed
eligible to take part, as 37 (0.3%) had died, 101 (0.9%) had emigrated, 4 (0.0%) were
issued in error (duplication), 676 (5.5%) could not be traced, and 37 (0.3%) were not
reissued or traced due to lack of time. Productive interviews were completed for 9,790
cohort members (85.4% of confirmed eligible sample). Of these, 9,385 people had
complete information on cognitive assessments (Supplementary Figure 1 &
Supplementary Table 1).
182
Supplementary Figure 1: Flow chart showing available study sample.
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Supplementary Table 1: Missing data for each key variable (N=9385)
Measure N with dataavailable (%)
N with missing
data (%)
Affective symptoms
Malaise Score Age 23 7886 (84.03) 1499 (15.97)
Malaise Score Age 33 8113 (86.45) 1272 (13.55)
Malaise Score Age 42 8703 (92.73) 682 (7.27)
Malaise Score Age 50 9309 (99.19) 76 (0.81)
Accumulation of Malaise Score 6680 (71.18) 2705 (28.82)
Covariates
Childhood Affective Symptoms 8133 (86.66) 1252 (13.34)
Childhood Cognitive Score 8145 (86.79) 1240 (13.21)
Childhood SEP 7767 (82.76) 1618 (17.24)
Adulthood SEP 7972 (84.94) 1413 (15.06)
Education 9385 (100) 0 (0)
* Sample with cognitive data (N = 9385)
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Supplementary Material 1B: Additional information on covariates
Childhood cognition was assessed at age 11, using a general ability test
administered at the child’s school. This test (Douglas 1964) comprised verbal and non-
verbal components, which combined into an overall cognitive score. Childhood mental
health also assessed at age 11 using the Bristol Social Adjustment Guides (BSAG)
(Mcdermott et al. 2017). This questionnaire was completed by teachers and is designed
to assess behaviour which may be indicative of maladjustment and emotional
disturbance. Teachers were asked to underline descriptions of the child which they felt
to be most accurate. This information was then coded and summed to create a
quantitative score of emotional disturbance and adjustment to school at age 11.
A measure of household socio-economic position at age 11 was derived using
guidelines from the Centre for Longitudinal Studies (CLS) (Elliott & Lawrence 2014),
based on measures of father’s occupation, mother’s occupation, and household tenure.
Specifically, cohort members were categorised as being ‘middle class’ if their father
was in Registrar General's Social Classes class I or II (professional, managerial,
administrative etc.) during the sweep at age 11 (1969), they were not living in rented
council accommodation, and their mother was not in a manual occupation while she
was pregnant or when the cohort member was age 11. Cohort members were
categorised as being ‘intermediate class’ if their father was in Registrar General's Social
Classes I or II (professional, managerial, administrative etc.) during the sweep at age 11,
but either resided in council accommodation or the mother was working in manual
labour either during the pregnancy or once the child was 11 years old. Additionally,
children were categorised as being ‘intermediate class’ if their father was in routine
non-manual (Class IIIa). Finally, children were also categorised as ‘intermediate class’
if their father was either in manual work when the child was 11, or was in routine
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service work (class IVa), but were residing in owner occupied accommodation. Finally,
cohort members were categorised as ‘working class’ if their father was working in
routine service (Class IVa) and at age 11 they were not residing in owner-occupied
accommodation, or if their father was working in a manual occupation.
Highest educational attainment was derived by combining education data from
1991, 2000, 2004, and 2008 to ascertain the highest academic qualification the cohort
member had achieved by age 50. Adult socio-economic position was derived using the
same method as for the age 11 social class variable (Elliott & Lawrence 2014). This was
based on occupation, creating three categories (working, intermediate and middle class).
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Supplementary Material 1C: Technical details of multiple imputation process
The process of multiple imputation involves replacing missing cases with
plausible values generated from analysing distributions and the relationships between
the observed variables within data. Multiple imputation with this data involved 7 stages.
Firstly a number of variables from birth (birthweight, mother’s age at birth, husband’s
age in years, socioeconomic position of mother’s husband, mother’s father’s socio-
economic position, and mother’s education) were imputed. Imputation method used
varied depending on the nature of the variable (continuous, ordinal or binary). Next, all
birth variables plus sex were used as auxiliary variables to impute variables at age 7
(father’s education, whether parents had mental illness or neurosis, BSAG score,
arithmetic score, and reading score). Next, all birth and age 7 variables were used to
impute age 11 variables (BSAG score, cognitive score, household socioeconomic
position). As a next step, birth, age 7, and age 11 variables were used to impute malaise
scores at age 23. Birth, age 7, age 11 variables, plus malaise scores at age 23 were used
to impute malaise scores at age 33. Malaise scores at age 42 were then imputed from
birth, age 7, and age 11 variables, as well as malaise scores at age 23 and 33. Finally,
birth age 7, age 11 variables, as well as malaise scores at age 23, 33, and 42 were used
to impute age 50 variables (malaise score, socioeconomic position, and educational
attainment).
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Supplementary Table 2: Model fit statistics for confirmatory factor analysis
of items in Malaise Inventory Scale at ages 23, 33, 42, 50 (N=14,745).
Fit statistic Fit value
CFI .963
TLI .960
RMSEA .025
X2 5885.35 (588), <.001
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Supplementary Table 3: Demographic information of the complete case and imputed sample (N = 9,385).
Complete Case Sample Imputed Sample
Characteristics N = 4,625 N = 9,385
Sex
Male 2289 (49.5) 4614 (49.2)
Female 2336 (50.5) 4771 (50.8)
Highest educational attainment by age 50, N (%)a
No academic qualification 501 (10.8) 1772 (18.9)
GCSE to A-Level and Scottish equivalent 2916 (63.1) 5329 (56.8)
Diploma, degree, PGCE, or higher degree 1208 (26.1) 2284 (24.3)
Childhood social class, N (%)
Middle 1048 (22.7) 1994 (21.2)
Intermediate 1788 (38.7) 3449 (36.8)
Working 1789 (38.7) 3942 (42.0)
Adult social class, N (%)
Middle 2274 (49.2) 4320 (46.0)
Intermediate 1429 (30.9) 2996 (31.9)
Working 921 (19.9) 2062 (22.0)
Childhood cognitive score, Mean (SD) 47.27 (14.68) 45.34 (15.39)
Mean cognitive scores, Mean (SD)
Immediate Memory 6.67 (1.42) 6.55 (1.47)
Delayed Memory 5.55 (1.77) 5.42 (1.83)
Verbal Fluency 22.71 (6.22) 22.30 (6.26)
Letter cancellation - Processing speed 336.03 (90.00) 333.97 (88.81)
Letter cancellation - Accuracy 4.25 (4.03) 4.41 (4.12)
Case-level at each time-point, N (%)
Age 23 235 (5.1) 593 (6.3)
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Age 33b 208 (4.5) 560 (6.0)
Age 42 431 (9.3) 1191 (12.7)
Age 50 542 (11.7) 1374 (14.6)
Malaise scores at each time-point, Mean (SD)
Age 23 2.35 (2.59) 2.58 (2.77)
Age 33 2.05 (2.57) 2.32 (2.86)
Age 42 3.14 (3.08) 3.54 (3.51)
Age 50 1.28 (1.74) 1.48 (1.93)
Accumulation of case-level affective symptoms, N (%)
No time-points 3692 (79.8) 7025 (74.9)
1 time-point 597 (12.9) 1427 (15.2)
2 time-points 224 (4.8) 599 (6.4)
3 time-points 77 (1.7) 243 (2.6)
4 time-points 35 (0.8) 91 (1.0)
a Frequency data is presented as N (%); Continuous data is presented as Mean (SD).
b In the structured model to compare accumulation and sensitive period hypotheses, malaise data from ages 33 and 43 were merged to create one
time-point representing middle adulthood.
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Supplementary Table 4: A structured modelling approach comparing life-course hypotheses of the association between lifetime
affective problems and midlife cognitive function (no effect hypothesis, accumulation hypothesis, sensitive period hypothesis) using
imputed data (N=9,385)a.
Immediate Memory Delayed Memory Verbal Fluency Processing Speed Accuracy
F P F P F P F P F P
Saturated model Reference Reference Reference Reference Reference Reference Reference Reference Reference Reference
No effect 16.07 <.001 15.67 <.001 20.3 <.001 0.59 0.77 6.21 <.001
Accumulation 1.05 .39b 0.82 0.55 1.28 0.26 0.68 0.66 0.82 0.55
Critical period 1
(age 23) 13.36 <.001 11.8 <.001 18.23 <.001 0.58 0.75 6.38 <.001
Critical period 2
(age 33-42) 8.81 <.001 9.73 <.001 5.67 <.001 0.55 0.77 3 0.01
Critical period 3
(age 50) 6.34 <.001 5.72 <.001 11.81 <.001 0.68 0.67 2.01 0.06
Best fitting
model Accumulation Accumulation Accumulation Critical Period 2 Accumulation
a Estimates are based on the imputed sample (N = 9,385).
b Bold values represent estimates which are non-significant at the p < .05 level. Non-significant P values represent a good fit of the data. The
hypothesis with the smallest F statistic is taken as the hypothesis with the best fit of the data.
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Supplementary Table 5: Linear regressions of number of time-point with case-level affective symptoms (Range 0-4) on cognitive
outcomes at age 50 using imputed data (N=9,385)a.
Model 1b Model 2 Model 3 Model 4 Model 5
b SE P b SE P b SE P b SE P b SE P
Immediate memory -0.2c 0.02 <.001 -0.23 0.02 <.001 -0.12 0.02 <.001 -0.1 0.02 <.001 -0.11 0.02 <.001
Delayed memory -0.24 0.02 <.001 -0.29 0.02 <.001 -0.15 0.02 <.001 -0.13 0.02 <.001 -0.13 0.02 <.001
Verbal fluency -0.92 0.08 <.001 -0.93 0.08 <.001 -0.45 0.08 <.001 -0.36 0.08 <.001 -0.37 0.08 <.001
Information processing
speed -0.04 1.15 .97 -2.41 1.15 .04 -0.53 1.17 .65 0.14 1.17 .90 0.07 1.17 .95
Letter cancellation
accuracy 0.34 0.05 <.001 0.32 0.05 <.001 0.17 0.05 .002 0.17 0.05 .002 0.18 0.05 .001
a Estimates are based on the imputed sample (N = 9,385).
b Results are presented for model 1 (unadjusted estimates), model 2 (estimates adjusted for sex), model 3 (estimates adjusted for sex, childhood
socioeconomic status, childhood emotional adjustment, and childhood cognition), and model 4 (estimates adjusted for sex, childhood
socioeconomic status, childhood emotional adjustment, childhood cognition, adult socioeconomic status, and highest educational attainment at
age 50). Model 5 is a sensitivity analysis, using all the covariates in Model 4, but excluding childhood emotional adjustment.
c Bold values represent estimates significant at the p < .05 level.
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Supplementary Table 6: Comparison of 2-class, 3-class, 4-class, and 5-class growth mixture models.
2-class 3-class 4-class 5-classa
AIC 7354.32 6101.344 4899.587 4665.861
BIC 7445.504 6215.324 5036.362 4825.433
Entropy .815 .776 .865 .764
Sample Proportion 13; 87 16; 75; 10 43; 5; 18; 34 7; 51; 8; 28; 5
Classification Accuracy .738 - .98 .746 - .951 .875 - .966 .622 - .911
Lo-Mendel-Rubin Adjusted LRT <.001 <.001 .038 <.001
a 5-class model was selected for subsequent analysis, due to lower AIC, BIC, and significant Lo-Mendel-Rubin Adjusted LRT.
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Supplementary Table 7: Unadjusted and partially adjusted structural equation model output for class membership predicting midlife
cognitive test scores.
Model 1a Model 2 Model 3 Model 4
b SE P b SE P b SE P b SE P
Immediate Memory
No affective symptoms Reference Reference Reference Reference
Mild/moderate affective symptoms -0.15 0.04 <.001b -0.21 0.04 <.001 -0.10 0.04 .01 -0.09 0.04 .02
Initially low and rapidly increasing affective
symptoms -0.27 0.06 <.001 -0.30 0.06 <.001 -0.21 0.06 .001 -0.15 0.07 .03
Initially high and persistently increasing
affective symptoms -0.47 0.06 <.001 -0.55 0.06 <.001 -0.29 0.06 <.001 -0.25 0.07 <.001
Initially high and steadily decreasing affective
symptoms -0.32 0.06 <.001 -0.42 0.06 <.001 -0.16 0.07 .02 -0.14 0.07 .05
Delayed Memory
No affective symptoms Reference Reference Reference Reference
Mild/moderate affective symptoms -0.05 0.04 .27 -0.15 0.05 .001 <.001 0.05 1.00 0.02 0.05 .65
Initially low and rapidly increasing affective
symptoms -0.35 0.07 <.001 -0.39 0.07 <.001 -0.26 0.08 <.001 -0.23 0.09 .006
Initially high and persistently increasing
affective symptoms -0.47 0.07 <.001 -0.60 0.07 <.001 -0.29 0.08 <.001 -0.23 0.09 .006
Initially high and steadily decreasing affective
symptoms -0.35 0.08 <.001 -0.51 0.08 <.001 -0.21 0.08 .01 -0.17 0.09 .05
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Verbal Fluency
No affective symptoms Reference Reference Reference Reference
Mild/moderate affective symptoms -0.91 0.15 <.001 -0.96 0.15 <.001 -0.41 0.17 .01 -0.34 0.18 .05
Initially low and rapidly increasing affective
symptoms -0.98 0.25 <.001 -1.00 0.25 <.001 -0.49 0.27 .06 -0.26 0.30 .39
Initially high and persistently increasing
affective symptoms -2.09 0.24 <.001 -2.15 0.24 <.001 -0.92 0.26 <.001 -0.82 0.30 .006
Initially high and steadily decreasing affective
symptoms -1.82 0.26 <.001 -1.90 0.26 <.001 -0.72 0.29 .01 -0.60 0.31 .06
Information Processing Speed
No affective symptoms Reference Reference Reference Reference
Mild/moderate affective symptoms 2.16 2.19 .32 -2.99 2.19 .17 0.12 2.50 .96 0.81 2.65 .76
Initially low and rapidly increasing affective
symptoms -0.37 3.58 .92 -2.47 3.54 .49 1.44 3.96 .72 6.40 4.46 .15
Initially high and persistently increasing
affective symptoms -2.58 3.39 .45 -9.16 3.39 .007 -8.03 3.85 .04 -2.24 4.47 .62
Initially high and steadily decreasing affective
symptoms 8.78 3.75 .02 -1.90 3.75 .93 7.56 4.26 .08 4.11 4.68 .38
Letter Cancellation Accuracy
No affective symptoms Reference Reference Reference Reference
Mild/moderate affective symptoms 0.26 0.10 .01 0.23 0.10 .02 0.08 0.12 .49 0.13 0.12 .30
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a Results are presented for model 1 (unadjusted estimates), model 2 (estimates adjusted for sex), and model 3 (estimates adjusted for sex,
childhood socioeconomic status, childhood emotional adjustment, and childhood cognition). Model 4 is a sensitivity analysis, adjusted for sex,
childhood socioeconomic status, childhood cognition, adult socioeconomic status, and highest educational attainment, but excluding childhood
emotional adjustment.
b Bold values represent estimates significant at the p < .05 level.
Initially low and rapidly increasing affective
symptoms 0.38 0.17 .02 0.36 0.17 .03 0.31 0.18 .09 0.51 0.21 .01
Initially high and persistently increasing
affective symptoms 0.74 0.16 <.001 0.70 0.16 <.001 0.21 0.18 .24 0.22 0.21 .29
Initially high and steadily decreasing affective
symptoms 0.78 0.17 <.001 0.74 0.18 <.001 0.51 0.20 .009 0.28 0.22 .20
N 9,643 9,643 7,423 6,359
Model Fit
X2(2)=102.46 p<.001,
CFI=.991, TLI=.867,
RMSEA=.072
X2(2)=73.53, p<.001,
CFI=.994, TLI=.893,
RMSEA=.061
X2(2)=8.35, p=.02,
CFI=.999, TLI=985,
RMSEA=.021
X2(2)=1.64, p=.44,
CFI=1.000, TLI=1.001,
RMSEA=.000
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CHAPTER 6
Study 5: Accumulation of affective symptoms and
midlife cognitive function: the role of inflammation.
Study 5 is under review in Brain, Behavior and Immunity.
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6.1. Abstract
The aim of the present study was to test whether C-Reactive Protein (CRP), a
proxy measure of inflammation, can mediate associations between affective symptoms
in childhood and adulthood and midlife cognitive function. Data were used from the
National Child Development Study (n = 6276). Measures of memory, verbal fluency,
information processing speed and accuracy were available in midlife (age 50). Affective
symptoms were assessed in childhood (ages 7, 11, 16) and in adulthood (ages 23, 33,
42, 50). The level of plasma CRP was measured at age 44. Pathway models, unadjusted
and fully adjusted for sex, education, childhood SEP, childhood cognitive ability and
affective symptoms at age 50, were fitted to test direct associations between affective
symptoms and midlife cognitive function, and indirect associations mediated by the
inflammatory pathway (CRP level). In a fully adjusted model, there were significant
indirect associations between adult affective symptoms and immediate memory (β = -
0.01, SE = 0.003, p = .03) and delayed memory (β = -0.01, SE = 0.004, p = .03)
mediated by CRP. In addition, there were significant indirect associations between
affective symptoms in childhood and immediate memory (β = -0.001, SE = 0.00, p =
.03) and delayed memory (β = -0.001, SE = 0.001, p = .03), mediated by adult affective
symptoms and associated CRP. Independent of CRP, there was a significant direct
association between adult affective symptoms and information processing errors (β = 
0.47, SE = 0.21, p = .02). There were no direct or indirect associations between
affective symptoms and verbal fluency or information processing speed. CRP can
mediate associations between affective symptoms and midlife cognitive function.
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6.2. Introduction
Systematic reviews have shown that affective symptoms (depression and
anxiety) are associated with faster cognitive decline and an increased risk of dementia in
older adulthood (Da Silva et al., 2013; Gulpers et al., 2016; John et al., 2018; Jorm,
2001; Livingston et al., 2017; Ownby et al., 2006) More recent studies using
longitudinal data from British birth cohorts suggest that persistent affective symptoms
are associated with poorer cognitive function, specifically verbal memory in early old
age (age 69) (James et al., 2018) and midlife (age 50) (John et al., 2019). Taken
together, these findings suggest that persistent affective episodes can affect cognitive
function as early as midlife.
There is a growing body of research, investigating possible biological
mechanisms that may contribute to observed associations between affective symptoms
and subsequent cognitive function. One plausible hypothesis is that inflammation plays
an important role in the association between affective symptoms and cognition (Byers
& Yaffe, 2011; Leonard, 2007; Leonard & Myint, 2006). Inflammation refers to the
immune system’s response to threat, such as infection or injury. C-Reactive Protein
(CRP) is an acute phase reactant, produced in the liver and released into the
bloodstream in response to inflammation. High concentrations of CRP are indicative of
elevated levels of inflammation and can therefore be used as an inflammatory marker.
There is evidence that peripheral measures correlate with inflammatory markers in the
brain (Schmidt et al., 2002).
Research has shown a cross-sectional association between depressive symptoms
and plasma levels of inflammatory markers, including CRP (Dantzer et al., 2008;
Raison et al., 2006). A growing body of research has also focussed on the association
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between depression and CRP over time, showing elevated CRP levels in people with
cumulative depressive symptoms across adolescence and early adulthood (Copeland et
al., 2012).
In addition to this, research has proposed that inflammatory changes may be an
important pathological feature of dementia (Leonard & Myint, 2006). Specifically,
evidence from longitudinal studies have shown that peripheral inflammatory markers
measured during midlife are associated with risk of dementia after 25 years, and that
these processes are operating long before emergence of clinical symptoms of dementia
(Schmidt et al., 2002). Systematic reviews have also shown that high concentrations of
peripheral inflammatory markers are associated with increased risk of cognitive
impairment and dementia (Koyama et al., 2013; Kuo et al., 2005). In addition to
dementia, markers of inflammation including CRP can also prospectively predict poorer
cognitive function after follow up and faster cognitive decline over time (Yaffe et al.,
2003). These converging lines of evidence suggest that inflammation may play an
important mediating role within the association between affective symptoms and
midlife cognitive function. However, to the best of our knowledge this hypothesis has
never been directly tested in a prospective population-based birth cohort.
The aim of the present study was therefore to test whether inflammation,
measured with CRP, can mediate associations between affective symptoms over the life
course and midlife cognitive outcomes. In order to address this aim, direct associations
of affective symptoms in childhood and adulthood, as well as their indirect associations
with midlife cognitive function, mediated by the inflammatory pathway were estimated.
The conceptual framework for this chapter is presented in Figure 6.6.1. The
previous chapters showed that: 1.) Affective symptoms in older adulthood are
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associated with decline in cognitive state; 2.) Affective symptoms in adolescence are
associated with cognitive intercept but not slope from midlife to early old age; 3.)
Affective symptoms are associated with poorer subsequent cognitive scores from
midlife to early old age, but the association did not operate in the opposite direction; 4.)
Accumulation of affective symptoms, rather than timing, are associated with poorer
midlife cognition and trajectories with greater experience of affective symptoms predict
poorer midlife cognition. This chapter extends those findings by testing whether
inflammation can mediate observed associations between affective symptoms from
early to mid adulthood and cognitive outcomes in midlife.
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6.3. Method
Participants.
Data were used from the National Child Development Study (NCDS), a national
representative sample of 18,558 people born in England, Scotland and Wales during one
week of 1958. Data have been collected at ages 0, 7, 11, 16, 23, 33, 42, 44, 46, 50, and
55 (Power & Elliott, 2006). At age 44, biomedical data were collected from a subset of
cohort members (N=9377), and blood samples were drawn. Ethical approval for the
biomedical sweep at age 44 was provided by the South-East Multi-centre Research
Ethics Committee. Additional ethical approval for the present study was obtained from
the University of Sussex (Reference number: ER/AJ316/1).
Measures.
Cognitive function.
Cognitive data were available at age 50. Short-term and delayed memory were
assessed using a word recall task consisting of a list of 10 common words recalled
immediately after presentation and again after a 5-minute delay. Verbal fluency was
captured by naming as many animals as possible in one minute ((Roth et al., 1986).
Information processing was measured using a letter cancellation task, in which
participants are required to cross out as many target letters (Ps and Ws) as possible
within a grid of random letters in one minute. Information processing speed is based on
the total number of letters searched, and information processing accuracy is based on
the number of target letters missed up to the last letter searched (higher scores represent
more errors). These cognitive tasks are described in detail elsewhere (Brown &
Dodgeon, 2010).
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Affective symptoms.
Affective symptoms were assessed repeatedly in childhood and adolescence
using the Rutter Behaviour Child Scale A at ages 7, 11 and 16. These questionnaires
were completed by cohort members’ parents, usually the mother. At ages 7 and 11, the
Rutter Behaviour scale comprised 14 items, and at age 16 this comprised 18 items,
encompassing both internalising and externalising symptoms. Consistent with previous
research (Clark, Rodgers, Caldwell, Power, & Stansfeld, 2007; Winning et al., 2015), at
age 16 five items from this scale were used to create a measure of internalising (worries,
solitary, miserable, fearful, fussy). Four of these items were also available at ages 7 and
11 (worries, solitary, miserable, fearful) and these were used to create a measure of
internalising at these time-points. Confirmatory factor analysis (CFA) was used to
derive latent scores of affective symptoms at each time-point. This was a good fit to the
data (Supplementary Table 1). Mean latent score was also calculated across ages 7, 11
and 16 to derive an overall measure of affective symptoms in childhood.
Affective symptoms were assessed repeatedly in adulthood at ages 23, 33, 42,
and 50 using the Malaise Inventory Scale (Rodgers, Pickles, Power, Collishaw, &
Maughan, 1999). At ages 23, 33, and 42, this was a 24-item self-completion
questionnaire designed to capture psychological distress. At age 50, the short-form
questionnaire (9 items) was used. These 9 items were selected from all four time-points
to make scores more comparable over time. CFA was conducted on these 9 items at
each available time-point to derive latent scores of affective symptoms at ages 23, 33,
42, and 50. This fitted the data well (Supplementary Table 1). Mean latent score was
calculated for ages 23, 33, and 42 and this was used to predict CRP at age 44. The latent
affective symptom score at age 50 was used as a covariable.
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Inflammation.
For the purposes of this paper, inflammation status was assessed by recorded
level of C-Reactive Protein (CRP) in citrated plasma (mg/L), acquired from blood
samples collected during the biomedical sweep at age 44 by trained nurses and analysed
by partnered laboratories (Elliott, Johnson, & Shepherd, 2008). CRP values of >10mg/L
(N = 230) are indicative of recent infection (Pepys & Hirschfield, 2003) and as such
these cases were excluded from the analysis to be consistent with previous research
(Lacey, Kumari, & Bartley, 2014; Lacey, Kumari, & McMunn, 2013).
Covariables.
Covariables selected for the study were based on previous research and
comprised measures of sex, educational attainment (Brayne et al., 2010; Richards et al.,
2019; Richards & Sacker, 2003), childhood cognition (Hatch, Jones, et al., 2007;
McGurn et al., 2008; Richards et al., 2019; Richards & Sacker, 2003), and childhood
socio-economic position (Kaplan et al., 2001; Richards et al., 2019). Affective
symptoms at age 50 were also included in the model to account for concurrent affective
symptoms. Education was captured by cohort member’s highest educational
qualification achieved by age 50. This was categorised into 1) Low education (up to
GCSE level); 2) middle education (up to A Level); and 2) high education (Degree). Two
measures of childhood cognitive ability (reading and mathematics) at age 7 were
included. Reading ability was captured using the Southgate Group Reading Test, a task
designed to assess word recognition and comprehension, producing a score ranging
from 0-30. Mathematical ability was measured using the Problem Arithmetic Test,
requiring completion of 10 problem questions, producing a score ranging from 0-10.
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Socio-economic position at age 11 was based on parental occupation and household
tenure, categorised into working, intermediate and middle (Elliott & Lawrence, 2014).
Analytical procedure.
A series of pathway mediation models were run, estimating the direct
associations between childhood and adult affective symptoms and cognitive function at
age 50. Indirect pathways between symptoms and cognitive function through CRP were
also estimated. All measures of cognitive function were included in the same model to
account for covariances between different cognitive domains; non-significant
covariances were removed from the model. Pathway analysis was conducted in Mplus
Version 8 (Muthén & Muthén, 2017).
The initial pathway model was unadjusted, and subsequent models were
adjusted for sex, education, childhood cognitive ability, childhood socioeconomic
position, and affective symptoms at age 50. Including sex as a stratifying variable did
not significantly improve model fit, and as such this was used in all analyses as a
covariable (Supplementary Table 2). Model fit was assessed using chi-square goodness
of fit, CFI, TLI and RMSEA statistics. All missing data were addressed using full
information maximum likelihood (FIML) (Enders, 2001b, 2001a; Enders & Bandalos,
2001).
To check whether missing data for covariables affected the results, a sensitivity
analysis was run using multiple imputation technique to impute data for all the
covariables, using the MICE package in R (Azur et al., 2011; Buuren & Groothuis-
Oudshoorn, 2011). Sixteen imputations were conducted across 5 sweeps, resulting in
imputed data for the sample of 9377 participants (John et al., 2019).
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6.4. Results
Missing data and demographic information.
The initial sample was comprised of 9377 participants who took part in the
biomedical sweep at age 44. Of these 9377 people, 7928 (84.5%) had complete
information on all cognitive domains. Within the sample with complete cognitive data,
7859 (99.1%) also had complete information on affective symptoms. There were 6325
(80.5%) people who also had a CRP measure. Finally, there were 4908 (77.6%) people
who also had complete covariable data (Figure 6.6.2). This final sample did not differ
significantly from the sample with missing data on sex (p = .94), childhood affective
symptoms (p = .08), education (p = .09), or childhood socioeconomic position (p = .27).
However, the sample with complete information showed significantly lower adult
affective symptoms (p < .001). Additionally, the sample with complete information also
had significantly lower CRP levels (p = .02), and had significantly higher childhood
cognitive scores, based on maths (p = .002) and reading (p < .001). The full information
maximum likelihood (FIML) method resulted in the analytical sample of 6276
participants (see Table 6.6.1).
Direct associations with midlife cognitive function.
After adjustment for all key covariables, adult affective symptoms (age 23 to 42)
were directly associated with information processing accuracy (β = 0.47, SE = 0.21, p =
.02) at age 50, but no other cognitive domains. In this fully adjusted model, there were
no significant direct associations between childhood affective symptoms and any
cognitive domain. There were, however, significant direct associations between CRP
and immediate memory (β = -0.04, SE = 0.01, p < .001) and delayed memory (β = -
0.05, SE = 0.01, p < .001) at age 50 (Table 6.6.2; Figure 6.6.3).
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Indirect associations with midlife cognitive function
After adjustment for the covariables, there were significant indirect associations
between adult affective symptoms on immediate (β = -0.01, SE = 0.003, p = .03) and
delayed memory (β = -0.01, SE = 0.004, p = .03) at age 50, mediated by CRP level. In
this fully adjusted model, there were significant indirect associations between childhood
affective symptoms and information processing accuracy (β = 0.07, SE = 0.03, p = .03)
mediated by adult affective symptoms. Finally, there were significant indirect
associations between childhood affective symptoms and immediate memory (β = -0.001, 
SE = 0.00, p = .03) and delayed memory (β = -0.001, SE = 0.001, p = .03) mediated by
an indirect pathway through adult affective symptoms and subsequent CRP level (Table
6.6.2; Figure 6.6.3).
Total associations with midlife cognitive function.
The fully adjusted model showed a significant total association between adult
affective symptoms and immediate memory (β = -0.22, SE = 0.04, p < .001), delayed
memory, (β = -0.24, SE = 0.05, p < .001), verbal fluency (β = -0.92, SE = 0.18, p <
.001), and information processing accuracy (β = 0.55, SE = 0.12, p < .001), but not
information processing speed (β = -1.32, SE = 2.58, p = .61). There were no significant
total associations between childhood affective symptoms and any cognitive domains
(Table 6.6.2).
Sensitivity analysis.
The results using imputed data were similar to the models using non-imputed
data (Supplementary table 3). However, in fully adjusted models using imputed data,
there were also direct associations between adult affective symptoms and verbal fluency
as well as indirect associations mediated by CRP level.
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6.5. Discussion
Summary of findings & comparison to previous research.
This study suggests that inflammation may contribute to the link between adult
affective symptoms and midlife memory. Specifically, there were significant indirect
associations between adult affective symptoms and immediate memory and delayed
memory, mediated by CRP level at age 44. Similarly, there were significant indirect
associations between childhood affective symptoms and immediate and delayed
memory, mediated by an indirect pathway through adult affective symptoms and
subsequent CRP level. There was also a direct association between adult affective
symptoms and information processing accuracy, independent of CRP level. There were
no significant direct or indirect associations between affective symptoms and verbal
fluency or information processing speed.
These results support previous research, showing elevated levels of CRP in
chronic depression (Copeland et al., 2012). Additionally, findings from the current
study also support previous research, showing that peripheral inflammation levels can
be associated with poorer verbal memory function in healthy older adults, and that
participants with detectable CRP levels had reduced medial temporal lobe volume
(Bettcher et al., 2012). Indeed, other studies have also shown that chronically high
levels of inflammation in healthy older adults may lead to changes in brain morphology,
including reduced total grey matter volume (Satizabal, Zhu, Mazoyer, Dufouil, &
Tzourio, 2012), white matter integrity (Wersching et al., 2010), and hippocampal
volume (Satizabal et al., 2012). There is also evidence that the effects of inflammation
on brain structure can be observed during midlife (Gianaros, Marsland, Sheu, Erickson,
& Verstynen, 2013; Marsland, Gianaros, Abramowitch, Manuck, & Hariri, 2008;
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Marsland et al., 2015; Verstynen et al., 2013). Therefore, impaired midlife memory
function can be a consequence of structural brain changes accompanying chronically
elevated inflammation levels. In the current study, the absence of brain imaging data
limits interrogation of the precise biological mechanism behind the observed
associations noted here.
In contrast to the association between affective symptoms and memory, there
were only significant direct associations between adult affective symptoms and
information processing accuracy. This may be related to the differences in brain
structures that the information processing accuracy measure draws on compared to
memory measures. The inflammation hypothesis is closely linked with hippocampal
volume change, so this could potentially explain why CRP level selectively contributed
to the association between affective symptoms and memory measures, but not for other
cognitive outcomes.
Strengths and limitations.
Key strengths include the use of data from a large prospective birth cohort
followed up until age 50. Multiple measures of affective symptoms were available from
age 7 through age 50, testing the effects of persistent affective symptoms on cognitive
function, with a follow up period of more than 40 years.
However, there was only one time point in which measurements of CRP were
available in this dataset (age 44), meaning that CRP levels from earlier in the life course
could not be explored. Additionally, only one single peripheral marker of inflammation
(CRP) was used, meaning that caution should be used when interpreting these findings,
and that results should be confirmed using other large longitudinal and prospective
cohorts. There was also no brain imaging data available in this study and as such the
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neural mechanisms behind observed associations could not be tested. In addition,
measures of cognitive function were only available at one time point in this dataset (age
50), so cognitive trajectories and rate of decline over time could not be modelled in this
analysis. An additional limitation is the presence of missing data in the study. Attrition
is common in long running cohorts; however, in this study it was addressed using full
information maximum likelihood (FIML) in main analyses and multiple imputation as
an additional sensitivity analysis.
Future research & conclusions.
These findings show that inflammation may contribute to the observed
associations between accumulation of affective symptoms and memory function as early
as in midlife, a period when differences in ageing related cognitive trajectories can first
be observed prior to the presence of clinical cognitive impairment (Salthouse, 2004).
Results revealed that observed associations between adult affective symptoms and
information processing accuracy were independent of CRP level. Further research is
needed to identify the particular biological mechanisms which may underlie this
association.
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6.6. Tables & figures
Figure 6.6.1: Conceptual framework of Chapter 6
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Table 6.6.1: Demographic information about sample included in fully adjusted model (n = 6276)
Measures Mean (SD) (unless specified otherwise)
Immediate memory 6.60 (1.47)
Delayed memory 5.49 (1.82)
Verbal fluency 22.54 (6.25)
Information processing speed 333.21 (87.78)
Information processing accuracy 4.26 (3.89)
Child affective symptoms 0.03 (0.53)
Adult affective symptoms 0.05 (0.46)
Age 50 affective symptoms 0.07 (0.54)
CRP level 1.61 (1.82)
Sex
N (%)
Male 3067 (48.9)
Female 3209 (51.1)
Child SEP
N (%)
Middle 1356 (21.6)
Intermediate 2326 (37.1)
Working 2594 (41.3)
Childhood cognition Reading 24.49 (6.32)Arithmetic 5.39 (2.43)
Education
N (%)
Degree level 1626 (25.9)
Up to A Level 565 (9.0)
Up to GCSE Level 4085 (65.1)
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Table 6.6.2: Unadjusted and adjusted mediation models showing direct, indirect and total associations between child and adult affective
symptoms and mid-life cognitive outcomes
Immediate memory Delayed memory Verbal fluency Informationprocessing speed
Information
processing accuracy
Model 1: Unadjusted (N = 9292)
(X2 (1) = 10.42, p = .001; CFI =1.00; TLI =
0.97; RMSEA = 0.03)
Childhood/
adolescence
affective
symptoms
Direct 0.01 (0.03), .83 -0.02 (0.04), .59 -0.02 (0.14), .91 -2.02 (1.98), .31 0.06 (0.09), .53
Indirect (child AS -> CRP ->
cognition) 0.00 (0.002), .90 0.00 (0.003), .90 0.001 (0.01), .90 0.00 (0.01), .93 0.00 (0.001), .90
Indirect (child AS -> adult AS ->
CRP -> cognition) -0.003, (0.001), <.001 -0.004 (0.001), <.001 -0.01 (0.003), <.001 -0.004 (0.04), .91 0.001 (0.002), .40
Indirect (child AS -> adult AS ->
cognition) -0.05 (0.01), <.001 -0.04, (0.01), <.001 -0.29 (0.03), <.001 0.64 (0.40), .11 0.11 (0.02), <.001
Total direct and indirect -0.04 (0.03), .19 -0.07 (0.04), .09 -0.32 (0.14), .02 -1.39 (1.94), .47 0.17 (0.09), .06
Adulthood
affective
symptoms
Direct -0.26 (0.04), <.001 -0.24 (0.05), <.001 -1.61 (0.16), <.001 3.56 (2.22), .11 0.61 (0.10), <.001
Indirect (adult AS -> CRP ->
cognition) -0.02 (0.004), <.001 -0.02 (0.01), <.001 -0.06 (0.02), <.001 -0.02 (0.19), .91 0.01 (0.01), .40
Total -0.28, (0.04), <.001 -0.26 (0.05), <.001 -1.67 (0.16), <.001 3.53 (2.21), .11 0.62 (0.10), <.001
Model 2: Fully adjusted (N = 6276)
(X2 (3) = 1.41, p = 70; CFI =1.00; TLI = 1.00;
RMSEA = 0.00)
Childhood
affective
symptoms
Direct -0.02 (0.03), .59 -0.04 (0.04), .39 -0.03 (0.15), .86 -3.78 (2.14), .08 -0.05 (0.10), .61
Indirect (child AS -> CRP ->
cognition) 0.00 (0.002), .85 0.001 (0.002), .85 0.001 (0.004), .85 -0.01 (0.03), .85 0.00 (0.00), .94
Indirect (child AS -> adult AS ->
cognition) -0.02 (0.01), .16 -0.003 (0.01), .82 -0.06 (0.05), .21 0.63 (0.73), .39 0.07 (0.03), .03
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Immediate memory Delayed memory Verbal fluency Informationprocessing speed
Information
processing accuracy
Indirect (child AS -> adult AS ->
CRP -> cognition) -0.001 (0.00), .03 -0.001 (0.001), .03 -0.002 (0.001), .17 0.01 (0.02), .49 0.00 (0.001), .94
Total -0.05 (0.03), .12 -0.07 (0.04), .09 -0.17 (0.14), .24 -3.99 (2.10), .06 0.04 (0.10), .69
Adulthood
affective
symptoms
Direct -0.10 (0.07), .16 -0.02 (0.09), .82 -0.39 (0.31), .21 4.03 (4.63), .39 0.47 (0.21), .02
Indirect (adult AS -> CRP ->
cognition) -0.01 (0.003), .03 -0.01 (0.004), .03 -0.01 (0.01), .17 0.08 (0.11), .49 0.00 (0.01), .94
Total -0.22 (0.04), <.001 -0.24 (0.05), <.001 -0.92 (0.18), <.001 -1.32 (2.58), .61 0.55 (0.12), <.001
Sex 0.28 (0.04), <.001 0.47 (0.05), <.001 -0.05 (0.16), .74 25.09 (2.34),<.001 0.24 (0.11), .02
Education 0.25 (0.02), <.001 0.35 (0.03), <.001 1.26 (0.09), <.001 8.13 (1.39), <.001 0.11 (0.06), .08
Childhood cognition (maths) 0.06 (0.01), <.001 0.06 (0.01), <.001 0.27 (0.04), <.001 1.12 (0.54), .04 -0.05 (0.02), .05
Childhood cognition (reading) 0.03 (0.003), <.001 0.04 (0.004), <.001 0.08 (0.01), <.001 0.51 (0.21), .02 -0.04 (0.01), <.001
Childhood socioeconomic position -0.07 (0.03), <.001 -0.06 (0.03), .06 -0.67 (0.11), <.001 -2.68 (1.55), .08 0.02 (0.07), .83
Affective symptoms at age 50 -0.11 (0.06), .07 -0.20 (0.08), .01 -0.51 (0.26), .05 -5.34 (3.78), .16 0.08 (0.17), .64
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Figure 6.6.2: Flow chart to show missing data patterns
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Figure 6.6.3: Significant pathways in fully adjusted mediation model
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6.7. Supplementary material
Supplementary Table 1: Model fit for CFAs of childhood and adulthood affective
symptoms
Supplementary Table 2: Fit statistics for model stratified by sex and model which was
not stratified
Supplementary Table 3: Unadjusted and adjusted mediation models showing direct,
indirect and total associations between child and adult affective symptoms and mid-life
cognitive outcomes using imputed data
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Supplementary Table 1: Model fit for CFAs of childhood and adulthood affective symptoms.
Childhood affective symptoms Adulthood affective symptoms
X2 X2 (129) = 2167.92, p < .001 X2 (588) = 4907.10, p < .001
CFI 0.90 0.96
TLI 0.89 0.96
RMSEA 0.04 0.03
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Supplementary Table 2: Fit statistics for model stratified by sex and model which was not stratified.
X2 CFI TLI RMSEA
Model 1: Not stratified by sex X2 (1) = 10.421, p = .001 0.999 0.972 0.032
Model 2: Stratified by sex X2 (2) = 10.994, p = .004 0.999 0.973 0.031
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Supplementary Table 3: Unadjusted and adjusted mediation models showing direct, indirect and total associations between child and adult
affective symptoms and mid-life cognitive outcomes using imputed data.
Immediate
memory Delayed memory Verbal fluency
Information
processing speed
Information
processing
accuracy
Model 1: Unadjusted (N = 9377)
(X2 (1) = 9.98, p = .002; CFI = 1.00; TLI =
0.97; RMSEA = 0.03)
Childhood
affective
symptoms
Direct 0.01 (0.03), .82 -0.02 (0.04), .65 -0.02 (0.14), .90 -2.15 (1.97), .27 0.04 (0.09), .63
Indirect (child AS -> CRP -
> cognition) 0.001 (0.002), .56 0.002 (0.003), .56 0.01 (0.01), .56 0.01 (0.02), .69 -0.001 (0.001), .61
Indirect (child AS -> adult
AS -> cognition) -0.05 (0.01), <.001 -0.04 (0.01), <.001 -0.28 (0.03), <.001 0.72 (0.40), .07 0.11 (0.02), <.001
Indirect (child AS -> adult
AS -> CRP -> cognition)
-0.003 (0.001),
<.001
-0.004 (0.001),
<.001 -0.01 (0.003), <.001 -0.02 (0.03), .59 0.001 (0.001), .32
Total direct and indirect -0.04 (0.03), .22 -0.06 (0.04), .11 -0.31 (0.14), .02 -1.45 (1.93), .45 0.15 (0.09), .08
Adulthood
affective
symptoms
Direct -0.26 (0.04), <.001 -0.24 (0.05), <.001 -1.58 (0.15), <.001 4.00 (2.21), .07 0.61 (0.10), <.001
Indirect (adult AS -> CRP -
> cognition) -0.02 (0.004), <.001 -0.02 (0.01), <.001 -0.07 (0.02), <.001 -0.09 (0.17), .59 0.01 (0.01), .32
Total -0.27 (0.04), <.001 -0.26 (0.05), <.001 -1.64 (0.15), <.001 3.90 (2.20), .08 0.62 (0.10), <.001
Model 3: Fully adjusted (N = 9377)
(X2 (3) = 5.48, p = .14; CFI = 1.00; TLI =
1.00; RMSEA = 0.01)
Childhood
affective
symptoms
Direct 0.01 (0.03), .72 -0.02 (0.04), .60 0.02 (0.13), .90 -2.79 (1.94), .15 0.01 (0.09), .87
Indirect (child AS -> CRP -
> cognition) 0.001 (0.001), .46 0.001 (0.002), .46 0.003 (0.004), .47 0.001 (0.02), .93 0.00 (0.001), .73
Indirect (child AS -> adult
AS -> cognition) -0.02 (0.01), .08 -0.00 (0.01), .98 -0.14 (0.04), .002 0.34 (0.63), .59 0.05 (0.03), .08
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Indirect (child AS -> adult
AS -> CRP -> cognition) -0.001 (0.00), .01 -0.001 (0.00), .002 -0.003 (0.001), .02 -0.001 (0.02), .93 0.00 (0.001), .70
Total -0.03 (0.03), .42 -0.06 (0.04), .13 -0.16 (0.13), .22 -2.83 (1.91), .14 0.10 (0.09), .28
Adulthood
affective
symptoms
Direct -0.11 (0.07), .08 -0.002 (0.08), .98 -0.89 (0.28), .001 2.18 (4.08), .59 0.33 (0.19), .08
Indirect (adult AS -> CRP -
> cognition) -0.01 (0.002), .01 -0.01 (0.003), .002 -0.02 (0.01), .02 -0.01 (0.10), .93 0.002 (0.01), .70
Total -0.24 (0.04), <.001 -0.25 (0.05), <.001 -1.16 (0.15), <.001 -0.25 (2.25), .91 0.52 (0.10), <.001
Sex 0.30 (0.03), <.001 0.47 (0.04), <.001 0.19 (0.14), .18 24.80 (2.05), <.001 0.16 (0.09), .08
Education 0.28 (0.02), <.001 0.37 (0.02), <.001 1.32 (0.08), <.001 7.41 (1.22), <.001 0.01 (0.06), .83
Childhood cognition (maths) 0.05 (0.01), <.001 0.05 (0.01), <.001 0.24 (0.03), <.001 0.77 (0.47), .10 -0.04 (0.02), .08
Childhood cognition (reading) 0.03 (0.003), <.001 0.03 (0.004), <.001 0.07 (0.01), <.001 0.47 (0.18), .01 -0.04 (0.01), <.001
Childhood socioeconomic position -0.09 (0.02), <.001 -0.08 (0.03), .002 -0.64 (0.09), <.001 -2.03 (1.36), .14 -0.01 (0.06), .94
Affective symptoms at age 50 -0.12 (0.05), .03 -0.24 (0.07), <.001 -0.26 (0.23), .26 -2.43 (3.35), .47 0.19 (0.15), .21
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CHAPTER 7
General Discussion
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This thesis uses a life course approach to test associations between affective
symptoms from childhood through to later adulthood and cognitive function from
middle to later adulthood. Additionally, this thesis tests inflammation as a plausible
biological mechanism which may contribute to associations between affective
symptoms and cognitive function. The general discussion reviews the evidence from the
empirical studies included in this thesis, with consideration of key strengths and
limitations of the work, directions for future research and the potential implications of
these findings for research, public health, policy, and clinical practice.
7.1. Integrated summary of the research findings
All the results of the empirical chapters are included in Figure 7.6.1. Study 1, using a
meta-analytical approach for a combined sample of 68,793 people without dementia,
suggested that depression in older adulthood is significantly associated with faster
cognitive decline. At the same time, there was limited and mixed evidence regarding
associations between anxiety and cognitive decline. Study 2 used data from the National
Survey of Health and Development (NSHD), and results from linear mixed modelling
showed that affective symptoms in adolescence were associated with poorer memory
and information processing speed in midlife, but not with the rate of decline from mid
to later life. Next, results from cross lagged models in Study 3, also using NSHD data,
showed that affective symptoms predicted poorer memory and information processing
speed over a period of 16 years from middle to late adulthood. However, this
association was not operated in the opposite direction and cognitive function at ages 53
and 60-64 did not predict subsequent level of affective symptoms. Study 4 used data
from the National Child Development Study (NCDS) and results from a structured
modelling approach revealed that persistent affective symptoms accumulating across
adulthood were a better predictor of midlife memory function than particular sensitive
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periods at ages 23, 33-42, and 50. Moreover, growth mixture modelling showed that
there were five key longitudinal trajectories of adult affective symptoms, with the
trajectories with more experience of affective symptoms showing worse memory, but
not information processing speed, at age 50. Finally, Study 5 employed a mediation
modelling technique using data from NCDS, and revealed that C-Reactive Protein
(CRP), a marker of inflammation, mediated associations between affective symptoms
and midlife memory function. This suggested that inflammatory pathways could be an
important biological mechanism underlying observed associations.
Studies 2-5 focused on four different cognitive domains: verbal memory, verbal
fluency, information processing speed, and information processing accuracy. The
strongest effects of affective symptoms were observed on memory function, with
inconsistent evidence for other cognitive domains, including verbal fluency, information
processing speed and information processing accuracy. It is possible that associations
between affective symptoms and information processing speed may not emerge until
later in the life course. This is supported by Studies 4 and 5 using data from NCDS,
which showed no associations between affective symptoms from early to midlife and
information processing speed in midlife. This is consistent with evidence from Study 3
using data from NSHD, which showed that affective symptoms predicted subsequent
information processing speed in early old age (in this cohort, age 69), but not in midlife
(in this cohort, age 53). Taken together, this suggests that effects of affective symptoms
can be observed on memory function as early as in midlife, but that effects on
information processing speed cannot be observed until early old age.
Taken together, these findings suggest that chronic and persistent affective symptoms
across the life course play an important but complex role in contributing to cognitive
function across mid to later life, with particularly strong effects observed on memory
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function. In addition, inflammation may be one important explanatory mediator of the
association between affective symptoms and midlife memory function.
7.2. Methodological considerations
The studies included in the present thesis are subject to several key strengths and
limitations which must be acknowledged and taken into account when interpreting and
generalising the findings.
Key strengths of the empirical studies included in this thesis are the use of rich
longitudinal data available from the British birth cohorts. Specifically, data were
prospectively measured with long periods of follow up from birth through to midlife
(most recent data used at age 50) in the National Child Development Study (NCDS) and
through to older adulthood (most recent data used at age 69) in the National Survey of
Health and Development (NSHD). These long follow up periods meant that a life
course approach could be used to explore associations between affective symptoms and
cognitive ageing, taking earlier life influences from childhood, adolescence and
adulthood into account.
Additionally, the empirical work of this study benefits from the use of two different
cohort studies with different complementary strengths. Specifically, four repeated
measures of affective symptoms were available across early adulthood to midlife in
NCDS. This allowed for effective modelling of adult affective symptoms across this
period of life. Strengths of NSHD are the long period of follow up, from birth through
to age 69. Measures of affective symptoms were available across adolescence to later
life, with consistent assessment used across three time-points in midlife to later age.
NSHD also includes measures of cognitive function in childhood, as well as repeated
assessments of cognitive function across mid to later life. In addition to this, both
225
NSHD and NCDS also included a wealth of information about other factors which may
play an important role in the association between affective symptoms and cognitive
ageing, including sex, socioeconomic position, educational attainment, and emotional
adjustment in childhood, meaning that these factors could be taken into account in
statistical analyses.
However, there are also important limitations of this empirical work, which should
be noted and considered when interpreting conclusions. In particular, issues of attrition
are very common in long running birth cohort resources. Indeed, missing data is present
in both NCDS and NSHD, which may have an important influence on findings. In this
thesis, missing data has been explored in depth to test how participants with missing
data differ from those with complete data on key variables. Next, missing data was dealt
with using various statistical techniques, including full information maximum
likelihood (FIML) (Enders, 2001b, 2001a; Enders & Bandalos, 2001) and multiple
imputation (Azur et al., 2011; Buuren & Groothuis-Oudshoorn, 2011).
Findings from the two cohorts used in this thesis cannot necessarily be directly
compared to one another. Specifically, differences in study design, measures used, and
ages of assessment may render results from these two cohorts incomparable with each
other. Careful harmonisation of data in these cohorts is necessary in order to test
whether differences observed in results across cohorts are a consequence of real cohort
effects or simply measurement differences. In addition, due to the observational nature
of this data, causality between variables cannot be determined, and only associations
can be inferred. In order to establish causality between affective symptoms and
cognitive ageing, more complex causal inference statistical techniques are needed.
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Moreover, these studies are also limited, albeit necessarily so, by the cognitive data
available in the datasets. For example, in NCDS there is only one time point available in
adulthood with cognitive data (age 50), meaning that cognitive trajectories across
adulthood could not be modelled. In addition to this, both NCDS and NSHD have
cognitive data for select cognitive domains (memory and information processing speed
in NSHD and memory, information processing, and verbal fluency in NCDS), meaning
associations between affective symptoms and other cognitive domains, such as attention
or executive function, could not be estimated. However, memory and information
processing are both clinically relevant cognitive domains, and as such associations
between affective symptoms and these cognitive functions hold particular importance.
Beyond being limited in breadth, these cognitive assessments may also be limited in
depth, as single tests are used to capture these functions (word recall test for memory,
letter cancellation for information processing, and animal naming task for verbal
fluency), rather than a more comprehensive cognitive battery. Reliance on these limited
neuropsychological measures available in the data may have had an important influence
on the results. For example, people with affective symptoms may have less motivation
to perform well in these cognitive tests, and as such may show lower scores than people
without affective symptoms, even if underlying cognitive processes are normal. The
results across this thesis attempt to partially deal with this issue by taking into account
history of affective symptoms across the life course from childhood through to early old
age, instead of considering cross-sectional associations between cognitive function and
contemporaneous affective symptoms.
Finally, although childhood cognitive function was included in the statistical
analyses in this thesis, this does not completely eliminate the possibility of reverse
causality. These limitations of the data for cognitive function are addressed in part by
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the use of two different complementary cohorts with different strengths and
weaknesses, using the cohort which is the best match for the particular research
questions.
In addition to this, limitations of the available data for affective symptoms should
also be acknowledged. In NCDS, the measures used to capture affective symptoms in
childhood were not consistent with those in adulthood, and in some cases relied on
parent or teacher report rather than direct reports from the cohort member. The Malaise
Inventory Scale was used across early to mid-adulthood to measure affective symptoms.
However, this is a generic instrument designed to assess overall psychological distress,
and as such individual effects of depression and anxiety could not be disentangled. In
NSHD, the measures used to assess affective symptoms varied over time, with
consistent measures available only across mid to later life. Evidence suggests that there
is low content overlap between different measures of affective symptoms, and that
scales capture largely different symptoms (Fried, 2017). For this reason, different types
of symptoms may be captured across the life course in NSHD, due to the different
scales used, limiting the continuity of how the construct of affective symptoms over the
time is measured.
Additionally, limitations of the biomedical data used for this thesis from NCDS must
also be noted. Specifically, in the final study, a measure of C-reactive protein (CRP)
provided a proxy measure of inflammation, however this was a single biomarker of
inflammation measured at one time point during midlife. As such, these preliminary
results should be interpreted with all due caution, and results should be replicated in
other long running cohort studies. Beyond this, neuroimaging data were not used to
explore the neurological mechanisms which may underlie potential associations
between affective symptoms, cognitive ageing and inflammatory processes. Finally,
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only inflammation was considered as a potential explanatory pathway in this study,
meaning that other possible biological and socio-behavioural mechanisms, such as
cortisol, vascular factors, education, socioeconomic position, and many others, were not
considered.
7.3. Competing explanatory hypotheses and plausible mechanisms
7.3.1. Competing explanatory hypotheses.
There are several competing hypotheses to explain associations between affective
symptoms and cognitive ageing. These possibilities are not mutually exclusive, and it is
possible, even likely, that more than one may be operating simultaneously (Bennett &
Thomas, 2014).
One possibility is that affective symptoms can emerge as a consequence of subjective
awareness of cognitive decline or as a psychological reaction to cognitive deficits
(Bennett & Thomas, 2014; Vinkers et al., 2004). Results from study 3 in the present
thesis do not support this hypothesis, as findings showed that this association was not
bidirectional in nature and that affective symptoms can predict subsequent cognitive
performance, but not vice versa.
Another possibility is that affective symptoms can be a prodromal symptom of
oncoming cognitive impairment (Bennett & Thomas, 2014). Results from study 2 and 4
suggest that it is unlikely that the prodromal hypothesis is acting in isolation.
Specifically, both of these studies highlight the importance of affective symptoms
present early in the life course across adolescence and early adulthood in predicting
later cognitive function, in the absence of dementia or cognitive impairment. Although
there is a long preclinical period of dementia, it is unlikely that prodromal symptoms
could be apparent this early in the life course. This does not necessarily rule out the
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prodromal hypothesis, but suggests that this is not the sole explanation of observed
associations between affective symptoms and cognitive ageing.
The next possibility is that affective symptoms can act as a causal risk factor for
poorer cognitive outcomes. Alternatively, affective symptoms and cognitive decline
may both be caused by some other common cause mechanism (Bennett & Thomas,
2014). The studies in this thesis cannot adequately distinguish between these two
possibilities. Findings from all the empirical studies show that there is an association
between affective symptoms over the life course and cognitive outcomes, but it is not
clear whether this link is causal in nature or whether another factor may be causing
both. Causal inference statistical methods are needed in order to differentiate between
these hypotheses. For example, causality could potentially be tested using techniques
like Mendelian randomisation (Davey Smith & Ebrahim, 2003, 2004; Davey Smith &
Hemani, 2014; Lawlor, Harbord, Sterne, Timpson, & Davey Smith, 2008), using
genetic variants that have been associated with affective symptoms as a proxy variable
to predict cognitive outcomes. This is beyond the scope of the present thesis.
7.3.2. Plausible socio-behavioural and biological mechanisms.
To date, there has been relatively limited evidence surrounding the particular
mechanisms which may underlie associations between affective symptoms over the life
course and cognitive ageing. It is likely that multiple biological and socio-behavioural
processes may be operating simultaneously and interacting with one another in a
complex and multifaceted way, resulting in observed associations between affective
symptoms and cognitive outcomes.
It is possible that socioeconomic position may influence and contribute to
associations between affective symptoms and cognitive ageing. Evidence suggests that
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socioeconomic position can act as an important predictor of depression, whereby
individuals with a lower socioeconomic position have a higher risk of depression
(Lorant et al., 2003). In addition, socioeconomic position can have an influence on the
rate of late-life cognitive decline as well as transition to cognitive conditions, such as
dementia (Cerhan et al., 1998; Kaplan et al., 2001; Stern et al., 1994; Zeki Al Hazzouri
et al., 2011). For example, according to Turrell et al (2002) cognitive function during
later life is also likely sensitive to changes in socioeconomic position throughout the life
course (social mobility) as well as cumulative disadvantage over time. Due to the
association of socioeconomic position with both affective problems and with late-life
cognitive health, it is plausible that socioeconomic position may act as an important
common cause mechanism between the two. It was beyond the scope of the current
thesis to thoroughly investigate how socioeconomic position might influence observed
associations between affective symptoms and cognitive ageing. Therefore, this is an
important question to be addressed in future research.
It has also been suggested that educational attainment can play an important role in
the association between affective symptoms and cognitive ageing. Specifically, some
research has shown that depression is associated with increased risk of Alzheimer’s
disease, but only in individuals with higher levels of education, suggesting that
education may be an important moderator in this association (Geerlings et al., 2000).
Unfortunately, this study only looked at late-onset depression, so it remains unclear
whether education can underlie associations between affective symptoms present earlier
in the life course and cognitive ageing.
Health behaviours may also play an important role in the association between
affective symptoms and cognitive ageing. For example, research shows a bidirectional
association whereby limited physical activity may increase affective symptoms and
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affective symptoms may lead to greater levels of inactivity (Strawbridge, Deleger,
Roberts, & Kaplan, 2002). In addition to this, Richards et al (2003) reported a protective
effect of regular physical activity from earlier in life on memory performance in mid-
life. Due to its association with both affective symptoms and cognitive ageing, physical
activity may act as a protective pathway in the relationship between the two.
Biological mechanisms which may underlie associations between affective
symptoms and cognitive ageing are also of interest. One primary pathway between
affective symptoms and cognitive function which has been hypothesised is elevated
cortisol and subsequent hippocampal atrophy. Specifically, affective symptoms disrupt
functionality of the hypothalamic pituitary adrenal (HPA) axis and lead to increased
secretion of glucocorticoids, impaired negative feedback, and changes in homeostatic
regulation. Ultimately, chronically elevated levels of glucocorticoids
(hypercortisolemia) can contribute to hippocampal atrophy, which is an early
neuropathological feature of Alzheimer’s disease and cognitive impairment (Butters et
al., 2008; Byers & Yaffe, 2011). This possibility is supported by studies showing
smaller hippocampal volumes in participants with later life depression (Videbech &
Ravnkilde, 2004), as well as other studies demonstrating an association between
lifetime depression and hippocampal atrophy (Bell-McGinty et al., 2002; Janssen et al.,
2007; Sheline, 1996; Sheline et al., 2003; Sheline, Sanghavi, Mintun, & Gado, 1999). If
affective symptoms contribute to higher cortisol levels, leading to disruption of
structure and function of the hippocampus, this can ultimately result in observable
cognitive impairments, particularly in memory function (Butters et al., 2008).
Chronic inflammation may also play an important role in the association between
affective symptoms and cognitive ageing. Byers & Yaffe (2011) propose that
inflammatory changes in the central nervous system may be involved in the depression-
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dementia association in two different ways. Firstly, depression is associated with an
increase in cytokines, which are important in brain development and in promoting
healthy brain function (Yirmiya & Goshen, 2011). This increase may then subsequently
result in reduced anti-inflammatory and immunosuppressant regulation and increased
CNS pro-inflammatory changes, both of which predict transition to dementia (Sorrells
& Sapolsky, 2007; Yaffe et al., 2003). The second possible pathway is that pro-
inflammatory cytokines may disrupt metabolism of serotonin, decreasing hippocampus
neurogenesis and synaptic plasticity, and as a result leading to subsequent dementia and
late-life cognitive impairment (Caraci et al., 2010; Maes et al., 2009).
There is also evidence that vascular function may be involved in the association
between affective problems and cognitive ageing. The vascular depression hypothesis
states that cerebrovascular disease can work to predispose, trigger and maintain
depressive symptoms in later life (Alexopoulos, 2003, 2005). There has been some
suggestion that a reciprocal relationship between vascular disease and depression may
exist, whereby each condition is related to a higher risk of subsequently developing the
other (Alexopoulos, 2006; Alexopoulos et al., 1997; Newberg et al., 2006), through
biological and behavioural pathways. In addition to this, vascular disease may also be
involved in the presentation of late-life cognitive conditions, such as dementia (Snyder
et al., 2015; Zlokovic, 2002). This may occur through ischemic damage in frontostriatal
brain areas, resulting in impaired delivery of nutrients and elimination of toxins, and
impairments in cognitive function. It is therefore reasonable to propose vascular disease
and associated ischemic structural brain changes as potential mechanisms underlying
the association between depression and dementia (Byers & Yaffe, 2011).
One particular area of interest is the interaction between affective problems and
specific genes in relation to cognitive ageing. The strongest and most extensively
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studied genetic risk factor for dementia is the apolipoprotein ε4 allele (APOE4) (Huang,
2010). Several studies have considered the association between affective problems and
late-life cognitive health with reference to the APOE4 genotype. Two studies reported a
significant interaction between APOE4 allele and late-onset depression, whereby only
participants with both risk exposures (APOE4 and depression) had an increased risk of
the subsequent development of dementia (Irie et al., 2008; Kim et al., 2010). This
finding has not been consistently replicated, however, with two studies reporting no
significant interaction (Meng & D’arcy, 2013; Steffens et al., 1997). It is worth noting
however, that although not significant, the pattern of results in these two studies was
similar. It is also possible that the temporal relationship between affective problems and
dementia may be important for interaction with the APOE4 allele. Karlsson et al (2015),
for example, reported that age of onset of depression influences its interaction between
APOE4 allele and risk of subsequent dementia. Specifically, late-life depression
increased risk of dementia irrespective of APOE4, whereas remote early-onset
depression (more than 10 years interval between depression and dementia) predicted
risk for subsequent dementia in APOE4 carriers only. These findings demonstrate the
multifaceted and complex nature of the temporal relationship between depression and
cognitive ageing, especially with consideration of the role of genetic risk in this
association.
7.4. Future research and implications
7.4.1. Directions for future research.
Future research should focus on testing the biological and socio-behavioural
mechanisms and pathways which can potentially underlie associations between
affective symptoms and cognitive ageing. Specifically, future research could extend our
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findings on the role of inflammation in the association between affective symptoms and
cognitive function by replicating these findings using multiple biomarkers for
inflammation across different stages of the life course. Beyond this, future research
should investigate other important potential mechanisms, including the role of
glucocorticoids, vascular factors, nerve growth factors, in associations between affective
symptoms and cognitive ageing. Research should make use of the rich genetic,
biomedical, and neuroimaging data available in long running longitudinal cohort studies
in order to clarify these longitudinal life course associations.
The findings reported in this thesis suggest that accumulation of affective symptoms
over the life course are associated with subsequent cognitive ageing outcomes. An
important avenue for future research is therefore to investigate whether effective
management and treatment of affective disorders to prevent recurrence can contribute to
a reduced risk of poorer cognitive outcomes in later life. Additionally, results from this
thesis show that affective symptoms present during adolescence may have particular
importance in predicting later cognitive health. Future research could test whether early
intervention to manage affective symptoms during this adolescent period to prevent
continuation of affective disorders into adulthood can have long lasting effects on
cognitive health into older adulthood. Beyond this, it is unclear whether different
methods of treating affective disorders (i.e. medication, talking therapies, or
combination treatment) can have differential effects on risk reduction for subsequently
poorer cognitive function. Future research should therefore focus on testing how
different treatment approaches affect later cognitive health.
Additionally, future research could test how particular features of affective
symptoms are associated with cognitive outcomes. For example, it is possible that
different types of symptoms (mood symptoms, somatic symptoms, social symptoms
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etc.) may be differentially associated with cognitive function. Future research should
test whether certain categories of symptoms are closely linked with cognitive health. In
addition, Evidence has shown that comorbid depression and anxiety is associated with
higher symptom burden, increased persistence, and poorer functional outcomes than
either of these disorders in isolation (Kaufman & Charney, 2000; Roy-Byrne et al.,
2000). As such, it is important for future research to test how comorbidity between
depression and anxiety over the life course can affect cognitive health.
7.4.2. Implications.
Findings from the thesis improve our knowledge of associations of affective
symptoms over the life course with cognitive ageing. These findings have important
implications for research, public health, policy, and clinical practice, specifically
through potential for identifying individuals who may be at a greater risk of cognitive
deficits later in life. Understanding life course associations between affective symptoms
and cognitive function can help in the development of better predictive models for
dementia and cognitive ageing outcomes. Effective predictive models are critical for the
development of preventative intervention efforts.
In addition, results also showed that cognitive differences in individuals with
persistent affective problems can already be observed as early as midlife. This may have
important implications, as this period in which cognitive differences can be observed in
the absence of dementia pathology represents an important window to target for
prevention and early intervention efforts. Findings also highlight that affective
symptoms during adolescence may play a particularly important role in later cognitive
function. Given the high and rapidly increasing prevalence of mental health disorders
during adolescence (Fink et al., 2015; Patalay & Fitzsimons, 2017), these findings
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suggest that early intervention to tackle mental health problems which emerge early in
the life course may be key in protecting future cognitive health.
Overall, results from this thesis show that affective symptoms over the life course are
associated with cognitive ageing outcomes. This therefore raises the possibility that
early intervention to prevent and manage affective disorders may have important
implications for reducing risk of poorer cognitive outcomes, though further research is
needed to formally test this possibility. Specifically, based on these findings it is
possible that effective management of affective symptoms may help to maintain better
cognitive health for longer. In addition, results suggest that individuals who present
with affective disorders, particularly in older age, may benefit from careful monitoring
of cognitive status, because these individuals may be at greater risk of poorer cognitive
outcomes. Given the expected increases in average life expectancy increases in the UK
and the negative individual, social, and economic costs associated with poorer cognitive
ageing, all research into potentially modifiable risk factors, such as affective symptoms,
is increasingly important for the health policy development and for promotion of
healthy cognitive ageing.
7.5. Conclusions
In conclusion, five studies included in the thesis provide strong evidence that
affective symptoms across the life course are associated with poorer cognitive ageing
outcomes from middle to later adulthood, particularly on memory functions.
Specifically, affective symptoms in older adulthood are associated with a faster
subsequent cognitive decline, whereas affective disorders in adolescence are associated
with poorer cognitive function in midlife, but not rate of decline over time. Affective
symptoms can predict later cognitive function across mid to later adulthood, but the
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association does not operate in the opposite direction. Persistent and accumulating
affective symptoms across early to mid-adulthood are associated with poorer memory
function in midlife, but associations with information processing speed may not emerge
until later in the life course. Finally, associations between affective symptoms and
memory function may be mediated by inflammatory pathways, as measured by CRP in
citrated plasma. These results highlight the importance of life course affective
symptoms in the context of cognitive ageing. Given the rapidly ageing population, this
research area is increasingly important for the development of better predictive models
and to design better preventative intervention strategies. Future research should focus
on the particular biological and socio-behavioural mechanisms which underlie
associations between affective symptoms and cognitive function, and importantly
whether effective treatment of affective disorders at key points during the life course
can affect cognitive ageing outcomes.
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7.6. Tables and figures
Figure 7.6.1: Results of all empirical studies
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